syndrome	score	normalized_score
DRAVET SYNDROME	2.8321856999999997	100.0
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.02066968	71.3466521633804
BIRDSHOT CHORIORETINOPATHY	2.00826446	70.90864345512374
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	70.61683843682991
CHILDHOOD ABSENCE EPILEPSY	1.52074085	53.69495545436869
PITUITARY APOPLEXY	1.38049451	48.74307888780034
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	1.3206216539999998	46.62906298834854
PERIPHERAL CONE DYSTROPHY	1.25	44.13552402301869
DIGEORGE SYNDROME; DGS	1.226615373	43.30984980963643
MYOCLONIC-ASTASTIC EPILEPSY	1.219235154	43.049265943260714
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	42.147448170506614
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15814036	40.89210534464601
TURCOT SYNDROME WITH POLYPOSIS	1.111111	39.23157298619226
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	1.0781868099999998	38.069071883245506
RETINITIS PIGMENTOSA 75; RP75	1.0666667	37.66231500992326
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	1.066017619	37.639396985868544
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.02930401	36.343097488275575
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.0291128189999998	36.336346836296784
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.0149112699999998	35.83491259065392
MOWAT-WILSON SYNDROME; MOWS	1.010261329	35.67073052448503
IDIOPATHIC INTRACRANIAL HYPERTENSION	1.00826446	35.60022423670877
EHLERS-DANLOS SYNDROME, TYPE I	1.0	35.308419218414954
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	35.308419218414954
BROWN SYNDROME	1.0	35.308419218414954
STRABISMUS, SUSCEPTIBILITY TO	1.0	35.308419218414954
LEBER CONGENITAL AMAUROSIS 17	1.0	35.308419218414954
MYOCLONIC EPILEPSY OF LAFORA	0.94270522	33.2854311071481
CRANIOPHARYNGIOMA	0.798843373	28.205896703736627
LAFORA DISEASE	0.78194566	27.60926516930017
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.77869296	27.494417474108428
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	27.2092716236792
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	26.431139878998756
MENINGIOMA	0.735725	25.97728672946834
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.7214750139999999	25.474142249923798
EARLY MYOCLONIC ENCEPHALOPATHY	0.720372604	25.435217895493228
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.69182474	24.42723794559093
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.6877593499999999	24.283695451184574
ROLANDIC EPILEPSY	0.6114546	21.589495349828226
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.61096717	21.572284967048596
COG4-CDG	0.596351694	21.056235613363913
TSH-SECRETING PITUITARY ADENOMA	0.595264119	21.017835059332445
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5939684000000001	20.97208526969118
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.5893574	20.80927814867507
MUCOPOLYSACCHARIDOSIS TYPE 2	0.588586973	20.782075589181883
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.58524564	20.66409840286956
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.5797020500000001	20.46836300317455
SPINOCEREBELLAR ATAXIA TYPE 10	0.5755583	20.32205374103824
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.568346009	20.067399146885037
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.558844	19.731898229695886
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	19.61579002393805
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.550180064	19.42598834532637
PLACENTAL INSUFFICIENCY	0.53522694	18.89801717450943
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	18.831145147014904
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	18.60849025542358
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.521519964	18.414045519684674
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.519276729	18.334840437899256
INHALATIONAL ANTHRAX	0.5172414	18.262976188319854
PERSISTENT PLACOID MACULOPATHY	0.5133333	18.12498735517237
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.5129803690000001	18.1125259194692
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5121951	18.08479931241797
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.507604834	17.922724276165933
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	17.902860324448362
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.5027009	17.749574118674495
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.5023323030000001	17.73655954127585
RESTRICTIVE DERMOPATHY	0.50189394	17.721081636702003
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.501086973	17.692588907570578
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	17.654209609207477
PAROXYSMAL HEMICRANIA	0.5	17.654209609207477
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.5	17.654209609207477
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	17.654209609207477
CREST SYNDROME	0.5	17.654209609207477
PAPILLARY TUMOR OF THE PINEAL REGION	0.5	17.654209609207477
PINEOCYTOMA	0.5	17.654209609207477
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.5	17.654209609207477
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.47239697999999997	16.679590607353184
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.468482674	16.541382650156027
PINEOBLASTOMA	0.464368929	16.39613281713837
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.4519231	15.956690269285664
NELSON SYNDROME	0.4519231	15.956690269285664
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.442944399	15.639666530340863
CONGENITAL MYASTHENIC SYNDROME	0.442944399	15.639666530340863
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.43686985000000006	15.42518380768606
JUVENILE GLAUCOMA	0.43124969999999996	15.226745195415683
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.42581059400000004	15.03469896059429
DUANE RETRACTION SYNDROME 1	0.42514088	15.011052417925846
ACUTE BILIRUBIN ENCEPHALOPATHY	0.422764019	14.927129213313945
DUANE-RADIAL RAY SYNDROME; DRRS	0.41791163	14.75579902829112
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.4095316	14.459913415988227
NON-DISTAL MONOSOMY 20Q	0.401688479	14.18298521173947
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.37351413	13.188193486041541
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.368045154	12.99509258873809
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	12.872034132507626
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.364298264	12.862795825852805
LEBER HEREDITARY OPTIC NEUROPATHY	0.3581731	12.646525967559263
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.357688054	12.629399760051047
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	12.623383417266743
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	12.623383417266743
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.35592553400000004	12.567167965010206
CENTRALOPATHIC EPILEPSY	0.35470090000000004	12.523928074349083
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.34778266	12.279655956175475
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.347573019	12.272253863862105
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.347573019	12.272253863862105
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34726515999999996	12.261383849229942
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.34605429	12.21862994365094
OROFACIODIGITAL SYNDROME TYPE 3	0.3455281	12.200051006542404
PROLACTINOMA	0.345264119	12.190730254728708
NON-FUNCTIONING PITUITARY ADENOMA	0.345264119	12.190730254728708
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.34410233	12.149709321673365
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.34180758	12.068685326671908
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34173636	12.066170661055173
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.34037525	12.018112018572795
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.018112018572795
SPINOCEREBELLAR ATAXIA TYPE 42	0.33457833	11.81343193703718
ELSAHY-WATERS SYNDROME; ESWS	0.333878554	11.788723952670194
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	11.769461303331912
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	11.769461303331912
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	11.769461303331912
GLAUCOMA 1, OPEN ANGLE, F; GLC1F	0.333333	11.769461303331912
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.33194444	11.72043344474199
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.32399069	11.439599105383524
XQ21 MICRODELETION SYNDROME	0.318999003	11.26335052818041
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	10.637770468228831
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.2991457	10.562361782986194
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.29177275	10.302034573509783
OPTIC ATROPHY 1; OPA1	0.28798984	10.168466001364248
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.28798984	10.168466001364248
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.2849752	10.062023828451645
RETINAL CAPILLARY MALFORMATION	0.283056	9.994259910287663
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.282337273	9.968882796068069
NARP SYNDROME	0.278387673	9.829428663523018
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27616419	9.750920993633997
MARFAN SYNDROME; MFS	0.27066968	9.556918531154226
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.26912256	9.502292169613032
WILLIAMS-BEUREN SYNDROME; WBS	0.26769955999999995	9.452048289065225
RETINOSCHISIS OF FOVEA	0.26520889999999997	9.36410702165469
SLC35A2-CDG	0.26463345399999993	9.343788933049128
ALLAN-HERNDON-DUDLEY SYNDROME	0.26322136	9.293930126121323
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.26013600000000003	9.184990941801594
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.2599044	9.176813511910607
HYPEREKPLEXIA 1; HKPX1	0.25925926	9.15403463833604
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25847458	9.126328827943734
CATARACT 7; CTRCT7	0.25826446	9.11890982289756
UVEAL MELANOMA	0.25826446	9.11890982289756
NEOVASCULAR GLAUCOMA	0.25826446	9.11890982289756
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.257686639	9.098507876796356
TRICHOTHIODYSTROPHY	0.25696008400000003	9.072854368271122
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.256097019	9.042380907438378
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.256035929	9.040223916108326
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.025889580616132
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.25549451	9.021107267083513
OPTIC ATROPHY 9; OPA9	0.25549451	9.021107267083513
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.25541804900000004	9.018407550041655
PALLISTER-HALL SYNDROME	0.252439494	8.913239481436547
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.250545554	8.846367453942023
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.250541419	8.846221453628553
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.250541419	8.846221453628553
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	0.25	8.827104804603739
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	8.827104804603739
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	8.827104804603739
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	8.827104804603739
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24444441	8.630945703878105
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.244048764	8.616976069048016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	8.581540186436223
RETINITIS PUNCTATA ALBESCENS	0.2366153	8.35451220589102
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.211725311655941
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.230957884	8.154757790070052
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	7.977201141860156
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.22359056300000002	7.894629331685421
POLYARTERITIS NODOSA	0.2208333	7.797274733785995
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.21720738000000003	7.669249230373561
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.21561073400000003	7.612874184062155
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.213878854	7.551724238986167
PITUITARY CARCINOMA	0.21382781	7.549921956035581
USHER SYNDROME TYPE 3	0.21096707000000003	7.448913748840694
CRI-DU-CHAT SYNDROME	0.21070892000000002	7.43979888041946
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20986120000000003	7.409867227279625
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20900901000000002	7.379777745505884
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.20847458000000002	7.360907867022987
RETINITIS PIGMENTOSA 18	0.2083333	7.355919493555809
SLC39A8-CDG	0.206728199	7.299245914559911
JUVENILE MYOCLONIC EPILEPSY	0.2042519	7.211811711357768
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.20416972	7.208910065466401
USHER SYNDROME TYPE 1	0.20250361400000003	7.1500824963560845
PREECLAMPSIA/ECLAMPSIA 1	0.202435359	7.147672520202331
LINEAR VERRUCOUS NEVUS SYNDROME	0.20178674900000002	7.124771126413075
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.201086973	7.10006314204609
TRANSALDOLASE DEFICIENCY	0.20054555400000001	7.080946493021274
ROMANO-WARD SYNDROME	0.200541419	7.080800492707806
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.200541419	7.080800492707806
EPISODIC ATAXIA, TYPE 4	0.2	7.0616838436829905
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.0616838436829905
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	7.0616838436829905
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2	7.0616838436829905
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.0616838436829905
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.2	7.0616838436829905
HELLP SYNDROME	0.2	7.0616838436829905
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.0616838436829905
MALARIA	0.2	7.0616838436829905
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	7.0616838436829905
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.0616838436829905
CARPENTER SYNDROME	0.2	7.0616838436829905
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.2	7.0616838436829905
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.0616838436829905
BENIGN SCHWANNOMA	0.2	7.0616838436829905
UNILATERAL POLYMICROGYRIA	0.19630751000000002	6.931307858803186
ADNP SYNDROME	0.191612939	6.765549977884573
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18213795400000002	6.43100323541638
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.400915519063599
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.400915519063599
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.17785471399999997	6.279768801883294
RIFT VALLEY FEVER	0.17547247900000001	6.195655849826515
USHER SYNDROME TYPE 2	0.17493106000000003	6.176539200801701
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.174899193	6.175414027406466
MUCOLIPIDOSIS TYPE II	0.17407441	6.1462922434782445
MACULAR CORNEAL DYSTROPHY	0.173611	6.129929968928238
CEREBROOCULONASAL SYNDROME	0.17269110000000001	6.09744975408922
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.17266915	6.096674734287374
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.017598139839489
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.16971255000000002	5.99228186202621
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.16876496000000002	5.958823957059032
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.16876496000000002	5.958823957059032
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.168435409	5.947188032197183
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.167753973	5.923127604238664
SPINOCEREBELLAR ATAXIA TYPE 13	0.167753973	5.923127604238664
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.167208419	5.90386495490038
POSTENCEPHALITIC PARKINSONISM	0.167208419	5.90386495490038
DERMATOLEUKODYSTROPHY	0.166667	5.884748305875565
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	5.884748305875565
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	5.884748305875565
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.166667	5.884748305875565
MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	0.166667	5.884748305875565
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.161921074	5.71717716108799
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.158117219	5.582869054101926
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.156639614	5.530697157322701
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.469163056645614
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.153907144	5.434217961060957
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.150545654	5.315529062942447
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.241651350757121
JOUBERT SYNDROME 5	0.14769169000000001	5.214760105596184
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.145189303	5.126404776353471
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.14498452300000003	5.119174318265926
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14464788399999998	5.107288127328656
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.14394397299999998	5.082434142648203
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.14353632000000002	5.068040559628559
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.044054844285105
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.044054844285105
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.139244154	4.916490963145532
XP21 MICRODELETION SYNDROME	0.137080583	4.840098691268727
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.13248749999999998	4.67792419119975
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13133251399999998	4.637143461320351
CONE-ROD DYSTROPHY 2	0.13071191	4.615230915119725
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.13015825	4.595682055735258
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.129721224	4.580251358517911
RETINITIS PIGMENTOSA 58	0.1291667	4.560671992659239
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.12824465	4.528115864718899
LISSENCEPHALY, X-LINKED, 2	0.128223419	4.527366231670473
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.127020933	4.4849083518781985
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.12677254400000001	4.476138128936956
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.126768409	4.475992128623487
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.126718313	4.474223318054322
GLYCOGEN STORAGE DISEASE II	0.12622699	4.456875479598673
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.125620063	4.435445846647697
HURLER SYNDROME	0.125545554	4.432815051640153
PHENYLKETONURIA	0.125541419	4.432669051326684
THORACOLARYNGOPELVIC DYSPLASIA	0.125	4.413552402301869
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.125	4.413552402301869
ADENOHYPOPHYSITIS	0.125	4.413552402301869
PANHYPOPHYSITIS	0.125	4.413552402301869
SHEEHAN SYNDROME	0.125	4.413552402301869
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.125	4.413552402301869
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.125	4.413552402301869
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.125	4.413552402301869
CENTRAL PRECOCIOUS PUBERTY	0.125	4.413552402301869
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.12480951000000001	4.406826501524954
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.12437784399999999	4.391585057434617
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.122614673	4.329330276612866
SCHINZEL-GIEDION SYNDROME	0.12072416000000001	4.262579251071003
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.11953011	4.220419233103254
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.11934559	4.213904123589072
COG8-CDG	0.11905982899999999	4.203814354404798
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.191067132356469
W SYNDROME	0.11869880399999999	4.191067132356469
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.171804483018186
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.117676519	4.1549718650157725
FOVEAL HYPOPLASIA 2; FVH2	0.11660550999999998	4.117156230257076
DDOST-CDG	0.11371689900000001	4.015163942110153
BILATERAL POLYMICROGYRIA	0.113135344	3.9946301543715865
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.11290198400000002	3.9863905816627785
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.11287940899999999	3.9855934940989215
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.11235632999999999	3.9671244014825726
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.11235632999999999	3.9671244014825726
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.11219797299999999	3.961533066140402
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.112057244	3.956564147612214
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.11165655399999999	3.942416417115587
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11165241899999999	3.9422704168021183
GANGLIOCYTOMA	0.11111110000000002	3.9231572986192265
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11111099999999999	3.9231537677773036
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11111099999999999	3.9231537677773036
MUCOLIPIDOSIS III ALPHA/BETA	0.11111099999999999	3.9231537677773036
MYOTONIA, POTASSIUM-AGGRAVATED	0.11111099999999999	3.9231537677773036
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.11111099999999999	3.9231537677773036
SUDDEN INFANT DEATH SYNDROME	0.11111099999999999	3.9231537677773036
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.10903684000000001	3.8499184569712366
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.10887481899999998	3.8441977515810493
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.108691154	3.8377128307653
TRICHOHEPATOENTERIC SYNDROME 1	0.10822884	3.8213892542427574
OPTIC ATROPHY 5; OPA5	0.10817310000000001	3.8194211629555235
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.10768421900000001	3.8021595476596053
RING CHROMOSOME 7 SYNDROME	0.10679109	3.770624574511481
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.7694867253937487
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.10644866	3.7585339125185193
BECKWITH-WIEDEMANN SYNDROME	0.10615976	3.748333310206319
MELAS	0.10553470000000002	3.726263429689657
SALT-AND-PEPPER SYNDROME	0.105439164	3.7228902045512062
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.10525225399999999	3.7162907079150918
AICARDI SYNDROME; AIC	0.10491369	3.7043365482708293
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10327048400000001	3.646317541960614
CONGENITAL ENTEROVIRUS INFECTION	0.10256786000000001	3.6215089992156946
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.10140257400000002	3.580364592618345
NOCARDIOSIS	0.10111611900000002	3.570250319391134
SANJAD-SAKATI SYNDROME	0.100459529	3.547067164416515
ROBERTS SYNDROME	0.09985801400000001	3.5258286206303504
SARCOSINEMIA	0.09974223400000001	3.521740611853242
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.09921533	3.5031364645333816
SENIOR-LOKEN SYNDROME 3	0.09917356000000001	3.5016616318626284
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.098953104	3.4938776789954136
BOWEN-CONRADI SYNDROME	0.09885792900000001	3.490517200196301
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.09868667	3.4844703156293746
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.474131445547515
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.09816821	3.4661643126013955
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.4645274142864295
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.4645274142864295
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.4645274142864295
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.4645274142864295
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.4645274142864295
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.097738334	3.4509860705814597
LATE-ONSET RETINAL DEGENERATION; LORD	0.09762186000000002	3.4468735577614145
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.09639854	3.403680062363143
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.095610474	3.3758546976633634
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.09481737999999999	3.3478518022317534
TRISOMY 8P	0.094663299	3.342411445690161
RETINAL CONE DYSTROPHY 3B	0.09358764000000001	3.3044316267821006
PRADER-WILLI SYNDROME	0.092858149	3.2786744527380396
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.092677509	3.272296339890425
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.09226190000000001	3.2576218430874793
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.09199607300000001	3.2482359119319058
20Q11.2 MICRODUPLICATION SYNDROME	0.09199607300000001	3.2482359119319058
AICA-RIBOSIDURIA	0.09145051900000001	3.2289732625936223
STURGE-WEBER SYNDROME	0.09114414900000002	3.218155822197677
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.0909091	3.2098566135688076
ROBERTS SYNDROME; RBS	0.0909091	3.2098566135688076
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.0909091	3.2098566135688076
ULBRIGHT-HODES SYNDROME	0.0909091	3.2098566135688076
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.0909091	3.2098566135688076
%179900 RETINAL APLASIA;;AMAUROSIS CONGENITA	0.0909091	3.2098566135688076
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.0909091	3.2098566135688076
RHEUMATOID ARTHRITIS	0.0901315	3.182400786784568
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.08967097300000001	3.166140306407169
OROFACIODIGITAL SYNDROME TYPE 14	0.089272544	3.1520724082463945
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.08882781000000001	3.1363695537337124
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08825100000000001	3.1160033044443387
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.08772485000000001	3.0974257796725695
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08767721	3.095743686581004
AICARDI SYNDROME	0.08723209999999999	3.080027556102695
ADENYLOSUCCINASE DEFICIENCY	0.08662165299999999	3.0584736375160713
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	3.0429628961123565
NEUROTROPHIC KERATOPATHY	0.08593211	3.0341269642029483
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.08522724000000001	3.0092391187484644
8Q12 MICRODUPLICATION SYNDROME	0.08510584400000001	3.0049528178890257
CITRULLINEMIA TYPE I	0.08510170900000001	3.0048068175755573
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.084560494	2.9856973714682624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.084429733	2.9810804072628434
TOWNES-BROCKS SYNDROME 1; TBS1	0.08387885400000002	2.9616297405922225
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.082959029	2.9291521738846438
WHITE-SUTTON SYNDROME; WHSUS	0.082733894	2.9212030129239057
CENTRAL AREOLAR CHOROIDAL DYSTROPHY	0.08241761	2.9100355248598286
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08239085400000001	2.909090812795221
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.082141554	2.90028842388407
GAUCHER DISEASE TYPE 2	0.08193319000000002	2.8929314204220447
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.08187854400000001	2.891001956545435
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.08063971	2.847260686331409
CONE-ROD DYSTROPHY 10	0.0803653	2.8375717030136833
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.08012261400000001	2.8290028439872437
USHER SYNDROME	0.07956821	2.809427715138877
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.078834883	2.783535097998694
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07870984900000001	2.77912034511014
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.07843296300000001	2.7693439381464295
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07829105999999998	2.7643335675340777
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.07750898299999999	2.736719664956998
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.735149711404871
CONE-ROD DYSTROPHY 11; CORD11	0.07692310000000001	2.7160330623800557
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.7160330623800557
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.7160330623800557
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.7160330623800557
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.076504843	2.701265068883019
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.694353692979949
HYDROXYKYNURENINURIA	0.076281954	2.6933952106318455
SENIOR-LOKEN SYNDROME 4; SLSN4	0.07583329999999999	2.6775539471158267
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07550507999999999	2.665965017759958
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.07524900300000001	2.6569233436917647
LEIGH SYNDROME; LS	0.07498789300000001	2.647703962349645
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0749364	2.6458858259188305
MONOSOMY 18Q	0.07481295299999999	2.6415271074915743
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.073777854	2.604979398067013
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.073513684	2.5956519729620835
2Q24 MICRODELETION SYNDROME	0.072968019	2.5763854043892676
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.07279345000000001	2.5702216489547283
PEHO SYNDROME	0.072761414	2.5690905084366467
CONE-ROD DYSTROPHY 8; CORD8	0.0726908	2.566597239721958
CONE-ROD DYSTROPHY 6; CORD6	0.07216120999999999	2.547898253988077
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.072110964	2.546124147156029
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.541293602322758
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.07197001900000001	2.54114760200929
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.07197001900000001	2.54114760200929
TAKAYASU ARTERITIS	0.07197001900000001	2.54114760200929
SPONTANEOUS PERIODIC HYPOTHERMIA	0.07197001900000001	2.54114760200929
SCLERODERMA	0.07197001900000001	2.54114760200929
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.07154332999999999	2.526081887921403
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07154332999999999	2.526081887921403
ALAND ISLAND EYE DISEASE	0.07150901	2.5248701029738267
CLEFT LIP AND ALVEOLUS	0.07142860000000001	2.522030952984475
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.07142860000000001	2.522030952984475
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.07142860000000001	2.522030952984475
RELAPSING POLYCHONDRITIS	0.07142860000000001	2.522030952984475
PYCNODYSOSTOSIS	0.07142860000000001	2.522030952984475
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.07142860000000001	2.522030952984475
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.070574673	2.491880140486551
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.070443254	2.487239943341286
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.070351524	2.484001102046381
FG SYNDROME TYPE 1	0.06955916300000001	2.4560240876860586
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0694877	2.4535008421234528
DISTAL MONOSOMY 12Q	0.069239254	2.4447286066023146
SILVER-RUSSELL SYNDROME	0.0691208	2.4405461831122164
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.069065519	2.438594298389403
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.068980663	2.435598167168205
NIEMANN-PICK DISEASE, TYPE C2	0.068980663	2.435598167168205
JOUBERT SYNDROME 2	0.068967284	2.4351257758274825
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.425465957264031
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06856063999999999	2.420767819002829
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0685241	2.4194776493645884
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.068111574	2.4049120084180924
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.06810996999999999	2.4048553737136658
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06791203	2.397866425213573
LISSENCEPHALY 8; LIS8	0.067753673	2.3922750898714025
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.067753673	2.3922750898714025
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.067212254	2.3731584408465873
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.067212254	2.3731584408465873
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.067212254	2.3731584408465873
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.067212254	2.3731584408465873
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.067212254	2.3731584408465873
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.067212254	2.3731584408465873
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.066772329	2.3576253845219264
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.066772329	2.3576253845219264
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.066772329	2.3576253845219264
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.066772329	2.3576253845219264
RETINITIS PIGMENTOSA 41	0.0666667	2.353895791508304
PROGRESSIVE SUPRANUCLEAR PALSY	0.0666667	2.353895791508304
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.353895791508304
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.353895791508304
SPINOCEREBELLAR ATAXIA TYPE 40	0.0666667	2.353895791508304
PERRY SYNDROME	0.0666667	2.353895791508304
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.353895791508304
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0666667	2.353895791508304
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0666667	2.353895791508304
KUFOR-RAKEB SYNDROME	0.0666667	2.353895791508304
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0666667	2.353895791508304
CARIBBEAN PARKINSONISM	0.0666667	2.353895791508304
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.353895791508304
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0666667	2.353895791508304
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.0666667	2.353895791508304
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0666667	2.353895791508304
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.353895791508304
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.353895791508304
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.353895791508304
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 57	0.0666667	2.353895791508304
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.353895791508304
CHROMOSOME 16P13.2 DELETION SYNDROME	0.066059293	2.3324492105161045
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.065913673	2.327307598509519
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.065832769	2.3244510061610724
RETINITIS PIGMENTOSA 20	0.06566456	2.318511812272762
HADDAD SYNDROME	0.065513739	2.3131865611778215
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06522628	2.303036838297715
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.06483230300000001	2.289126133219302
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.2885081299577217
LEBER CONGENITAL AMAUROSIS	0.064813963	2.288478576810836
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	2.270740933407015
OCULODENTODIGITAL DYSPLASIA	0.064236409	2.268086058057563
DIETHYLSTILBESTROL SYNDROME	0.06395896000000001	2.2582897724538338
BRONCHOPULMONARY DYSPLASIA	0.06395896000000001	2.2582897724538338
AMISH INFANTILE EPILEPSY SYNDROME	0.06368481000000001	2.248609969325105
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.06326349	2.2337338261400026
XQ12-Q13.3 DUPLICATION SYNDROME	0.06256965	2.209235432549497
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.0625	2.2067762011509346
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0625	2.2067762011509346
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.0625	2.2067762011509346
ARNOLD-CHIARI MALFORMATION TYPE I	0.0625	2.2067762011509346
MULTIPLE SYSTEM ATROPHY	0.0625	2.2067762011509346
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.0625	2.2067762011509346
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.0625	2.2067762011509346
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.0625	2.2067762011509346
HEREDITARY METHEMOGLOBINEMIA	0.061877909	2.184811151330932
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.061804412999999996	2.1822161237520548
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.060068830000000004	2.120935431599701
CHROMOSOME 1P36 DELETION SYNDROME	0.059992733	2.118248566822437
JOUBERT SYNDROME 3; JBTS3	0.05994715	2.116639103149204
HYPOPLASMINOGENEMIA	0.0596073	2.104639536877826
PGM3-CDG	0.05944951899999999	2.099068539185125
YUNIS-VARON SYNDROME	0.059369054	2.096227447232715
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.059364919	2.0960814469192472
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.059364919	2.0960814469192472
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.059364919	2.0960814469192472
17Q24.2 MICRODELETION SYNDROME	0.059364919	2.0960814469192472
MENTAL RETARDATION, X-LINKED 98; MRX98	0.059306853	2.0940312282489106
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.059266440000000004	2.092604309103037
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.059205240000000006	2.09044343384687
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0588235	2.076964797894432
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.058167563	2.0538046993175625
CONE-ROD DYSTROPHY 20; CORD20	0.05802111	2.048633675397768
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.0400466678438494
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.05761994399999999	2.034469138093593
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.057594530000000005	2.033571809927577
JOUBERT SYNDROME 1	0.057328144	2.0241661413656598
JUVENILE ABSENCE EPILEPSY	0.056942849999999996	2.01056201929132
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.056642573	1.9999597130936722
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.056642573	1.9999597130936722
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.056572029	1.997468915968328
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.056106379000000005	1.9810275505592734
JOUBERT SYNDROME 7	0.056101154	1.980843064068857
WOLFRAM SYNDROME	0.056097019000000005	1.9806970637553891
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.056097019000000005	1.9806970637553891
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.05590010399999999	1.9737443063849942
CREUTZFELDT-JAKOB DISEASE; CJD	0.05579616	1.9700742080577556
APNEA, OBSTRUCTIVE SLEEP	0.0555984	1.9630916150731221
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.9615804147305742
GITELMAN SYNDROME	0.055555600000000004	1.9615804147305742
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.9615804147305742
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.9615804147305742
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.9615804147305742
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.9615804147305742
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.9615804147305742
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.9615804147305742
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.9615804147305742
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.9615804147305742
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.9615804147305742
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	1.9615804147305742
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.9615804147305742
17P11.2 MICRODUPLICATION SYNDROME	0.054305743999999996	1.9174499751199225
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.054031649	1.9077721139542512
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.05387693	1.9023092306411975
ADULT-ONSET DYSTONIA-PARKINSONISM	0.053718573	1.8967178952990267
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05348399999999999	1.888435493477705
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.053466803	1.8878282945924065
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.053247009000000005	1.880067715898714
KUFOR-RAKEB SYNDROME	0.053173019	1.8774552459607436
INHERITED CREUTZFELDT-JAKOB DISEASE	0.053173019	1.8774552459607436
INFANTILE MYOFIBROMATOSIS	0.0530914	1.8745734080925553
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0530914	1.8745734080925553
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0526316	1.8583385969359285
SPASTIC PARAPLEGIA TYPE 7	0.0526316	1.8583385969359285
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0526316	1.8583385969359285
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.0526316	1.8583385969359285
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0526316	1.8583385969359285
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.0526316	1.8583385969359285
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0526316	1.8583385969359285
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.0526316	1.8583385969359285
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.0526316	1.8583385969359285
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.0526316	1.8583385969359285
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.0526316	1.8583385969359285
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.052624818999999996	1.8580991705452083
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.05252171	1.8544585547480168
ZELLWEGER SYNDROME	0.05249653900000001	1.8535698065278705
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.052440749999999994	1.851599985128094
JUVENILE XANTHOGRANULOMA	0.051742760000000006	1.8269550615978327
XP22.13P22.2 DUPLICATION SYNDROME	0.051624879	1.8227928698319467
PRADER-WILLI-LIKE SYNDROME	0.051568463	1.8208009100533205
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.05128121399999999	1.8106586019412496
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.8071244057195828
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.050781449000000006	1.7930126898105592
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.05051374299999999	1.7835604141352737
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.05044311	1.7810664745606195
ACHROMATOPSIA	0.05038954	1.7791750025430888
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.049793032999999993	1.75811328332037
CHARGE SYNDROME	0.049612213999999995	1.7517288502657153
ERYTHERMALGIA, PRIMARY	0.0494995	1.7477490971019312
DESMOID TUMOR	0.0494995	1.7477490971019312
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.7328261349529448
MOHR-TRANEBJAERG SYNDROME	0.04894842	1.728291333439047
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.04859377	1.7157692025632358
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.048517149999999995	1.7130638714827209
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.048288373	1.7049861172591898
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.047921653999999994	1.6920378490718317
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.047786803	1.6872764734318095
BIOTINIDASE DEFICIENCY	0.047750204	1.6859842205968347
9P13 MICRODELETION SYNDROME	0.04767712	1.683403740086676
NEUROFIBROMATOSIS TYPE 1	0.047184279	1.6660023034506533
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.047042869	1.6610093398889771
CONGENITAL DISORDER OF GLYCOSYLATION	0.047032702999999995	1.6606503944992024
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.046841813999999996	1.6539104056630185
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.046617570000000004	1.6459927045038045
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.046541473	1.6433058397265408
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.046235233	1.6324929894250932
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.046225913	1.6321639149579779
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.046000054	1.6241891907017258
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.046000054	1.6241891907017258
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.6226584294949302
GALLOWAY-MOWAT SYNDROME	0.045855563	1.6190874419004377
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	1.6175775479694006
CONE-ROD DYSTROPHY, X-LINKED, 3	0.04575352	1.6154844648781328
YOU-HOOVER-FONG SYNDROME; YHFS	0.045693814	1.613376340400278
CHRISTIANSON SYNDROME	0.045689740000000006	1.6132324939003826
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.045689679000000004	1.6132303400868104
AMYLOIDOSIS	0.04554079999999999	1.6079736579419917
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04551705	1.6071350829855544
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0454545	1.6049265413634426
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.04540045999999999	1.6030184743888791
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.04537224	1.6020220707985355
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.04532904899999999	1.6004970648640728
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.045282199999999995	1.5988429007321094
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.04514712	1.5940734394640859
GLUTAMINE DEFICIENCY, CONGENITAL	0.044985889	1.588380627725082
MICROHYDRANENCEPHALY; MHAC	0.04497356	1.587945310224538
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.04497356	1.587945310224538
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.586248740681093
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04478762999999999	1.5813804158392577
WHITE FORELOCK WITH MALFORMATIONS	0.04472363000000001	1.5791206770092798
PSEUDOTRISOMY 13 SYNDROME	0.04470529	1.578473120600814
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.044567273000000004	1.573599958505546
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.569261860195114
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297954	1.5640907303500615
CANAVAN DISEASE	0.04428809	1.5637424481028912
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.044216963	1.5612310661691429
OPTIC PATHWAY GLIOMA	0.044080003	1.5563952250729889
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	1.5542666923288262
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.04350680900000001	1.5361566510275089
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	1.535150043304011
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	1.535150043304011
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	1.535150043304011
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.535150043304011
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	1.535150043304011
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	1.535150043304011
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.535150043304011
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	1.535150043304011
LICHTENSTEIN SYNDROME	0.043478300000000004	1.535150043304011
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	1.535150043304011
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.04332055299999999	1.5295802460975634
DEND SYNDROME	0.043216219	1.5258963774868295
PRADER-WILLI SYNDROME; PWS	0.043153242999999994	1.5236727944781303
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.04289368999999999	1.514508388344733
49,XYYYY SYNDROME	0.04289368999999999	1.514508388344733
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.042822559	1.5119968651773084
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.04280941299999999	1.5115327006982626
COFS SYNDROME	0.04280571899999999	1.5114022713976698
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.5096661917331202
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.5096661917331202
WEST SYNDROME	0.0426748	1.5067797284620144
ALG13-CDG	0.0426748	1.5067797284620144
ALPERS-HUTTENLOCHER SYNDROME	0.042616694000000004	1.5047280974549093
CHERUBISM	0.04227	1.4924868803624
16P13.11 MICRODELETION SYNDROME	0.042255454	1.491973284096449
SCHWARTZ-JAMPEL SYNDROME	0.042240549999999995	1.4914470474164176
COG2-CDG	0.04221225399999999	1.4904479603862133
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04202195399999999	1.483728768208949
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.04181266399999999	1.4763390691507268
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.041719813999999994	1.473060682426297
HAMAMY SYNDROME; HMMS	0.041666699999999994	1.47118531104793
49,XXXYY SYNDROME	0.041666699999999994	1.47118531104793
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.47118531104793
HISTIDINEMIA	0.041666699999999994	1.47118531104793
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.47118531104793
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	1.47118531104793
GYRATE ATROPHY OF CHOROID AND RETINA	0.041540719000000004	1.4667371210863753
NORRIE DISEASE	0.041036809	1.4489448555580238
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.040928619000000006	1.4451248376827837
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.040928619000000006	1.4451248376827837
MENTAL RETARDATION, X-LINKED 106; MRX106	0.040905854	1.4443210415192762
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.04088870399999999	1.4437155021296801
CONGENITAL ANALBUMINEMIA	0.040661459999999996	1.4356918757128108
OSTEOPETROSIS AND RELATED DISORDERS	0.04061194	1.433943402793115
DOORS SYNDROME	0.040533033999999996	1.4311573566662665
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.040528854	1.431009767473934
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.040447574	1.428139899159861
OCULOCUTANEOUS ALBINISM	0.04044589999999999	1.428080792866089
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04020156	1.419453533714262
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.040015769	1.4128935471992534
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.039858799	1.4073511846345388
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.039817654	1.405898419725797
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.039661713999999994	1.4003924248328772
OPTIC ATROPHY 8	0.03951446	1.395193118869289
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.386635770387514
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.039092333	1.380288481789877
MARSHALL-SMITH SYNDROME; MRSHSS	0.03905765	1.3790638798861248
LISSENCEPHALY 2; LIS2	0.038809543999999994	1.3703036492275207
COSTELLO SYNDROME; CSTLO	0.038765643999999995	1.3687536096238322
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.038742149999999996	1.3679240736227147
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.038735919	1.3677040668625648
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.038535394	1.3606238460987923
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.3601262092383277
CEDNIK SYNDROME	0.038492572999999995	1.3591119042794404
1P36 DELETION SYNDROME	0.038423753	1.3566819788688294
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.038421223000000004	1.3565926485682067
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.038298733	1.352267720298143
MYHRE SYNDROME	0.038197682999999996	1.348699804536122
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.038149659	1.347004153011577
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.038124033	1.346099339460686
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.344357469215384
SCLEROSTEOSIS 1; SOST1	0.03801564	1.3422721539763445
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.038007514	1.3419852377617754
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.3375980254402102
XIA-GIBBS SYNDROME	0.037591533999999996	1.327297641535299
13Q12.3 MICRODELETION SYNDROME	0.03740978	1.3208801951086753
X-LINKED RETINOSCHISIS	0.0374056	1.3207326059163422
CARTILAGE-HAIR HYPOPLASIA	0.03733678	1.3183026805057312
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.037274100000000004	1.316089548789121
JOUBERT SYNDROME 30; JBTS30	0.037117343	1.3105547069176997
MYOCLONUS AND ATAXIA	0.037037	1.3077179225924347
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.3077179225924347
MCLEOD SYNDROME; MCLDS	0.037037	1.3077179225924347
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3077179225924347
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3077179225924347
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3077179225924347
HALLERMANN-STREIFF SYNDROME; HSS	0.03685898	1.3014323178031724
SOTOS SYNDROME	0.036803592999999996	1.299476690387922
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.2993947748553356
MACULAR DYSTROPHY, RETINAL, 2	0.03674451	1.2973905630552405
MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD	0.03674451	1.2973905630552405
MACULAR DYSTROPHY, RETINAL, 3; MCDR3	0.03674451	1.2973905630552405
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.03674451	1.2973905630552405
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.03674451	1.2973905630552405
ACHROMATOPSIA 7; ACHM7	0.03674451	1.2973905630552405
STARGARDT DISEASE	0.03674451	1.2973905630552405
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.036676943	1.2950048790939097
19P13.3 MICRODUPLICATION SYNDROME	0.03641583399999999	1.2857855330602084
BAKER-GORDON SYNDROME; BAGOS	0.036275593999999994	1.280833880349018
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.036259854	1.2802781258305205
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.036255719000000006	1.2801321255170524
SCHAAF-YANG SYNDROME; SHFYNG	0.036208803	1.278475595721001
16P13.2 MICRODELETION SYNDROME	0.036208803	1.278475595721001
ALSTROM SYNDROME; ALMS	0.036110713999999995	1.2750122281882859
SAETHRE-CHOTZEN SYNDROME	0.035953348999999996	1.26945591879798
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.03592458399999999	1.2684402721191619
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.035924053	1.2684215233485574
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.03590774	1.2678455371058475
SECKEL SYNDROME 2; SCKL2	0.03590774	1.2678455371058475
ROWLEY-ROSENBERG SYNDROME	0.03590774	1.2678455371058475
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.03568606999999999	1.260018719817701
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.2593189069487922
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.2593189069487922
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.035624383	1.2578406493613752
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.035520753999999995	1.2541816731861897
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.035422659999999995	1.2507181291113785
SMITH-MAGENIS SYNDROME; SMS	0.035171673	1.2418561748970065
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.035146913999999994	1.2409819737455774
DYSOSTEOSCLEROSIS	0.035136919	1.2406290660954897
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.03506331299999999	1.2380301545904986
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.034979514	1.2350713443684151
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.034948963	1.233992636852873
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.03483398399999999	1.2299329101195589
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.2294409226061698
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.034783003	1.228132851599385
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03473042	1.226276228991623
22Q11.2 MICRODUPLICATION SYNDROME	0.034535003	1.2193763636332182
CONE-ROD DYSTROPHY 17; CORD17	0.03441456	1.2151237116972944
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.034407544	1.214875987828058
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.034152039999999995	1.2058545454840761
MEIER-GORLIN SYNDROME 5; MGORS5	0.034152039999999995	1.2058545454840761
SECKEL SYNDROME	0.034152039999999995	1.2058545454840761
ISOTRETINOIN-LIKE SYNDROME	0.034152039999999995	1.2058545454840761
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.03403064399999999	1.2015682446246374
CHROMOSOME 17Q12 DELETION SYNDROME	0.03397144	1.1994778449732304
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0337422	1.1913837429516012
POTOCKI-LUPSKI SYNDROME	0.033537612999999994	1.184160099388963
SPINOCEREBELLAR ATAXIA TYPE 34	0.03350343	1.1829531516948202
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03350343	1.1829531516948202
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.033485089999999995	1.1823055952863541
DENT DISEASE	0.033485089999999995	1.1823055952863541
PITT-HOPKINS SYNDROME	0.033401602999999995	1.1793578012910664
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.033377719	1.178514495006454
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.032803653999999995	1.1582451673278342
NETHERTON SYNDROME; NETH	0.032803653999999995	1.1582451673278342
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.1582451673278342
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.032799519	1.1580991670143665
TUBEROUS SCLEROSIS-1	0.032799519	1.1580991670143665
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.1580991670143665
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.1580991670143665
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.1580991670143665
RETINITIS PIGMENTOSA 11	0.032795210000000005	1.1579470230359545
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.03271235399999999	1.155021508653193
WILLIAMS SYNDROME	0.03266388	1.1533099683399999
LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD	0.03252151	1.148283108695874
1Q21.1 MICRODELETION SYNDROME	0.032480233	1.1468256830757955
3P25.3 MICRODELETION SYNDROME	0.0324539	1.1458959064725172
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.0324507	1.145782919531018
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.1389825179895514
MILD CANAVAN DISEASE	0.0322581	1.1389825179895514
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.1389825179895514
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	1.1389825179895514
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.1389825179895514
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.1389825179895514
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.1389825179895514
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.1389825179895514
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	1.1389825179895514
THROMBOCYTOPENIA 1	0.0322581	1.1389825179895514
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.1389825179895514
COG1-CDG	0.0322581	1.1389825179895514
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.1389825179895514
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.1389825179895514
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.1389825179895514
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.1389825179895514
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	1.1389825179895514
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0322581	1.1389825179895514
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.1389825179895514
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0322581	1.1389825179895514
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.1389825179895514
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.1389825179895514
DYSTONIA, JUVENILE-ONSET	0.0322581	1.1389825179895514
FETAL ALCOHOL SYNDROME	0.032256224	1.1389162793950978
CARDIOFACIOCUTANEOUS SYNDROME	0.032223133999999994	1.13774792380316
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.032136004	1.13467150123666
GIANT CELL ARTERITIS	0.03207396	1.1324808256746726
X-LINKED ADRENOLEUKODYSTROPHY	0.03207396	1.1324808256746726
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.032062943999999996	1.1320918681285623
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.031944440000000004	1.1279076792175036
ACHONDROPLASIA	0.03169233	1.1190060736483487
TYSHCHENKO SYNDROME	0.031676154	1.1184349246590717
TETRASOMY X	0.031589274	1.1153673291973758
PENTASOMY X	0.031589274	1.1153673291973758
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.031589274	1.1153673291973758
DISTAL MONOSOMY 7Q36	0.031585139	1.1152213288839077
C SYNDROME	0.031585139	1.1152213288839077
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.031529959999999996	1.1132730456198547
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.031483779	1.1116424675119294
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.03134496	1.1067409880644479
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.03134496	1.1067409880644479
SHORT SYNDROME	0.03130574	1.1053561918627017
CRANIOSYNOSTOSIS 2	0.031295359	1.1049896551627956
COFFIN-LOWRY SYNDROME	0.031254449	1.10354518773257
CONE-ROD DYSTROPHY 18	0.03125	1.1033881005754673
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.03125	1.1033881005754673
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.03125	1.1033881005754673
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.102572829175714
JOUBERT SYNDROME 23; JBTS23	0.031081413999999998	1.0974355954131116
DOWN SYNDROME	0.03104372	1.0961046798590925
TURNPENNY-FRY SYNDROME; TPFS	0.031010894	1.094945645689829
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.030987784	1.0941296681216914
DYSTONIA 28, CHILDHOOD-ONSET	0.030831163999999998	1.0885996635037032
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.03082266	1.08829940070667
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.030758713000000003	1.08604153322291
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.030657129999999998	1.0824547980734456
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.03063879	1.08180724166498
WYBURN-MASON SYNDROME	0.030628033	1.0814274289994474
KOOLEN-DE VRIES SYNDROME	0.030586293	1.0799536555812708
RAVINE SYNDROME	0.030535859999999998	1.0781729460748284
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.030468094	1.0757802357380735
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.03046534	1.075682996351546
BARATELA-SCOTT SYNDROME	0.030387864	1.07294744126418
LOWRY-MACLEAN SYNDROME	0.030302329	1.0699273356263328
7Q11.23 MICRODUPLICATION SYNDROME	0.030220109000000002	1.0670242773981948
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.03019156	1.0660162573379282
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.030110103000000003	1.063140139433654
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.030044874	1.0608370065564559
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.029979310000000002	1.0585220453588198
NAVAJO NEUROHEPATOPATHY	0.029957354	1.05774681370646
RAHMAN SYNDROME	0.029947144	1.0573863147462401
RETINAL CONE DYSTROPHY 4	0.02993567	1.056981185944128
RETINITIS PIGMENTOSA 4; RP4	0.029833600000000002	1.0533772555945045
ALG12-CDG	0.02979839	1.052134046153824
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.02979839	1.052134046153824
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.02979839	1.052134046153824
COG7-CDG	0.02979839	1.052134046153824
VASCULAR EHLERS-DANLOS SYNDROME	0.029782214	1.051562897164547
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.029756709	1.0506623559323813
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.0490474900710078
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.029658373000000002	1.0471902672201192
ALG1-CDG	0.029658373000000002	1.0471902672201192
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.029658373000000002	1.0471902672201192
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.029568354	1.0440118386304966
EPILEPSY, PYRIDOXINE-DEPENDENT	0.029568354	1.0440118386304966
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.029564549000000002	1.0438774900953707
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02954584	1.0432169048802131
SUSAC SYNDROME	0.02954106	1.0430481306363493
LEBER OPTIC ATROPHY AND DYSTONIA	0.02954106	1.0430481306363493
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.0384841643681768
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.0384841643681768
IMMUNE SUPPRESSION	0.0294118	1.0384841643681768
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.0384841643681768
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	1.0384841643681768
MYELOPEROXIDASE DEFICIENCY	0.0294118	1.0384841643681768
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.0384841643681768
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.0384841643681768
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.0384841643681768
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	1.0384841643681768
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	1.0384841643681768
MONOMELIC AMYOTROPHY	0.0294118	1.0384841643681768
MYASTHENIA GRAVIS; MG	0.0294118	1.0384841643681768
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	1.0384841643681768
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.0384841643681768
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.0384841643681768
RAGWEED SENSITIVITY	0.0294118	1.0384841643681768
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.0384841643681768
USHER SYNDROME, TYPE IIIA	0.029304010000000002	1.034678269860624
CAVITARY OPTIC DISC ANOMALIES; CODA	0.029304010000000002	1.034678269860624
RETINITIS PIGMENTOSA 78; RP78	0.029304010000000002	1.034678269860624
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.029304010000000002	1.034678269860624
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.029297874	1.0344616174002998
KEPPEN-LUBINSKY SYNDROME	0.029225428999999997	1.0319036989700217
AURICULOCONDYLAR SYNDROME	0.029116954	1.028073618195304
PROPIONIC ACIDEMIA	0.029116954	1.028073618195304
MUCOPOLYSACCHARIDOSIS, TYPE II	0.029112819	1.0279276178818362
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.029004790000000003	1.02411328466209
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.028864773000000003	1.0191695057283852
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.028864773000000003	1.0191695057283852
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.028864773000000003	1.0191695057283852
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.028864773000000003	1.0191695057283852
DISTAL MONOSOMY 6P	0.028817884	1.017513929259653
RENPENNING SYNDROME	0.028813749	1.0173679289461846
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.028762458999999997	1.015556960124472
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.02875232	1.0151989680620166
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0106681917079097
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0106681917079097
EMANUEL SYNDROME	0.028583053	1.009222417866173
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	1.008810968857021
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.008810968857021
HURLER-SCHEIE SYNDROME	0.0285714	1.008810968857021
SCHEIE SYNDROME	0.0285714	1.008810968857021
ACRODYSOSTOSIS	0.0285714	1.008810968857021
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.008810968857021
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	1.008810968857021
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	1.008810968857021
CHEILITIS GLANDULARIS	0.0285714	1.008810968857021
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.008810968857021
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.008810968857021
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0285714	1.008810968857021
ALPHA-THALASSEMIA	0.0285714	1.008810968857021
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	1.008810968857021
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	1.008810968857021
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.008810968857021
TETRASOMY 9P	0.028509313	1.0066187750330073
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.028509313	1.0066187750330073
STÜVE-WIEDEMANN SYNDROME	0.02850919	1.0066144320974433
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.02827233	0.9982512799213696
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.02827233	0.9982512799213696
NANOPHTHALMOS	0.02827233	0.9982512799213696
PEHO-LIKE SYNDROME; PEHOL	0.028270504	0.9981868067478767
BETA-UREIDOPROPIONASE DEFICIENCY	0.028270504	0.9981868067478767
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.02822104	0.9964403110996571
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.02822104	0.9964403110996571
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.028177523	0.9949037946205294
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.027943950000000002	0.9866567012184267
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.027807463999999997	0.9818375963129818
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.027799489	0.9815560116697151
GIANT AXONAL NEUROPATHY	0.027777800000000002	0.9807902073652871
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.9807902073652871
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.027777800000000002	0.9807902073652871
OROFACIODIGITAL SYNDROME XVII	0.027777800000000002	0.9807902073652871
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	0.9807902073652871
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	0.9807902073652871
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.027777800000000002	0.9807902073652871
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.02762186	0.9752842124723673
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.9735432955543841
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	0.9733972952409161
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.027327753999999996	0.964899794529716
BARDET-BIEDL SYNDROME 21; BBS21	0.0273007	0.9639445605561813
ALEXANDER DISEASE	0.027274609	0.9630233285903533
TRISOMY 13	0.027198759	0.9603451849926367
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.027178294	0.9596225981933317
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.954280646216101
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.027027	0.954280646216101
HYPEROPIA, HIGH	0.027027	0.954280646216101
ACRAL PEELING SKIN SYNDROME	0.027027	0.954280646216101
BENIGN OCCIPITAL EPILEPSY	0.027027	0.954280646216101
MICROPHTHALMIA, ISOLATED 6; MCOP6	0.027027	0.954280646216101
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.027027	0.954280646216101
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.027027	0.954280646216101
MICROPHTHALMIA, ISOLATED 1	0.027027	0.954280646216101
CRANIOECTODERMAL DYSPLASIA	0.027027	0.954280646216101
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.027027	0.954280646216101
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.954280646216101
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.026832889	0.9474268936531952
RETINITIS PIGMENTOSA 19	0.02677111	0.9452455748223008
RETINITIS PIGMENTOSA 10; RP10	0.02677111	0.9452455748223008
RETINITIS PIGMENTOSA 83; RP83	0.02677111	0.9452455748223008
CHERUBISM	0.02677111	0.9452455748223008
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.02677111	0.9452455748223008
RETINITIS PIGMENTOSA 79	0.02677111	0.9452455748223008
RETINITIS PIGMENTOSA 72; RP72	0.02677111	0.9452455748223008
RETINITIS PIGMENTOSA 14	0.02677111	0.9452455748223008
ZUNICH NEUROECTODERMAL SYNDROME	0.026768409000000003	0.945150206781992
MAPLE SYRUP URINE DISEASE; MSUD	0.026768409000000003	0.945150206781992
ZIMMERMANN-LABAND SYNDROME 1	0.026768409000000003	0.945150206781992
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.026709563000000002	0.943072447544665
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02665816	0.9412574888715808
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.026500660000000002	0.9356964128446806
GABRIELE-DE VRIES SYNDROME	0.02650013	0.9356776993824947
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.026439254	0.9335282640541543
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02637401	0.9312246015506682
GALACTOSEMIA	0.026369563000000002	0.931067585010404
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.026286532999999997	0.9281359269626989
LINEAR NEVUS SEBACEUS SYNDROME	0.026219949	0.9257849511774598
MICROSPORIDIOSIS	0.026047279	0.9196882464310163
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.026040462999999996	0.9194475842456233
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.026035464	0.9192710774579508
CROUZON SYNDROME	0.025784609	0.9104137839549152
16P11.2P12.2 MICRODELETION SYNDROME	0.025745114	0.909019277937884
1P21.3 MICRODELETION SYNDROME	0.025683564	0.9068460447349904
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.025644760000000003	0.9054759368356391
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.025621114	0.9046410339548003
OCULOCEREBRORENAL SYNDROME OF LOWE	0.025606899	0.9041391247756106
ISOLATED PLAGIOCEPHALY	0.025600384	0.9039090904244027
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.025588783	0.9034994774530498
LYNCH SYNDROME	0.025577909	0.9031155337024689
FAMILIAL COLORECTAL CANCER TYPE X	0.025577909	0.9031155337024689
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.025541419000000003	0.901827129485189
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.025541419000000003	0.901827129485189
KEUTEL SYNDROME; KTLS	0.025541419000000003	0.901827129485189
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.025541419000000003	0.901827129485189
TOXIC EPIDERMAL NECROLYSIS	0.025505859999999998	0.9005715974062013
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.025502843	0.9004650719054192
PYRUVATE DEHYDROGENASE DEFICIENCY	0.025484503	0.8998175154969534
DPM1-CDG	0.025304819	0.8934731574981117
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.025147104	0.8879044901610795
GORLIN-CHAUDHRY-MOSS SYNDROME	0.025138009999999995	0.8875833953967072
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.025115699	0.8867956292555252
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.02507556	0.8853783846165173
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.8827104804603738
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	0.8827104804603738
HOOFT DISEASE	0.025	0.8827104804603738
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.8827104804603738
CZECH DYSPLASIA, METATARSAL TYPE	0.025	0.8827104804603738
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.8827104804603738
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.025	0.8827104804603738
ANDROGEN INSENSITIVITY SYNDROME	0.025	0.8827104804603738
MARFANOID HYPERMOBILITY SYNDROME	0.025	0.8827104804603738
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.025	0.8827104804603738
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.025	0.8827104804603738
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	0.8827104804603738
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.8827104804603738
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	0.8827104804603738
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.8827104804603738
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.8827104804603738
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.025	0.8827104804603738
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.8827104804603738
ALKAPTONURIA	0.025	0.8827104804603738
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	0.8827104804603738
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	0.8827104804603738
3MC SYNDROME 1	0.02492624	0.8801061314588234
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.024735203	0.8733609169765952
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.024587273	0.8681377425216151
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.024528009	0.866045224365055
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.02451503	0.8655869563920192
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.024482939999999998	0.8644539092193001
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.024482939999999998	0.8644539092193001
SNEDDON SYNDROME	0.024350919000000002	0.8597924564056659
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.024350919000000002	0.8597924564056659
FAMILIAL THROMBOCYTOSIS	0.024350919000000002	0.8597924564056659
AICARDI-GOUTIERES SYNDROME 7	0.024257513	0.8564944382001507
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.024077828999999995	0.8501500802013088
AGEL AMYLOIDOSIS	0.02399786	0.8473265012248314
HAREL-YOON SYNDROME; HAYOS	0.023945534	0.8454789528808089
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.0238095	0.8406758073808508
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0238095	0.8406758073808508
RETINITIS PIGMENTOSA 62; RP62	0.0238095	0.8406758073808508
FUNCTIONING GONADOTROPIC ADENOMA	0.0238095	0.8406758073808508
BEST VITELLIFORM MACULAR DYSTROPHY	0.0238095	0.8406758073808508
ADULT-ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY	0.0238095	0.8406758073808508
PITUICYTOMA	0.0238095	0.8406758073808508
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.0238095	0.8406758073808508
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.0238095	0.8406758073808508
CRYPTOCOCCOSIS	0.023806919000000003	0.8405846763508482
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.023768323	0.8392219126026942
OROFACIODIGITAL SYNDROME TYPE 4	0.023716094	0.8373777891753356
INFANTILE REFSUM DISEASE	0.023590563000000002	0.8329454880024287
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.023590563000000002	0.8329454880024287
HERMANSKY-PUDLAK SYNDROME	0.02358764	0.8328422814930533
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.02358764	0.8328422814930533
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.023541368999999996	0.831208525627398
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.023518073	0.830385980693286
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.023295614	0.8225313050623764
CINCA SYNDROME	0.023295554	0.8225291865572233
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.023165603	0.8179408221713711
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.02313799	0.8169658507914931
ISOLATED CEREBELLAR AGENESIS	0.023045009	0.8136828386641457
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.023045008999999998	0.8136828386641456
6Q25 MICRODELETION SYNDROME	0.023029922999999997	0.8131501758518165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.022952294	0.8104092185763103
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.02276314	0.8037304898474703
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.02272724	0.802462917597529
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.022663584	0.8002153248637617
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.022620049	0.7986781728330881
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.022605844	0.7981766167380904
WIEACKER-WOLFF SYNDROME	0.022541333	0.7958988353058912
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.7949056447816963
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.7949056447816963
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.7949056447816963
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.7929054228329732
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.022363573	0.7896224107056258
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.022363573	0.7896224107056258
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.022342309999999997	0.7888716477877845
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.022342309999999997	0.7888716477877845
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.022342309999999997	0.7888716477877845
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.022237358999999998	0.7851659938823927
AYMÉ-GRIPP SYNDROME	0.022081614	0.7796668841312206
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.02207863	0.7795615238082729
OPTIC ATROPHY 11; OPA11	0.022068624	0.7792082277655735
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02196784	0.7756497040430648
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.7756429954434132
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.02196306	0.7754809297992007
SIALURIA	0.021920273	0.7739701884661024
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.021920273	0.7739701884661024
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021920273	0.7739701884661024
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.021822154	0.7705057616808108
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.021822154	0.7705057616808108
HUNTINGTON DISEASE; HD	0.021818019	0.7703597613673426
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.021818019	0.7703597613673426
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.021818019	0.7703597613673426
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.021756653	0.7681930249135854
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021756653	0.7681930249135854
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.021546533	0.760774019867412
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.021453503	0.7574892776275228
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.021444369	0.7571667705263819
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.021436594	0.7568922475669587
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.7547075391278193
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.7547075391278193
CEREBROTENDINOUS XANTHOMATOSIS	0.021343319	0.7535988547643611
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.021343319	0.7535988547643611
GAUCHER DISEASE, PERINATAL LETHAL	0.021343309	0.7535985016801688
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.021299298999999997	0.7520445781503664
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7515892760845448
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.7512431123425276
SPINOCEREBELLAR ATAXIA 12	0.0212766	0.7512431123425276
RETINITIS PIGMENTOSA 74; RP74	0.0212766	0.7512431123425276
RETINITIS PIGMENTOSA 25; RP25	0.0212766	0.7512431123425276
RETINITIS PIGMENTOSA 69	0.0212766	0.7512431123425276
GLAUCOMA 1, OPEN ANGLE, M	0.0212766	0.7512431123425276
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	0.7512431123425276
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.7512431123425276
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0212766	0.7512431123425276
RETINITIS PIGMENTOSA 1	0.0212766	0.7512431123425276
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.7512431123425276
NEUROFERRITINOPATHY	0.0212766	0.7512431123425276
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	0.7512431123425276
KURU, SUSCEPTIBILITY TO	0.0212766	0.7512431123425276
PRIMARY BASILAR INVAGINATION	0.0212766	0.7512431123425276
RETINITIS PIGMENTOSA 73; RP73	0.0212766	0.7512431123425276
RETINITIS PIGMENTOSA	0.0212766	0.7512431123425276
RETINITIS PIGMENTOSA 13; RP13	0.0212766	0.7512431123425276
RETINITIS PIGMENTOSA 6	0.0212766	0.7512431123425276
KID SYNDROME	0.021106009999999998	0.7452198491080582
JOUBERT SYNDROME WITH OCULAR DEFECT	0.021083013	0.7444078613912923
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.021000979	0.7415113705291289
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02097441	0.7405732611389148
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02097441	0.7405732611389148
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.020937633	0.7392747234053192
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.020937633	0.7392747234053192
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.020937633	0.7392747234053192
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.020937633	0.7392747234053192
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.020937633	0.7392747234053192
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.020928259999999997	0.7389437775919849
MENKES DISEASE	0.020903749000000003	0.7380783329285225
SECONDARY SHORT BOWEL SYNDROME	0.02089104	0.7376295982286755
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02089104	0.7376295982286755
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02089104	0.7376295982286755
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7355908901030043
CRANDALL SYNDROME	0.0208333	0.7355908901030043
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.7355908901030043
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7355908901030043
STICKLER SYNDROME, TYPE III	0.0208333	0.7355908901030043
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.7355908901030043
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7355908901030043
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7355908901030043
GLAUCOMA - SLEEP APNEA	0.0208333	0.7355908901030043
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.7355908901030043
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7355908901030043
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.0208333	0.7355908901030043
ACROMEGALY	0.0208333	0.7355908901030043
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7355908901030043
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7355908901030043
HYPOCHONDROPLASIA	0.0208333	0.7355908901030043
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.7355908901030043
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7355908901030043
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0208333	0.7355908901030043
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7355908901030043
UNIQUE GREEN PHENOMENON	0.0208333	0.7355908901030043
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7355908901030043
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7355908901030043
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.7355908901030043
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7355908901030043
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.7355908901030043
DERMOIDS OF CORNEA	0.0208333	0.7355908901030043
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.7355908901030043
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.7355908901030043
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7355908901030043
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7355908901030043
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.7355908901030043
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7355908901030043
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.7355908901030043
PUPIL, EGG-SHAPED	0.0208333	0.7355908901030043
CLEIDOCRANIAL DYSPLASIA	0.0208333	0.7355908901030043
GAUCHER DISEASE, TYPE I	0.0208333	0.7355908901030043
IMINOGLYCINURIA	0.0208333	0.7355908901030043
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7355908901030043
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7355908901030043
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7355908901030043
611426 TENTED EYEBROWS	0.0208333	0.7355908901030043
APNEA, CENTRAL SLEEP	0.0208333	0.7355908901030043
SOMATOMAMMOTROPINOMA	0.0208333	0.7355908901030043
ALSTRÖM SYNDROME	0.020809672999999997	0.7347566580821306
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.020801899999999998	0.734482205739546
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.020762933	0.7331063425678621
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7323266267462617
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7323266267462617
8Q24.3 MICRODELETION SYNDROME	0.020670523000000003	0.7298434915478885
MOEBIUS SYNDROME; MBS	0.020669680000000003	0.7298137265504873
SPINOCEREBELLAR ATAXIA TYPE 7	0.020648064	0.7290504997606619
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.020643039999999998	0.7288731102625086
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.020525164	0.7247110950387187
ANGELMAN SYNDROME	0.020427293000000003	0.7212554247413934
STEVENS-JOHNSON SYNDROME	0.02040596	0.7205021902342069
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.020365923999999997	0.7190885823623783
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.020304314	0.7169132306543319
RETINITIS PIGMENTOSA 80; RP80	0.020268254	0.7156400090573157
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.020264118999999997	0.7154940087438475
MIRAGE SYNDROME; MIRAGE	0.020222313000000002	0.7140179049700026
SMITH-FINEMAN-MYERS SYNDROME	0.020143928999999998	0.7112502898379862
SIALIDOSIS TYPE 1	0.020139908999999998	0.7111083499927282
GAUCHER DISEASE, TYPE II	0.020066142999999998	0.7085037891406626
TRANSIENT NEONATAL DIABETES MELLITUS	0.019967994	0.7050383031027945
PERMANENT NEONATAL DIABETES MELLITUS	0.019967994	0.7050383031027945
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.019837683	0.7004372276860236
DISTAL MONOSOMY 10Q	0.019744672999999997	0.6971531916145188
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0197227	0.6963773597190326
6Q TERMINAL DELETION SYNDROME	0.019693443	0.6953443412979595
LEUKOCYTE ADHESION DEFICIENCY	0.019676759000000002	0.6947552556317195
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.6947270442047639
PITT-HOPKINS-LIKE SYNDROME	0.019610859	0.6924284308052259
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0195983	0.6919849923682618
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.019575272999999997	0.6911719453989192
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.019502879	0.6886158276980214
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.019436834000000004	0.6862838831507414
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.019234638999999998	0.6791446973268737
CONE-ROD DYSTROPHY 16	0.01919311	0.6776783739851522
CONE DYSTROPHY 3	0.01919311	0.6776783739851522
PYRIDOXINE-DEPENDENT EPILEPSY	0.019185074	0.677394635528313
DYSEQUILIBRIUM SYNDROME	0.019142739	0.6758998536007015
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01913954	0.6757869019676218
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.019099134	0.6743602299806825
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.6737589276013928
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01893494	0.6685627993955341
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.018912918999999997	0.6677852726959252
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.018911083	0.6677204464382404
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01890171	0.6673895006249061
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.018842653	0.6653042913111242
OROFACIODIGITAL SYNDROME TYPE 6	0.018820813000000002	0.6645331554353942
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.018776583	0.6629714640533635
GAUCHER DISEASE	0.01877383	0.6628742599752552
ZTTK SYNDROME; ZTTKS	0.018710703	0.6606453453952543
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6544962782631096
HYPERPROLINEMIA, TYPE I	0.018481163	0.6525406508478594
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.01846839	0.6520896564091826
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.01846839	0.6520896564091826
MOSAIC TRISOMY 15	0.01846839	0.6520896564091826
ALG11-CDG	0.018461303	0.6518394256421817
ALG3-CDG	0.018442962999999996	0.6511918692337159
MULTIPLE CARBOXYLASE DEFICIENCY	0.018442962999999996	0.6511918692337159
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.018392943999999998	0.6494257774128299
X SMALL RINGS	0.018296724	0.6460284013156342
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.018285753000000002	0.6456410326483889
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.018285753000000002	0.6456410326483889
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.018285753000000002	0.6456410326483889
NEONATAL ADRENOLEUKODYSTROPHY	0.018258609	0.6446826209171242
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0182192	0.6432911514241458
XYLOSIDASE DEFICIENCY	0.018209209000000004	0.6429383850077347
SALLA DISEASE	0.018158703	0.6411550979866893
PREECLAMPSIA	0.018022939999999998	0.6363615210683395
FETAL PARVOVIRUS SYNDROME	0.018022939999999998	0.6363615210683395
LOEYS-DIETZ SYNDROME 5	0.01800905	0.6358710871253958
GERODERMA OSTEODYSPLASTICA	0.017901544	0.6320752202089008
CONGENITAL HYPOTHYROIDISM	0.017901544	0.6320752202089008
MPDU1-CDG	0.017897409	0.6319292198954327
CHOREOACANTHOCYTOSIS	0.017897409	0.6319292198954327
BENIGN FAMILIAL INFANTILE EPILEPSY	0.017897408999999996	0.6319292198954327
CURRARINO SYNDROME	0.017786954	0.6280292284506628
WHIM SYNDROME	0.017782819000000002	0.6278832281371947
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.017782819000000002	0.6278832281371947
YUNIS-VARON SYNDROME	0.017704710000000002	0.6251253228204635
COFFIN-SIRIS SYNDROME 1; CSS1	0.017626803	0.6223745498044143
PHELAN-MCDERMID SYNDROME	0.017580213	0.6207295305530285
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.017580213	0.6207295305530285
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.017580213	0.6207295305530285
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01752372	0.6187348520261226
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01752372	0.6187348520261226
STICKLER SYNDROME	0.017505430000000002	0.6180890610386178
MEHMO SYNDROME	0.017498358999999998	0.6178393952063242
HYPEREKPLEXIA 2; HKPX2	0.01748359	0.6173179251628875
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.017404578999999996	0.6145281716520212
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.017374329999999997	0.6134601272790834
TOWNES-BROCKS SYNDROME	0.017374329999999997	0.6134601272790834
EEM SYNDROME	0.017374329999999997	0.6134601272790834
WAARDENBURG SYNDROME TYPE 1	0.017374329999999997	0.6134601272790834
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.017317623	0.6114578927504648
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.017289374	0.6104604652159639
ISOLATED AGAMMAGLOBULINEMIA	0.0172414	0.6087665791123795
RAT-BITE FEVER	0.0172414	0.6087665791123795
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6087665791123795
MELIOIDOSIS	0.0172414	0.6087665791123795
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.0172414	0.6087665791123795
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6087665791123795
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0172414	0.6087665791123795
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.0172414	0.6087665791123795
TRANSSEXUALITY	0.0172414	0.6087665791123795
CYCLIC NEUTROPENIA	0.0172414	0.6087665791123795
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6087665791123795
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6087665791123795
269800 SENILE PLAQUE FORMATION	0.0172414	0.6087665791123795
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6087665791123795
X-LINKED AGAMMAGLOBULINEMIA	0.0172414	0.6087665791123795
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6087665791123795
PLAGUE	0.0172414	0.6087665791123795
FELTY SYNDROME	0.0172414	0.6087665791123795
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0172414	0.6087665791123795
COMBINED IMMUNODEFICIENCY DUE TO PARTIAL RAG1 DEFICIENCY	0.0172414	0.6087665791123795
WISKOTT-ALDRICH SYNDROME	0.0172414	0.6087665791123795
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6087665791123795
LAMELLAR ICHTHYOSIS	0.0172414	0.6087665791123795
CERVICAL RIB	0.0172414	0.6087665791123795
NEUROLEPTIC MALIGNANT SYNDROME	0.0172414	0.6087665791123795
IMMUNODEFICIENCY 46; IMD46	0.0172414	0.6087665791123795
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6087665791123795
ALCOHOL DEPENDENCE	0.0172414	0.6087665791123795
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6087665791123795
HIRSCHSPRUNG DISEASE	0.0172414	0.6087665791123795
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0172414	0.6087665791123795
THUMBS, CONGENITAL CLASPED	0.0172414	0.6087665791123795
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6087665791123795
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.0172414	0.6087665791123795
PYOMYOSITIS	0.0172414	0.6087665791123795
CHRONIC GRANULOMATOUS DISEASE	0.0172414	0.6087665791123795
OMENN SYNDROME	0.0172414	0.6087665791123795
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6087665791123795
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6087665791123795
RETICULAR DYSGENESIS	0.0172414	0.6087665791123795
SEVERE COMBINED IMMUNODEFICIENCY	0.0172414	0.6087665791123795
RETICULAR DYSGENESIA	0.0172414	0.6087665791123795
PALMOMENTAL REFLEX	0.0172414	0.6087665791123795
CLASSIC GALACTOSEMIA	0.0172414	0.6087665791123795
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6087665791123795
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6087665791123795
DIASTEMATOMYELIA	0.0172414	0.6087665791123795
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6087665791123795
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6087665791123795
MYOPATHY, CONGENITAL	0.0172414	0.6087665791123795
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6087665791123795
MOTION SICKNESS	0.0172414	0.6087665791123795
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6087665791123795
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6087665791123795
LEGIONELLOSIS	0.0172414	0.6087665791123795
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6087665791123795
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6087665791123795
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6087665791123795
BULLOUS IMPETIGO	0.0172414	0.6087665791123795
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6087665791123795
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6087665791123795
CALCIPHYLAXIS	0.0172414	0.6087665791123795
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6087665791123795
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.0172414	0.6087665791123795
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6087665791123795
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6087665791123795
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6087665791123795
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6087665791123795
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6087665791123795
ACQUIRED PURPURA FULMINANS	0.0172414	0.6087665791123795
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6087665791123795
RADIATION PROCTITIS	0.0172414	0.6087665791123795
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6087665791123795
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6087665791123795
CARDIAC ARRHYTHMIA	0.0172414	0.6087665791123795
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6087665791123795
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6087665791123795
SICKLE CELL ANEMIA	0.0172414	0.6087665791123795
RECOMBINANT 8 SYNDROME	0.017215973	0.607868791936913
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.017198779999999997	0.6072617342852906
SOTOS SYNDROME 2	0.017198779999999997	0.6072617342852906
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.017098354	0.6037158509768622
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.017021764	0.6010115791489239
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.017021764	0.6010115791489239
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.01698294	0.599640765081188
PHACE SYNDROME	0.016892592999999997	0.5964507553300619
OROFACIODIGITAL SYNDROME TYPE 2	0.016847064000000002	0.5948431983114667
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.016712754	0.5901009245262414
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016712754	0.5901009245262414
FARBER DISEASE	0.016674553999999998	0.5887521429120979
INSULINOMA	0.016670419	0.5886061425986298
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.016670419	0.5886061425986298
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.016670419	0.5886061425986298
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.016505993	0.5828005204602227
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.016499004	0.5825537499183052
JACOBSEN SYNDROME	0.01647257	0.5816204071646857
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.016439163	0.580440858803856
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.016439163	0.580440858803856
FUMARASE DEFICIENCY; FMRD	0.016431404	0.5801669007791403
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.016347038999999997	0.5771881059917786
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.016334882999999998	0.5767588968477596
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.016334882999999998	0.5767588968477596
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.5755805489731836
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.5755805489731836
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.5755805489731836
STERNAL CLEFT	0.016128999999999998	0.5694894935738147
CONGENITAL PRIMARY APHAKIA	0.016128999999999998	0.5694894935738147
DIPROSOPUS	0.016128999999999998	0.5694894935738147
FETAL CYTOMEGALOVIRUS SYNDROME	0.016128999999999998	0.5694894935738147
RHOMBENCEPHALOSYNAPSIS	0.016128999999999998	0.5694894935738147
FAMILIAL PTERYGIUM OF THE CONJUNCTIVA	0.016128999999999998	0.5694894935738147
NARCOLEPSY TYPE 1	0.016128999999999998	0.5694894935738147
ARACHNOIDITIS	0.016128999999999998	0.5694894935738147
ACRORENAL SYNDROME	0.016128999999999998	0.5694894935738147
SILENT SINUS SYNDROME	0.016128999999999998	0.5694894935738147
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.016128999999999998	0.5694894935738147
CENTRAL NEUROCYTOMA	0.016128999999999998	0.5694894935738147
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.016128999999999998	0.5694894935738147
WAARDENBURG SYNDROME	0.016128999999999998	0.5694894935738147
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.016128999999999998	0.5694894935738147
WAARDENBURG-SHAH SYNDROME	0.016128999999999998	0.5694894935738147
MCCUNE-ALBRIGHT SYNDROME	0.016128999999999998	0.5694894935738147
MULTIPLE EPIPHYSEAL DYSPLASIA	0.016128999999999998	0.5694894935738147
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.016128999999999998	0.5694894935738147
ALKAPTONURIA	0.016128999999999998	0.5694894935738147
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.01607346	0.5675284639704241
WITTEVEEN-KOLK SYNDROME	0.016047313	0.5666052547331202
FANCONI ANEMIA	0.015858393999999998	0.5599348234827963
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.01579181	0.5575838476975575
CONGENITAL TOXOPLASMOSIS	0.015775823	0.5570193719995127
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.015742659	0.5558484035845531
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01569499	0.5541652865488305
RING CHROMOSOME 14 SYNDROME	0.015689494	0.553971231476806
AMISH LETHAL MICROCEPHALY	0.01567665	0.5535177301403649
DUANE RETRACTION SYNDROME	0.015665602999999997	0.5531276780332588
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.015665602999999997	0.5531276780332588
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.015665602999999997	0.5531276780332588
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.015665602999999997	0.5531276780332588
MUENKE SYNDROME	0.015665602999999997	0.5531276780332588
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.015647262999999998	0.5524801216247932
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.015592539999999998	0.5505479389999038
KNOBLOCH SYNDROME	0.015485348999999997	0.5467631942354627
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.015471144	0.5462616381404651
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5462549295408137
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5462549295408137
NEURAMINIDASE DEFICIENCY	0.015467008999999999	0.546115637826997
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.015437559	0.5450758048810148
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.01541902	0.5444212220971246
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.01541902	0.5444212220971246
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.015415902999999998	0.5443111657544207
SEVERE CANAVAN DISEASE	0.015251322999999999	0.538500106119454
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.01522724	0.5376497734594169
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.015204414	0.5368438234823374
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.015193833	0.5364702250985873
MONOSOMY 22Q13.3	0.015090693	0.5328285147404
NEMALINE MYOPATHY 2; NEM2	0.01507321	0.5322112176472045
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.015019132999999999	0.5303018442611303
COHEN SYNDROME	0.015014439000000001	0.530136106541319
LOWE OCULOCEREBRORENAL SYNDROME	0.015014439000000001	0.530136106541319
1Q41Q42 MICRODELETION SYNDROME	0.015008109	0.5299126042476665
OCULOECTODERMAL SYNDROME; OES	0.014990953	0.5293068530075553
REFSUM DISEASE	0.014925589999999999	0.526998988802182
EPILEPSY, HOT WATER, 1	0.014925589999999999	0.526998988802182
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5269922802025305
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5269922802025305
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5269922802025305
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5269922802025305
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.014863314	0.524800121686936
ADAMS-OLIVER SYNDROME	0.014863009	0.5247893526190744
ADRENOLEUKODYSTROPHY	0.014829979	0.5236231155322902
DONNAI-BARROW SYNDROME	0.014785572999999998	0.5220552098684772
HSD10 DISEASE	0.014785572999999998	0.5220552098684772
RENPENNING SYNDROME 1; RENS1	0.014755289000000001	0.5209859297008669
NEURONAL CEROID LIPOFUSCINOSIS	0.014705768999999999	0.5192374567811708
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.014668233000000001	0.5179121199573884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.014668233000000001	0.5179121199573884
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.01465886	0.5175811741440542
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.014648279	0.5172075757603042
DESMOSTEROLOSIS	0.014633569999999999	0.5166882242220205
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.014607759000000001	0.5157768786135741
MARSHALL SYNDROME	0.014578629999999999	0.5147483796701607
CROUZON DISEASE	0.014578629999999999	0.5147483796701607
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.014578629999999999	0.5147483796701607
BENCZE SYNDROME	0.014578629999999999	0.5147483796701607
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.014578629999999999	0.5147483796701607
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.014578629999999999	0.5147483796701607
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.014578629999999999	0.5147483796701607
MORNING GLORY DISC ANOMALY	0.014578629999999999	0.5147483796701607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.014549274	0.513711865715585
WEBB-DATTANI SYNDROME; WEDAS	0.014518483	0.5126246841794307
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.014514644	0.5124891351580513
ELEJALDE DISEASE	0.014509063	0.5122920788703933
RETINAL DYSTROPHY AND OBESITY; RDOB	0.014503519999999999	0.5120963643026656
ÅLAND ISLANDS EYE DISEASE	0.014503519999999999	0.5120963643026656
EDICT SYNDROME	0.014503519999999999	0.5120963643026656
MEGALOCORNEA	0.014503519999999999	0.5120963643026656
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.014498680000000002	0.5119254715536486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.014477714	0.5111851952363152
RETT SYNDROME; RTT	0.014473579	0.5110391949228471
RETINOPATHY OF PREMATURITY	0.014427460000000001	0.509410805936913
CHÉDIAK-HIGASHI SYNDROME	0.014420272999999999	0.5091570443279902
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.014420272999999999	0.5091570443279902
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.014394272999999999	0.5082390254283115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5029385608436622
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.5029385608436622
MEDULLOBLASTOMA	0.014244153999999998	0.5029385608436622
JOUBERT SYNDROME 35; JBTS35	0.014244153999999998	0.5029385608436622
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5029385608436622
SENIOR-LOKEN SYNDROME	0.014244153999999998	0.5029385608436622
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5029385608436622
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.014244153999999998	0.5029385608436622
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.014240018999999998	0.502792560530194
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.014240018999999998	0.502792560530194
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.014234453000000001	0.5025960338688245
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.014234319	0.5025913025406492
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.014163233	0.5000813682520889
BRITTLE CORNEA SYNDROME	0.01407841	0.49708640220872524
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.01396909	0.4932264858197682
CRANIOFRONTONASAL SYNDROME; CFNS	0.013967644000000001	0.49317542984557833
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.013967644000000001	0.49317542984557833
2Q23.1 MICRODUPLICATION SYNDROME	0.013964454	0.4930627959882716
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.013963509	0.49302942953211015
16Q24.3 MICRODELETION SYNDROME	0.013960318999999999	0.4929167956748034
WRINKLY SKIN SYNDROME	0.013933794	0.491980239855035
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.013933794	0.491980239855035
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.013932159999999999	0.4919225458980321
CARNOSINASE DEFICIENCY	0.013932159999999999	0.4919225458980321
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.013878854	0.4900403953031753
PFEIFFER SYNDROME TYPE 3	0.013874718999999999	0.4898943949897071
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.013874718999999999	0.4898943949897071
CLASSIC HOMOCYSTINURIA	0.013874718999999999	0.4898943949897071
QAZI-MARKOUIZOS SYNDROME	0.013867059000000001	0.4896239324984941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.013867059000000001	0.4896239324984941
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.013766914	0.4860879708558659
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.013698599999999998	0.4836759115053791
CORNEAL DYSTROPHY, LATTICE TYPE I	0.013698599999999998	0.4836759115053791
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.4836759115053791
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.4836759115053791
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.013698599999999998	0.4836759115053791
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.4836759115053791
ANIRIDIA 3	0.013698599999999998	0.4836759115053791
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.4836759115053791
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.013698599999999998	0.4836759115053791
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.013698599999999998	0.4836759115053791
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.013698599999999998	0.4836759115053791
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.4836759115053791
RETINAL CONE DYSTROPHY 1; RCD1	0.013698599999999998	0.4836759115053791
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.013698599999999998	0.4836759115053791
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.013698599999999998	0.4836759115053791
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.4836759115053791
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.013698599999999998	0.4836759115053791
BEHR SYNDROME	0.013698599999999998	0.4836759115053791
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.013698599999999998	0.4836759115053791
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.4836759115053791
BASAL LAMINAR DRUSEN	0.013698599999999998	0.4836759115053791
CHOROIDEREMIA	0.013698599999999998	0.4836759115053791
BOUCHER-NEUHAUSER SYNDROME	0.013698599999999998	0.4836759115053791
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.013698599999999998	0.4836759115053791
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.4836759115053791
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.4836759115053791
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.013688899000000001	0.4833333845305413
MICRO SYNDROME	0.013641863	0.48167261772418385
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.013510793	0.47704474321722623
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.013510793	0.47704474321722623
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.013450318999999999	0.47490950187341174
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.013422090000000001	0.4739127805072952
X-LINKED RECESSIVE OCULAR ALBINISM	0.0134189	0.47380014664998843
OCULAR ALBINISM	0.0134189	0.47380014664998843
PELIZAEUS-MERZBACHER DISEASE	0.013336329000000001	0.4708846951667047
CATARACT 17, MULTIPLE TYPES	0.0133333	0.47077774596489214
SPONDYLOOCULAR SYNDROME; SOS	0.0133333	0.47077774596489214
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.0133333	0.47077774596489214
ISOLATED ECTOPIA LENTIS	0.0133333	0.47077774596489214
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.0133333	0.47077774596489214
CATARACT, ANTERIOR POLAR, 2	0.0133333	0.47077774596489214
CORNELIA DE LANGE SYNDROME	0.013311039	0.469991745244671
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.013285183999999998	0.4690788460657788
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.013282073	0.4689690015735904
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013282073	0.4689690015735904
SHUKLA-VERNON SYNDROME; SHUVER	0.013282073	0.4689690015735904
PERLMAN SYNDROME	0.013266844	0.4684312896573131
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.013233033000000002	0.46723747669511934
CHROMOSOME 5Q12 DELETION SYNDROME	0.013211193	0.46646634081938915
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.013211193	0.46646634081938915
COG5-CDG	0.013114648999999999	0.46305752479436646
CANAVAN DISEASE	0.013010963	0.4593965360392859
TAY-SACHS DISEASE	0.013010963	0.4593965360392859
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.012993253	0.45877122393492775
SCHINDLER DISEASE, TYPE I	0.012993253	0.45877122393492775
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.012993253	0.45877122393492775
KRABBE DISEASE	0.012969374	0.4579280941924112
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.012921609	0.4562415875484437
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012856194000000001	0.45393188730527106
JOUBERT SYNDROME WITH RENAL DEFECT	0.012818553	0.4526028430974707
48,XXYY SYNDROME	0.012818553	0.4526028430974707
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.012818553	0.4526028430974707
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.012818553	0.4526028430974707
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.012818553	0.4526028430974707
JOUBERT SYNDROME	0.012818553	0.4526028430974707
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01276962	0.450875096219856
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.012749003000000002	0.45014714254083
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.012740654	0.44985235254877537
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.012740654	0.44985235254877537
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.012740654	0.44985235254877537
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.012740654	0.44985235254877537
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.012740654	0.44985235254877537
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.012736519	0.4497063522353072
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.012730663000000001	0.44949958613236424
EPIDERMAL NEVUS SYNDROME	0.012719123999999998	0.4490921622830028
CORNELIA DE LANGE SYNDROME 1	0.012689698999999999	0.448053212047501
RING CHROMOSOME 12 SYNDROME	0.012669774000000002	0.4473496917945742
JACOBSEN SYNDROME	0.012629603000000001	0.4459313172861512
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.012621728999999998	0.44565329879322535
TEMPLE-BARAITSER SYNDROME	0.012621728999999998	0.44565329879322535
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.012515993	0.44191992777874706
KRABBE DISEASE	0.012465409	0.44013388670100273
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.012459654	0.4399306867484008
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.012441303	0.4392827419473237
HELSMOORTEL-VAN DER AA SYNDROME	0.012441303	0.4392827419473237
MICROPHTHALMIA, ISOLATED 5	0.01243895	0.43919966123690274
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.01243895	0.43919966123690274
MUCOPOLYSACCHARIDOSIS TYPE 1	0.01242382	0.43866544485412806
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.012395433	0.43766314475777496
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.012358719	0.4363668314545901
4Q21 MICRODELETION SYNDROME	0.012315089	0.43482632512409053
TARP SYNDROME	0.012240173	0.4321811595899238
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.0121951	0.4305897032104922
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.4305897032104922
LELIS SYNDROME	0.0121951	0.4305897032104922
FACIOCARDIOMELIC SYNDROME	0.0121951	0.4305897032104922
JUBERG-MARSIDI SYNDROME	0.0121951	0.4305897032104922
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0121951	0.4305897032104922
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0121951	0.4305897032104922
CATARACT 48; CTRCT48	0.0121951	0.4305897032104922
RHYNS SYNDROME; RHYNS	0.0121951	0.4305897032104922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.4305897032104922
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.4305897032104922
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0121951	0.4305897032104922
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0121951	0.4305897032104922
LOEYS-DIETZ SYNDROME 3; LDS3	0.0121951	0.4305897032104922
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.01217357	0.42982951294471977
LOWRY-WOOD SYNDROME	0.01217357	0.42982951294471977
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.012144023	0.42878625508207324
MICROFORM HOLOPROSENCEPHALY	0.012084049000000001	0.42666866794786806
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012084049	0.42666866794786806
ROIFMAN SYNDROME; RFMN	0.012069844000000001	0.4261671118528705
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.012045363	0.4253027264419844
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.42510821236051016
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.42510821236051016
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.42510821236051016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.42510821236051016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.42510821236051016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.42510821236051016
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.012026884	0.4246502621632473
PITT-HOPKINS SYNDROME	0.012022749	0.42450426184977913
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011962653	0.4223823670884293
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.011959423	0.42226832089435384
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.011823753	0.41747802765899145
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.011766262999999999	0.4154481466381248
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.011766262999999999	0.4154481466381248
RAYNAUD-CLAES SYNDROME; MRXSRC	0.011766262999999999	0.4154481466381248
SHPRINTZEN-GOLDBERG SYNDROME	0.01173158	0.41422354473437245
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.011639140000000001	0.41095963446182227
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.011591563000000001	0.4092797658006677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.011591563	0.40927976580066766
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.011573223	0.408632209392202
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.011573223	0.408632209392202
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.011573223	0.408632209392202
DIAMOND-BLACKFAN ANEMIA 1	0.01154263	0.407552018923053
2P15P16.1 MICRODELETION SYNDROME	0.011522284	0.40683363382563514
EXUDATIVE VITREORETINOPATHY 4	0.011518610000000002	0.40670391069342676
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.011518610000000002	0.40670391069342676
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.4061765088355612
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.4061765088355612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011503673	0.4061765088355612
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.011503673	0.4061765088355612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.4061765088355612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.011503673	0.4061765088355612
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.4061765088355612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.4061765088355612
PEHO SYNDROME; PEHO	0.011503673	0.4061765088355612
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.011503673	0.4061765088355612
HYPEREKPLEXIA 4; HKPX4	0.011503673	0.4061765088355612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.4061765088355612
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.405845563022227
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.405845563022227
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.405845563022227
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.405845563022227
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.011455493	0.404475349197618
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.011448504	0.4042285786557005
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.01142902	0.40354062941564894
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.011384273	0.4019606835808825
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.011384273	0.4019606835808825
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.011384273	0.4019606835808825
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.011384273	0.4019606835808825
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.011341312999999999	0.4004438338912593
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.011341312999999999	0.4004438338912593
DESANTO-SHINAWI SYNDROME	0.011341312999999999	0.4004438338912593
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0113107	0.399362937253726
DUBOWITZ SYNDROME	0.0113107	0.399362937253726
KOOLEN-DE VRIES SYNDROME; KDVS	0.011170683	0.3944191583200213
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0111532	0.39380186122682564
PRIMARY PULMONARY HYPOPLASIA	0.0111532	0.39380186122682564
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.011113389	0.39239619774932133
JOUBERT SYNDROME 21	0.011050144	0.3901631167758527
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.011031804	0.38951556036738694
RETT SYNDROME, CONGENITAL VARIANT	0.011028269	0.38939074510544985
HYPOPHOSPHATASIA, INFANTILE	0.011027669	0.3893695600539188
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.011027669	0.3893695600539188
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.010973033	0.3874404492615015
PIERPONT SYNDROME	0.010966703	0.3872169469678489
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.010962254000000001	0.38705985981074625
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.3869138594972781
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.3869138594972781
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.010958119	0.3869138594972781
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.010958119	0.3869138594972781
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.3869138594972781
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.3869138594972781
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.3869138594972781
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.010958119	0.3869138594972781
ISOLATED COMPLEX I DEFICIENCY	0.010935914000000001	0.38612983604853324
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.01090295	0.38496592931741735
MUSCLE-EYE-BRAIN DISEASE	0.010851198999999999	0.3831386833144451
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010842854	0.38284403455606747
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.010842854	0.38284403455606747
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.010842854	0.38284403455606747
PEDIATRIC-ONSET GRAVES DISEASE	0.010842854	0.38284403455606747
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.010799893999999999	0.38132718486644435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.010799893999999999	0.38132718486644435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.010799893999999999	0.38132718486644435
BARDET-BIEDL SYNDROME 1; BBS1	0.010799893999999999	0.38132718486644435
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.010799893999999999	0.38132718486644435
9Q33.3Q34.11 MICRODELETION SYNDROME	0.010795759	0.3811811845529762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.010788543000000001	0.38092639899989617
ADAMS-OLIVER SYNDROME 1; AOS1	0.010788543000000001	0.38092639899989617
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.010788543000000001	0.38092639899989617
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.010777419	0.38053362814451047
INFANTILE SIALIC ACID STORAGE DISEASE	0.010717323	0.37841173338316064
20P13 MICRODELETION SYNDROME	0.010708829	0.37811182367031937
COCKAYNE SYNDROME A; CSA	0.010625129	0.3751565089817381
WOLCOTT-RALLISON SYNDROME	0.010606789	0.3745089525732723
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.010578423	0.3735073939537228
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.010550563	0.37252370139429775
DISTAL MONOSOMY 10P	0.01054668	0.3723865988024726
MONOSOMY 5P	0.01052834	0.37173904239400696
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.01052834	0.37173904239400696
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.010520933	0.3714775129328561
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.010520933	0.3714775129328561
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.010520933	0.3714775129328561
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010520933	0.3714775129328561
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010520933	0.3714775129328561
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.010520933	0.3714775129328561
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.010520933	0.3714775129328561
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010520933	0.3714775129328561
GAUCHER DISEASE TYPE 3	0.01050459	0.3709004674375695
CAMPOMELIC DYSPLASIA	0.01048625	0.37025291102910385
STUVE-WIEDEMANN SYNDROME	0.01048625	0.37025291102910385
GENITOPATELLAR SYNDROME	0.010346233	0.365309132095399
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.010346233	0.365309132095399
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010346233	0.365309132095399
PROPIONIC ACIDEMIA	0.010346233	0.365309132095399
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.010346233	0.365309132095399
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.010346233	0.365309132095399
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010346233	0.365309132095399
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.010346233	0.365309132095399
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.010346233	0.365309132095399
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0102973	0.3635813852177843
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.0102973	0.3635813852177843
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.0102973	0.3635813852177843
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.0102973	0.3635813852177843
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0102973	0.3635813852177843
RESTRICTIVE DERMOPATHY, LETHAL	0.0102973	0.3635813852177843
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.0102973	0.3635813852177843
PEMPHIGOID GESTATIONIS	0.0102973	0.3635813852177843
VACTERL/VATER ASSOCIATION	0.0102973	0.3635813852177843
TEMPLE SYNDROME	0.0102973	0.3635813852177843
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.010254339999999999	0.3620645355281612
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.010254339999999999	0.3620645355281612
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.010254339999999999	0.3620645355281612
BRANCHIOGENIC DEAFNESS SYNDROME	0.010254339999999999	0.3620645355281612
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.010247124000000002	0.3618097499750812
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.010247124000000002	0.3618097499750812
OROFACIODIGITAL SYNDROME VI	0.010247124000000002	0.3618097499750812
ERMINE PHENOTYPE	0.010236	0.36141697911969545
MICROPHTHALMIA, SYNDROMIC 1	0.010215159000000001	0.3606811163547645
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.010215159	0.36068111635476446
GAPO SYNDROME; GAPOS	0.010109289	0.3569430140121109
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.010095983	0.35647320018599066
16P12.1P12.3 TRIPLICATION SYNDROME	0.01008371	0.35603985995692305
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.010065483	0.35539629339982903
MULTIPLE SULFATASE DEFICIENCY	0.010065483	0.35539629339982903
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.010065483	0.35539629339982903
1Q44 MICRODELETION SYNDROME	0.010060124	0.35520707558123754
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.009979514	0.3523608639080411
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.009975379	0.35221486359457294
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.009975379	0.35221486359457294
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.009975379	0.35221486359457294
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.009962314	0.35175355909748435
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.009958179000000001	0.3516075587840162
CHROMOSOME 1P35 DELETION SYNDROME	0.009925353	0.3504485246147525
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0099044	0.3497087073068691
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.0099044	0.3497087073068691
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.009842769	0.3475326141220189
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.009842769	0.3475326141220189
SECKEL SYNDROME 7; SCKL7	0.009842769	0.3475326141220189
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.346192483070584
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.346192483070584
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.009804814	0.346192483070584
OROFACIODIGITAL SYNDROME XVI; OFD16	0.009804814	0.346192483070584
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.346192483070584
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.346192483070584
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.346192483070584
JOUBERT SYNDROME 33; JBTS33	0.009804814	0.346192483070584
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.346192483070584
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.009804814	0.346192483070584
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.346192483070584
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.009804814	0.346192483070584
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.346192483070584
TENORIO SYNDROME; TNORS	0.009800679	0.34604648275711586
HYPOADRENOCORTICISM, FAMILIAL	0.009800679	0.34604648275711586
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.009800679	0.34604648275711586
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.009800679	0.34604648275711586
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.009800679	0.34604648275711586
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.009800679	0.34604648275711586
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.34604648275711586
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.009800679	0.34604648275711586
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.009800679	0.34604648275711586
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.34604648275711586
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00971991	0.3431946570452637
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00967374	0.3415644673299495
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009630350000000001	0.34003243502006253
CLASSICAL EHLERS-DANLOS SYNDROME	0.009630350000000001	0.34003243502006253
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009630350000000001	0.34003243502006253
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.009605869	0.3391680496091764
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.009583393	0.33837445757882334
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.009561553	0.3376033217030932
PMM2-CDG	0.009561553	0.3376033217030932
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.009561553	0.3376033217030932
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009561553	0.3376033217030932
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.009561553	0.3376033217030932
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.009561553	0.3376033217030932
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.009561553	0.3376033217030932
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.009561553	0.3376033217030932
OKAMOTO SYNDROME	0.009554564	0.3373565511611757
PEROXISOME BIOGENESIS DISORDER 5B	0.009524064	0.336279644375014
PEROXISOME BIOGENESIS DISORDER 6B	0.009524064	0.336279644375014
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.009524064	0.336279644375014
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00951457	0.3359444262429544
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.009509789999999999	0.3357756519990903
NANCE-HORAN SYNDROME	0.009509789999999999	0.3357756519990903
15Q OVERGROWTH SYNDROME	0.009494639	0.33524069413951213
KAGAMI-OGATA SYNDROME	0.009490333	0.33508865608635763
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.33508865608635763
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.33508865608635763
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009490333	0.33508865608635763
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.33508865608635763
KAGAMI-OGATA SYNDROME	0.009490333	0.33508865608635763
SUDANOPHILIC CEREBRAL SCLEROSIS	0.00943396	0.33309821456975797
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00943396	0.33309821456975797
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00943396	0.33309821456975797
POSTERIOR CORTICAL ATROPHY	0.00943396	0.33309821456975797
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.009383934	0.33133187558993754
SRD5A3-CDG	0.009351433	0.3301843166569198
PFEIFFER SYNDROME TYPE 2	0.009351433	0.3301843166569198
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.009351433	0.3301843166569198
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.009276743	0.3275471308254964
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.009276743	0.3275471308254964
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.32692983373230083
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00925926	0.32692983373230083
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00925926	0.32692983373230083
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00925926	0.32692983373230083
AORTIC ARCH DEFECTS	0.00925926	0.32692983373230083
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00925926	0.32692983373230083
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00925926	0.32692983373230083
PAINE SYNDROME	0.00925926	0.32692983373230083
GLYCINE ENCEPHALOPATHY	0.00925926	0.32692983373230083
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00925926	0.32692983373230083
LARYNGOTRACHEAL ANGIOMA	0.00925926	0.32692983373230083
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.32692983373230083
HYDROXYLYSINURIA	0.00925926	0.32692983373230083
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.32692983373230083
BUTYRYLCHOLINESTERASE	0.00925926	0.32692983373230083
MERRF	0.00925926	0.32692983373230083
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00925926	0.32692983373230083
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.32692983373230083
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.32692983373230083
CONGENITAL LEFT VENTRICULAR ANEURYSM	0.00925926	0.32692983373230083
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.32692983373230083
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00925926	0.32692983373230083
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.32692983373230083
CARNOSINEMIA	0.00925926	0.32692983373230083
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00925926	0.32692983373230083
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.009194159	0.32463122033276287
INTELLECTUAL DISABILITY, WOLFF TYPE	0.009194159	0.32463122033276287
21Q22.11Q22.12 MICRODELETION SYNDROME	0.009194159	0.32463122033276287
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.009194159	0.32463122033276287
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.009194159	0.32463122033276287
RETINITIS PIGMENTOSA 27; RP27	0.009188660000000001	0.3244370593354808
CHROMOSOME XP11.3 DELETION SYNDROME	0.009188660000000001	0.3244370593354808
HENNEKAM-BEEMER SYNDROME	0.009175819	0.3239836639242971
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.009175819	0.3239836639242971
ADRENOMYODYSTROPHY	0.009175819	0.3239836639242971
CONO-SPONDYLAR DYSPLASIA	0.009175819	0.3239836639242971
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.009146503	0.32294856230649005
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00914415	0.3228654815960691
COLOBOMA, OCULAR	0.00914415	0.3228654815960691
GM1 GANGLIOSIDOSIS	0.009037839	0.3191118082405402
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.009020134	0.3184866726782782
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009020134	0.3184866726782782
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.009020134	0.3184866726782782
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009020134	0.3184866726782782
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.009015999	0.31834067236481006
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.009015999	0.31834067236481006
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009015999	0.31834067236481006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.009015999	0.31834067236481006
PACHYGYRIA, FRONTOTEMPORAL	0.009015999	0.31834067236481006
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.009015999	0.31834067236481006
SIFRIM-HITZ-WEISS SYNDROME	0.00900901	0.3180939018228925
SVEINSSON CHORIORETINAL ATROPHY	0.00900901	0.3180939018228925
VAN BOGAERT-HOZAY SYNDROME	0.00900901	0.3180939018228925
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00900901	0.3180939018228925
HYDRANENCEPHALY	0.009005013000000001	0.31795277407127653
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00897851	0.31701699503673086
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.31597200706154266
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.31597200706154266
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	0.31597200706154266
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3158260067480745
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.3158260067480745
OLIVER SYNDROME	0.00893619	0.31552274273540754
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.008924432999999999	0.3151076216506566
MILLER-DIEKER SYNDROME	0.008863959000000001	0.31297238030684227
FONTAINE PROGEROID SYNDROME; FPS	0.00883838	0.31206922625165434
PELGER-HUET ANOMALY; PHA	0.008833134	0.3118839982844345
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.008810014	0.3110676676321048
ECTODERMAL DYSPLASIA SYNDROME	0.008805878999999999	0.31092166731863663
KNOBLOCH SYNDROME 1; KNO1	0.008805878999999999	0.31092166731863663
TYROSINEMIA TYPE 2	0.008805878999999999	0.31092166731863663
GLIOBLASTOMA	0.008805878999999999	0.31092166731863663
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.008805878999999999	0.31092166731863663
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.008805878999999999	0.31092166731863663
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.008794863	0.3105327097725266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.008735324	0.3084304818006814
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.008735324	0.3084304818006814
AARSKOG-SCOTT SYNDROME	0.008735324	0.3084304818006814
COFFIN-SIRIS SYNDROME 7; CSS7	0.008735324	0.3084304818006814
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.008735324	0.3084304818006814
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.008735324	0.3084304818006814
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.008735324	0.3084304818006814
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.008731189	0.3082844814872132
MENTAL RETARDATION, X-LINKED 1	0.008731189	0.3082844814872132
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.008716984	0.3077829253922157
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.008716984	0.3077829253922157
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00865907	0.3057380736016003
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00865907	0.3057380736016003
BLUE CONE MONOCHROMACY; BCM	0.00865907	0.3057380736016003
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00865907	0.3057380736016003
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00865907	0.3057380736016003
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00865907	0.3057380736016003
CONE DYSTROPHY 4	0.00865907	0.3057380736016003
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00865907	0.3057380736016003
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.008652739999999999	0.3055145713079478
CRANIOFACIAL DYSSYNOSTOSIS	0.008652739999999999	0.3055145713079478
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008494383	0.29992323596577725
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.29992323596577725
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.008494383	0.29992323596577725
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.29992323596577725
ACHALASIA-MICROCEPHALY SYNDROME	0.00847458	0.29922402333999504
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00847458	0.29922402333999504
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00847458	0.29922402333999504
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.29922402333999504
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00847458	0.29922402333999504
RICHIERI COSTA-DA SILVA SYNDROME	0.00847458	0.29922402333999504
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00847458	0.29922402333999504
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00847458	0.29922402333999504
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00847458	0.29922402333999504
TUFTED ANGIOMA	0.00847458	0.29922402333999504
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00847458	0.29922402333999504
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.2967093577232595
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.2967093577232595
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.2967093577232595
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.2967093577232595
NEMALINE MYOPATHY 10	0.00840336	0.2967093577232595
SCHISIS ASSOCIATION	0.00840336	0.2967093577232595
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.2967093577232595
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.2967093577232595
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.2967093577232595
DISTAL MONOSOMY 17Q	0.00840336	0.2967093577232595
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.2967093577232595
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.2967093577232595
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.2967093577232595
HYDROLETHALUS	0.00840336	0.2967093577232595
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.2967093577232595
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.2967093577232595
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.2967093577232595
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.2967093577232595
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.2967093577232595
EBSTEIN MALFORMATION	0.00840336	0.2967093577232595
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.2967093577232595
TEMPLE SYNDROME	0.00840336	0.2967093577232595
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.2967093577232595
FATCO SYNDROME	0.00840336	0.2967093577232595
GMS SYNDROME	0.00840336	0.2967093577232595
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.2967093577232595
OMPHALOCELE	0.00840336	0.2967093577232595
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.2967093577232595
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.2967093577232595
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.2967093577232595
HEC SYNDROME	0.00840336	0.2967093577232595
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.2967093577232595
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.2967093577232595
RENAL TUBULAR DYSGENESIS	0.00840336	0.2967093577232595
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.2967093577232595
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.2967093577232595
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.2967093577232595
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.2967093577232595
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.2967093577232595
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.2967093577232595
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.2967093577232595
FOUNTAIN SYNDROME	0.008378878999999999	0.29584497231237344
FLYNN-AIRD SYNDROME	0.008378878999999999	0.29584497231237344
CADASIL	0.008378878999999999	0.29584497231237344
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.008356403	0.2950513802820204
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.008338063000000001	0.2944038238735547
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.008338063000000001	0.2944038238735547
GM2-GANGLIOSIDOSIS, AB VARIANT	0.008338063000000001	0.2944038238735547
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.008335249	0.294304465981874
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00828627	0.29257509491697525
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00826446	0.29180501829382166
VON HIPPEL-LINDAU DISEASE	0.00826446	0.29180501829382166
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00826446	0.29180501829382166
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00826446	0.29180501829382166
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00826446	0.29180501829382166
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00826446	0.29180501829382166
NEUROMYELITIS OPTICA	0.00826446	0.29180501829382166
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.00826446	0.29180501829382166
SPONDYLO-OCULAR SYNDROME	0.00826446	0.29180501829382166
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00826446	0.29180501829382166
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00826446	0.29180501829382166
BLAU SYNDROME	0.00826446	0.29180501829382166
OPTICOCOCHLEODENTATE DEGENERATION	0.00826446	0.29180501829382166
CUSHING DISEASE	0.00826446	0.29180501829382166
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00826446	0.29180501829382166
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00826446	0.29180501829382166
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00826446	0.29180501829382166
RETINAL ARTERIES, TORTUOSITY OF	0.00826446	0.29180501829382166
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00826446	0.29180501829382166
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00826446	0.29180501829382166
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00826446	0.29180501829382166
NANCE-HORAN SYNDROME	0.00826446	0.29180501829382166
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00826446	0.29180501829382166
WEILL-MARCHESANI SYNDROME	0.00826446	0.29180501829382166
PEROXISOME BIOGENESIS DISORDER 11B	0.00826446	0.29180501829382166
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00826446	0.29180501829382166
X-LINKED CORNEAL DERMOID	0.00826446	0.29180501829382166
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00826446	0.29180501829382166
CATARACT 44; CTRCT44	0.00826446	0.29180501829382166
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00826446	0.29180501829382166
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00826446	0.29180501829382166
LCAT DEFICIENCY	0.00826446	0.29180501829382166
ISOLATED ANIRIDIA	0.00826446	0.29180501829382166
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00826446	0.29180501829382166
BRITTLE CORNEA SYNDROME	0.00826446	0.29180501829382166
STICKLER SYNDROME TYPE 1	0.00826446	0.29180501829382166
CONGENITAL GLAUCOMA	0.00826446	0.29180501829382166
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.008249309	0.2912700604342434
DILATED CARDIOMYOPATHY WITH ATAXIA	0.008249309	0.2912700604342434
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.008249309	0.2912700604342434
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.008232192999999999	0.29066572153090103
HARTNUP DISEASE	0.008232192999999999	0.29066572153090103
SMITH-MAGENIS SYNDROME	0.008232192999999999	0.29066572153090103
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.008189769999999999	0.2891678324623982
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.008189769999999999	0.2891678324623982
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.008189769999999999	0.2891678324623982
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.008189769999999999	0.2891678324623982
FLOATING-HARBOR SYNDROME	0.008189769999999999	0.2891678324623982
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.008189769999999999	0.2891678324623982
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.008146253	0.28763131598327046
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.008146253	0.28763131598327046
CONGENITAL RUBELLA SYNDROME	0.008072239	0.28501799864323873
MAN1B1-CDG	0.008031413	0.2835764971202277
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.2808065869409623
300270 ADRENOMYODYSTROPHY	0.007952964	0.2808065869409623
CROME SYNDROME	0.007948829	0.2806605866274941
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.2806605866274941
HALL-RIGGS SYNDROME	0.007948829	0.2806605866274941
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.2806605866274941
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.007948829	0.2806605866274941
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.2806605866274941
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007948829	0.2806605866274941
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.007948829	0.2806605866274941
LISSENCEPHALY 5; LIS5	0.007948829	0.2806605866274941
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.2806605866274941
8P INVERTED DUPLICATION/DELETION SYNDROME	0.007948829	0.2806605866274941
FRYNS SYNDROME	0.007948829	0.2806605866274941
HEART AND BRAIN MALFORMATION SYNDROME	0.007901173000000001	0.27897792860122134
BONNEMANN-MEINECKE-REICH SYNDROME	0.00783746	0.2767283232875584
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.007826813	0.27635239454814003
MOMO SYNDROME	0.007810849000000001	0.27578873094373724
ARIMA SYNDROME	0.007796644000000001	0.27528717484873966
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.007796644000000001	0.27528717484873966
JOUBERT SYNDROME 6	0.007796644000000001	0.27528717484873966
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.007792509000000001	0.27514117453527154
TRISOMY 18P	0.00770789	0.27215341140942845
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00770789	0.27215341140942845
6Q16 MICRODELETION SYNDROME	0.007690774	0.27154907250608606
ANGELMAN SYNDROME	0.007686639	0.2714030721926179
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.007686639	0.2714030721926179
KABUKI SYNDROME	0.007686639	0.2714030721926179
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.007604834	0.2685146669584555
MALAN OVERGROWTH SYNDROME	0.007600699	0.2683686666449873
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.26791336457916587
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.26791336457916587
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.26791336457916587
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.26791336457916587
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.26791336457916587
HYPOTONIA-CYSTINURIA SYNDROME	0.007586494	0.26786711054998974
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2677673642656977
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2677673642656977
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007489994	0.2644598480954127
JOUBERT SYNDROME 24	0.007489994	0.2644598480954127
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.007489994	0.2644598480954127
IMMUNODEFICIENCY 47	0.007485858999999999	0.2643138477819445
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.007485858999999999	0.2643138477819445
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.26154393760267913
TRISOMY XQ28	0.00740741	0.26154393760267913
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.26154393760267913
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.26154393760267913
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.26154393760267913
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.26154393760267913
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.26154393760267913
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.26154393760267913
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.007390803	0.26095757068471886
ABLEPHARON MACROSTOMIA SYNDROME	0.007359754	0.2598612795764063
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.007285394000000001	0.257235745523325
VITREORETINOCHOROIDOPATHY; VRCP	0.007269430000000001	0.25667208191892227
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.007269430000000001	0.25667208191892227
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.007269430000000001	0.25667208191892227
PIERSON SYNDROME	0.007251090000000001	0.2560245255104565
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.007251090000000001	0.2560245255104565
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.007251090000000001	0.2560245255104565
EHLERS-DANLOS SYNDROME, TYPE VI	0.007251090000000001	0.2560245255104565
RECOMBINANT CHROMOSOME 8 SYNDROME	0.007208933	0.2545360284814657
MUCOLIPIDOSIS TYPE IV	0.00714522	0.25228642316780286
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.007111073000000001	0.2510807465767517
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007111073000000001	0.2510807465767517
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.007111073000000001	0.2510807465767517
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.007111073000000001	0.2510807465767517
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.007111073000000001	0.2510807465767517
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.0071082590000000005	0.2509813886850711
BANGSTAD SYNDROME	0.0071082590000000005	0.2509813886850711
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00705928	0.24925201762017232
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.2486507152408827
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.2486507152408827
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.2486507152408827
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.2486507152408827
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.2486507152408827
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.2486507152408827
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.2486507152408827
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.2486507152408827
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.2486507152408827
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.2486507152408827
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.2486507152408827
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.2486507152408827
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.2486507152408827
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.2486507152408827
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.2486507152408827
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.2486507152408827
SCHIZENCEPHALY	0.007005203	0.2473426442340981
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.007005203	0.2473426442340981
KBG SYNDROME	0.007005203	0.2473426442340981
ISOLATED GLYCEROL KINASE DEFICIENCY	0.006986862999999999	0.24669508782563235
VICI SYNDROME	0.006986862999999999	0.24669508782563235
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.006986862999999999	0.24669508782563235
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.006986862999999999	0.24669508782563235
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.006986862999999999	0.24669508782563235
CRANIOECTODERMAL DYSPLASIA 4	0.00694444	0.24519719875712953
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00694444	0.24519719875712953
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00694444	0.24519719875712953
CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS	0.00694444	0.24519719875712953
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00694444	0.24519719875712953
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00694444	0.24519719875712953
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00694444	0.24519719875712953
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00694444	0.24519719875712953
BRACHYDACTYLY, TYPE B2	0.00694444	0.24519719875712953
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00694444	0.24519719875712953
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00694444	0.24519719875712953
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.006900923	0.24366068227800178
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.006900923	0.24366068227800178
DISTAL 16P11.2 MICRODELETION SYNDROME	0.006900923	0.24366068227800178
XQ28 (MECP2) DUPLICATION	0.006900923	0.24366068227800178
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.006900923	0.24366068227800178
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.006900923	0.24366068227800178
TETRASOMY 5P	0.006900923	0.24366068227800178
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.006900923	0.24366068227800178
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006849384	0.2418409216599039
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.006845249	0.24169492134643575
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.006831044	0.24119336525143817
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.006826909	0.24104736493797
CHYLOMICRON RETENTION DISEASE	0.006814199999999999	0.24059863023812317
INTESTINAL LYMPHANGIECTASIA	0.006814199999999999	0.24059863023812317
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.006814199999999999	0.24059863023812317
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00673984	0.23797309618504187
SPINOCEREBELLAR ATAXIA TYPE 25	0.00673984	0.23797309618504187
RETINOBLASTOMA	0.00673984	0.23797309618504187
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00673984	0.23797309618504187
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00673984	0.23797309618504187
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00673984	0.23797309618504187
LEBER CONGENITAL AMAUROSIS 16	0.00673984	0.23797309618504187
FOCAL DERMAL HYPOPLASIA; FDH	0.00673984	0.23797309618504187
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00673984	0.23797309618504187
INCONTINENTIA PIGMENTI	0.006723853	0.23740862048699704
CYCLIC VOMITING SYNDROME	0.0066633790000000005	0.23527337914318264
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.006581483000000001	0.23238176084287135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.006581483	0.2323817608428713
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.006569654000000001	0.2319640975519367
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.006569654000000001	0.2319640975519367
LIGNEOUS CONJUNCTIVITIS	0.006569654000000001	0.2319640975519367
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.006569654000000001	0.2319640975519367
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.006569654000000001	0.2319640975519367
BEHÇET DISEASE	0.0065655190000000006	0.23181809723846852
SANDHOFF DISEASE	0.0065655190000000006	0.23181809723846852
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0065655190000000006	0.23181809723846852
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.0065655190000000006	0.23181809723846852
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0065655190000000006	0.23181809723846852
TAY-SACHS DISEASE; TSD	0.0065655190000000006	0.23181809723846852
COCKAYNE SYNDROME	0.006459649	0.22807999489581496
XERODERMA PIGMENTOSUM	0.006459649	0.22807999489581496
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.006459649	0.22807999489581496
PRIMARY CUTIS VERTICIS GYRATA	0.006459649	0.22807999489581496
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.006441309	0.22743243848734923
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.006441309	0.22743243848734923
ALAZAMI-YUAN SYNDROME	0.006359504	0.22454403325318678
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.006359504	0.22454403325318678
ZEBRA BODY MYOPATHY	0.006359504	0.22454403325318678
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.006359504	0.22454403325318678
HARTSFIELD SYNDROME; HRTFDS	0.006359504	0.22454403325318678
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.006359504	0.22454403325318678
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.006359504	0.22454403325318678
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.006359504	0.22454403325318678
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.006355369	0.2243980329397186
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.006355369	0.2243980329397186
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.006355369	0.2243980329397186
47,XYY SYNDROME	0.006355369	0.2243980329397186
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.006355369	0.2243980329397186
MUCOLIPIDOSIS IV; ML4	0.0061824340000000005	0.21829197146218207
COFFIN-SIRIS SYNDROME 4; CSS4	0.006145473	0.21698693697945023
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.006145473	0.21698693697945023
COFFIN-SIRIS SYNDROME 3; CSS3	0.006145473	0.21698693697945023
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.006145473	0.21698693697945023
SENGERS SYNDROME	0.00612196	0.2161567301183676
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00612196	0.2161567301183676
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.006040064	0.21326511181805632
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.006040064	0.21326511181805632
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.006040064	0.21326511181805632
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.006035929000000001	0.21311911150458818
EPISODIC ATAXIA TYPE 6	0.006035929000000001	0.21311911150458818
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.006035929000000001	0.21311911150458818
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.006035929000000001	0.21311911150458818
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.006035929000000001	0.21311911150458818
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.006024100000000001	0.21270144821365355
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.006024100000000001	0.21270144821365355
FRASER SYNDROME	0.006024100000000001	0.21270144821365355
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.006024100000000001	0.21270144821365355
FLECK RETINA, FAMILIAL BENIGN; FRFB	0.006024100000000001	0.21270144821365355
STICKLER SYNDROME, TYPE I	0.006024100000000001	0.21270144821365355
CYSTINOSIS, NEPHROPATHIC; CTNS	0.006024100000000001	0.21270144821365355
FLECK RETINA OF KANDORI	0.006024100000000001	0.21270144821365355
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.006024100000000001	0.21270144821365355
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.006024100000000001	0.21270144821365355
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.006024100000000001	0.21270144821365355
SANDHOFF DISEASE	0.006024100000000001	0.21270144821365355
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006024100000000001	0.21270144821365355
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	0.006024100000000001	0.21270144821365355
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.006024100000000001	0.21270144821365355
TEMPORAL ARTERITIS	0.006024100000000001	0.21270144821365355
MUSK, INABILITY TO SMELL	0.006024100000000001	0.21270144821365355
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.006024100000000001	0.21270144821365355
RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	0.006024100000000001	0.21270144821365355
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.006024100000000001	0.21270144821365355
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.006024100000000001	0.21270144821365355
WEILL-MARCHESANI SYNDROME 1; WMS1	0.006024100000000001	0.21270144821365355
FREESIA FLOWERS, INABILITY TO SMELL	0.006024100000000001	0.21270144821365355
USHER SYNDROME, TYPE IID; USH2D	0.006024100000000001	0.21270144821365355
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.006024100000000001	0.21270144821365355
SORSBY FUNDUS DYSTROPHY; SFD	0.006024100000000001	0.21270144821365355
RETINITIS PIGMENTOSA 71; RP71	0.006024100000000001	0.21270144821365355
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G	0.006024100000000001	0.21270144821365355
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.006024100000000001	0.21270144821365355
RETINITIS PIGMENTOSA 35; RP35	0.006024100000000001	0.21270144821365355
RETINITIS PIGMENTOSA	0.006024100000000001	0.21270144821365355
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.006024100000000001	0.21270144821365355
HERPES SIMPLEX VIRUS STROMAL KERATITIS	0.006024100000000001	0.21270144821365355
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.006024100000000001	0.21270144821365355
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.006024100000000001	0.21270144821365355
RODRIGUES BLINDNESS	0.006024100000000001	0.21270144821365355
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.006024100000000001	0.21270144821365355
RETINITIS PIGMENTOSA 29; RP29	0.006024100000000001	0.21270144821365355
LEBER CONGENITAL AMAUROSIS, TYPE II	0.006024100000000001	0.21270144821365355
SARCOIDOSIS	0.006024100000000001	0.21270144821365355
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	0.006024100000000001	0.21270144821365355
IDIOPATHIC PANUVEITIS	0.006024100000000001	0.21270144821365355
NON-24-HOUR SLEEP-WAKE SYNDROME	0.006024100000000001	0.21270144821365355
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.006024100000000001	0.21270144821365355
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.006024100000000001	0.21270144821365355
MUCOUS MEMBRANE PEMPHIGOID	0.006024100000000001	0.21270144821365355
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.006024100000000001	0.21270144821365355
COGAN SYNDROME	0.006024100000000001	0.21270144821365355
WEILL-MARCHESANI SYNDROME 2; WMS2	0.006024100000000001	0.21270144821365355
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.006024100000000001	0.21270144821365355
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005981943	0.2112129511846628
GLYCEROL KINASE DEFICIENCY; GKD	0.005981943	0.2112129511846628
2P21 MICRODELETION SYNDROME	0.005963603	0.21056539477619707
VICI SYNDROME; VICIS	0.005963603	0.21056539477619707
KLEEFSTRA SYNDROME 2; KLEFS2	0.005963603	0.21056539477619707
COACH SYNDROME	0.005963603	0.21056539477619707
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00581395	0.20528138391490364
GERMAN SYNDROME	0.00581395	0.20528138391490364
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00581395	0.20528138391490364
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00581395	0.20528138391490364
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00581395	0.20528138391490364
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00581395	0.20528138391490364
EMERY-NELSON SYNDROME	0.00581395	0.20528138391490364
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.00581395	0.20528138391490364
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.00581395	0.20528138391490364
BETHLEM MYOPATHY 1	0.00581395	0.20528138391490364
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00581395	0.20528138391490364
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00581395	0.20528138391490364
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00581395	0.20528138391490364
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00581395	0.20528138391490364
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00581395	0.20528138391490364
NEMALINE MYOPATHY 3; NEM3	0.00581395	0.20528138391490364
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.00581395	0.20528138391490364
BETHLEM MYOPATHY	0.00581395	0.20528138391490364
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00581395	0.20528138391490364
RADICULONEUROPATHY, FATAL NEONATAL	0.00581395	0.20528138391490364
TYPICAL NEMALINE MYOPATHY	0.00581395	0.20528138391490364
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00581395	0.20528138391490364
FG SYNDROME 2; FGS2	0.00581395	0.20528138391490364
AMISH NEMALINE MYOPATHY	0.00581395	0.20528138391490364
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00581395	0.20528138391490364
MYOPATHY AND DIABETES MELLITUS	0.00581395	0.20528138391490364
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00581395	0.20528138391490364
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00581395	0.20528138391490364
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00581395	0.20528138391490364
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00581395	0.20528138391490364
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00581395	0.20528138391490364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.005759873	0.20337201052882942
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.005759873	0.20337201052882942
ARGININEMIA	0.0057598729999999996	0.2033720105288294
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.0057598729999999996	0.2033720105288294
CENTRAL BILATERAL MACROGYRIA	0.0057598729999999996	0.2033720105288294
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.0057598729999999996	0.2033720105288294
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0057598729999999996	0.2033720105288294
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0057598729999999996	0.2033720105288294
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0057598729999999996	0.2033720105288294
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0057598729999999996	0.2033720105288294
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00563688	0.1990293221238989
MOEBIUS SYNDROME	0.00563688	0.1990293221238989
PETERS PLUS SYNDROME	0.005604054	0.1978702879546352
FILIPPI SYNDROME; FLPIS	0.005599919	0.19772428764116703
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.005599919	0.19772428764116703
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00554358	0.19573504661082075
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00554358	0.19573504661082075
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.005496862999999999	0.19408554319019405
OCULOCUTANEOUS ALBINISM TYPE 5	0.00549451	0.19400246247977315
RETINITIS PIGMENTOSA 77; RP77	0.00549451	0.19400246247977315
PSEUDOXANTHOMA ELASTICUM; PXE	0.00549451	0.19400246247977315
STARGARDT DISEASE 3; STGD3	0.00549451	0.19400246247977315
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00549451	0.19400246247977315
RETINITIS PIGMENTOSA 76; RP76	0.00549451	0.19400246247977315
NANOPHTHALMOS 4; NNO4	0.00549451	0.19400246247977315
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.00549451	0.19400246247977315
INTERMEDIATE UVEITIS	0.00549451	0.19400246247977315
PRIMARY HYPEROXALURIA	0.00549451	0.19400246247977315
RETINITIS PIGMENTOSA 60; RP60	0.00549451	0.19400246247977315
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00549451	0.19400246247977315
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00549451	0.19400246247977315
CONE-ROD DYSTROPHY 21; CORD21	0.00549451	0.19400246247977315
CORNEAL DYSTROPHY, MEESMANN	0.00549451	0.19400246247977315
DERMOCHONDROCORNEAL DYSTROPHY	0.00549451	0.19400246247977315
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00549451	0.19400246247977315
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.00549451	0.19400246247977315
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00549451	0.19400246247977315
RAMOS-ARROYO SYNDROME	0.00549451	0.19400246247977315
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00549451	0.19400246247977315
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00549451	0.19400246247977315
RETINITIS PIGMENTOSA 56; RP56	0.00549451	0.19400246247977315
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.00549451	0.19400246247977315
KERATOCONUS 9; KTCN9	0.00549451	0.19400246247977315
CONE-ROD DYSTROPHY 5; CORD5	0.00549451	0.19400246247977315
MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	0.00549451	0.19400246247977315
MADRAS MOTOR NEURON DISEASE	0.00549451	0.19400246247977315
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00549451	0.19400246247977315
RETINITIS PIGMENTOSA 51; RP51	0.00549451	0.19400246247977315
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.00549451	0.19400246247977315
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00549451	0.19400246247977315
OCULOCUTANEOUS ALBINISM TYPE 6	0.00549451	0.19400246247977315
FRIEDREICH ATAXIA	0.00549451	0.19400246247977315
SENIOR-LOKEN SYNDROME 8; SLSN8	0.00549451	0.19400246247977315
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.00549451	0.19400246247977315
RETINITIS PIGMENTOSA 85; RP85	0.00549451	0.19400246247977315
IRVAN SYNDROME	0.00549451	0.19400246247977315
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00549451	0.19400246247977315
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00549451	0.19400246247977315
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4	0.00549451	0.19400246247977315
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00549451	0.19400246247977315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.005478523	0.19343798678172835
RFT1-CDG	0.005478523	0.19343798678172835
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.005478523	0.19343798678172835
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.005453233	0.19254503685969462
EMANUEL SYNDROME	0.005453233	0.19254503685969462
BOHRING-OPITZ SYNDROME	0.005453233	0.19254503685969462
WOLF-HIRSCHHORN SYNDROME	0.005453233	0.19254503685969462
SMITH-LEMLI-OPITZ SYNDROME	0.005453233	0.19254503685969462
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.005453233	0.19254503685969462
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.005453233	0.19254503685969462
COHEN SYNDROME	0.005453233	0.19254503685969462
COFFIN-SIRIS SYNDROME	0.005453233	0.19254503685969462
19P13.12 MICRODELETION SYNDROME	0.005453233	0.19254503685969462
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.005453233	0.19254503685969462
22Q11.2 DELETION SYNDROME	0.005453233	0.19254503685969462
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.005440524	0.19209630215984783
JOUBERT SYNDROME 14	0.005440524	0.19209630215984783
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.005440524	0.19209630215984783
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.005440524	0.19209630215984783
NEPHRONOPHTHISIS 11; NPHP11	0.005440524	0.19209630215984783
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.005440524	0.19209630215984783
DUPLICATION/INVERSION 15Q11	0.005436389	0.19195030184637965
ACROCALLOSAL SYNDROME; ACLS	0.005436389	0.19195030184637965
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.005422184	0.19144874575138207
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.005422184	0.19144874575138207
THYROID HEMIAGENESIS	0.005422184	0.19144874575138207
GALACTOSE EPIMERASE DEFICIENCY	0.005422184	0.19144874575138207
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.005422184	0.19144874575138207
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.005422184	0.19144874575138207
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.005422184	0.19144874575138207
FAMILIAL DYSAUTONOMIA	0.005418049	0.19130274543791395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.005418049	0.19130274543791395
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.005418049	0.19130274543791395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.005418049	0.19130274543791395
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.005418049	0.19130274543791395
14Q12 MICRODELETION SYNDROME	0.005418049	0.19130274543791395
LATHOSTEROLOSIS	0.005418049	0.19130274543791395
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.005218454	0.1842553615040144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.005218454	0.1842553615040144
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.005218454	0.1842553615040144
SYMMETRICAL THALAMIC CALCIFICATIONS	0.005214319	0.18410936119054624
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.18410936119054624
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.18410936119054624
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.005214319	0.18410936119054624
HUNTINGTON DISEASE-LIKE 1	0.005214319	0.18410936119054624
NEUROCUTANEOUS MELANOCYTOSIS	0.005214319	0.18410936119054624
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.005214319	0.18410936119054624
PARTINGTON SYNDROME	0.005214319	0.18410936119054624
RETT SYNDROME	0.005214319	0.18410936119054624
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.005214319	0.18410936119054624
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.18410936119054624
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.18410936119054624
DERMOTRICHIC SYNDROME	0.005214319	0.18410936119054624
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.005214319	0.18410936119054624
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.18410936119054624
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.18410936119054624
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.18410936119054624
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.18410936119054624
AUTISM	0.005214319	0.18410936119054624
EPILEPSY, READING	0.005214319	0.18410936119054624
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.005214319	0.18410936119054624
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.18410936119054624
ATYPICAL RETT SYNDROME	0.005214319	0.18410936119054624
ZLOTOGORA-OGUR SYNDROME	0.005214319	0.18410936119054624
SUPRABULBAR PARESIS, CONGENITAL	0.005214319	0.18410936119054624
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.18410936119054624
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005214319	0.18410936119054624
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.005214319	0.18410936119054624
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.18410936119054624
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.18410936119054624
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.18410936119054624
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.005214319	0.18410936119054624
PHAKOMATOSIS PIGMENTOVASCULARIS	0.005214319	0.18410936119054624
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.18410936119054624
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.005214319	0.18410936119054624
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.18410936119054624
OSTEOGENESIS IMPERFECTA	0.0050585	0.17860763861635204
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0050585	0.17860763861635204
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004955444	0.17496889416537906
TREACHER-COLLINS SYNDROME	0.004955444	0.17496889416537906
HYPERTRYPTOPHANEMIA; HYPTRP	0.004955444	0.17496889416537906
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.004951309	0.17482289385191094
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.004951309	0.17482289385191094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004951309	0.17482289385191094
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0049371039999999995	0.17432133775691333
INFANTILE NEUROAXONAL DYSTROPHY	0.004932969	0.17417533744344518
TRIPLE A SYNDROME	0.004932969	0.17417533744344518
KALLMANN SYNDROME	0.004932969	0.17417533744344518
TRISOMY 17P	0.0049118140000000005	0.17342838783487965
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0049118140000000005	0.17342838783487965
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0049118140000000005	0.17342838783487965
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004907679	0.17328238752141148
MARDEN-WALKER SYNDROME	0.004907679	0.17328238752141148
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00489497	0.17283365282156465
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00487663	0.17218609641309893
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00487663	0.17218609641309893
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00487663	0.17218609641309893
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00487663	0.17218609641309893
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00487663	0.17218609641309893
HYPOTONIA-CYSTINURIA SYNDROME	0.00487663	0.17218609641309893
ESOPHAGEAL ATRESIA	0.00487663	0.17218609641309893
GLYCOGEN STORAGE DISEASE IXC	0.00487663	0.17218609641309893
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.004736613000000001	0.16724231747939414
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.004736613000000001	0.16724231747939414
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004736613000000001	0.16724231747939414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.004736613	0.1672423174793941
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.004736613	0.1672423174793941
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.004736613	0.1672423174793941
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004736613	0.1672423174793941
RING CHROMOSOME 22 SYNDROME	0.004736613	0.1672423174793941
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.004736613	0.1672423174793941
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004736613	0.1672423174793941
CLASSIC PHENYLKETONURIA	0.004736613	0.1672423174793941
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.004736613	0.1672423174793941
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004736613	0.1672423174793941
ARGININOSUCCINIC ACIDURIA	0.0046729	0.16499271216573122
HUNTINGTON DISEASE	0.0046729	0.16499271216573122
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.16499271216573122
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.0046729	0.16499271216573122
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.0046729	0.16499271216573122
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.16499271216573122
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.16499271216573122
ISAAC SYNDROME	0.0046729	0.16499271216573122
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.0046729	0.16499271216573122
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0046729	0.16499271216573122
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.16499271216573122
SCHIZOPHRENIA	0.0046729	0.16499271216573122
SACCHAROPINURIA	0.0046729	0.16499271216573122
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.0046729	0.16499271216573122
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.16499271216573122
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0046729	0.16499271216573122
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.16499271216573122
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.16499271216573122
OCULOCUTANEOUS ALBINISM TYPE 4	0.00440989	0.1557062448270959
X-LINKED RETINAL DYSPLASIA	0.00440989	0.1557062448270959
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00440989	0.1557062448270959
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00440989	0.1557062448270959
APERT SYNDROME	0.00440989	0.1557062448270959
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00440989	0.1557062448270959
RENAL COLOBOMA SYNDROME	0.00440989	0.1557062448270959
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00440989	0.1557062448270959
BUSCHKE-OLLENDORFF SYNDROME	0.00440989	0.1557062448270959
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00440989	0.1557062448270959
SPASTIC PARAPLEGIA 16, X-LINKED	0.00440989	0.1557062448270959
ACRO-RENAL-OCULAR SYNDROME	0.00440989	0.1557062448270959
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00440989	0.1557062448270959
OCULOCUTANEOUS ALBINISM TYPE 2	0.00440989	0.1557062448270959
HALLERMANN-STREIFF SYNDROME	0.00440989	0.1557062448270959
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00439155	0.1550586884186302
MARFAN SYNDROME	0.00439155	0.1550586884186302
FETAL METHYLMERCURY SYNDROME	0.00439155	0.1550586884186302
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00439155	0.1550586884186302
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00439155	0.1550586884186302
ABETALIPOPROTEINEMIA	0.00439155	0.1550586884186302
GOLDENHAR SYNDROME	0.00439155	0.1550586884186302
JOHANSON-BLIZZARD SYNDROME; JBS	0.00436626	0.15416573849659648
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.004251533	0.1501149094849254
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004251533	0.1501149094849254
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.004251533	0.1501149094849254
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004251533	0.1501149094849254
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.004251533	0.1501149094849254
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004251533	0.1501149094849254
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.004251533	0.1501149094849254
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004251533	0.1501149094849254
COFFIN-SIRIS SYNDROME 2; CSS2	0.004251533	0.1501149094849254
JABERI-ELAHI SYNDROME; JABELS	0.004251533	0.1501149094849254
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004251533	0.1501149094849254
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.004251533	0.1501149094849254
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.004251533	0.1501149094849254
BOHRING-OPITZ SYNDROME	0.004226243	0.14922195956289167
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.004226243	0.14922195956289167
MATERNAL PHENYLKETONURIA	0.004226243	0.14922195956289167
15Q24 MICRODELETION SYNDROME	0.004226243	0.14922195956289167
DISTAL MONOSOMY 15Q	0.004226243	0.14922195956289167
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.004226243	0.14922195956289167
8P23.1 MICRODELETION SYNDROME	0.004226243	0.14922195956289167
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.004207903	0.14857440315442594
LATHOSTEROLOSIS	0.004207903	0.14857440315442594
FILIPPI SYNDROME	0.004207903	0.14857440315442594
WOLMAN DISEASE	0.004195194	0.1481256684545791
LIG4 SYNDROME	0.004195194	0.1481256684545791
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.004195194	0.1481256684545791
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.004195194	0.1481256684545791
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.004195194	0.1481256684545791
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.004195194	0.1481256684545791
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.004195194	0.1481256684545791
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.004195194	0.1481256684545791
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.004195194	0.1481256684545791
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.004195194	0.1481256684545791
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.004195194	0.1481256684545791
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.004195194	0.1481256684545791
JOUBERT SYNDROME 10	0.004195194	0.1481256684545791
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004195194	0.1481256684545791
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.004195194	0.1481256684545791
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.004195194	0.1481256684545791
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004195194	0.1481256684545791
MONOSOMY 13Q34	0.004195194	0.1481256684545791
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.004195194	0.1481256684545791
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0041910590000000005	0.147979668141111
ZIMMERMANN-LABAND SYNDROME	0.0041910590000000005	0.147979668141111
HEREDITARY FRUCTOSE INTOLERANCE	0.0041910590000000005	0.147979668141111
THREONINEMIA	0.0041910590000000005	0.147979668141111
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.0041910590000000005	0.147979668141111
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0041910590000000005	0.147979668141111
20Q13.33 MICRODELETION SYNDROME	0.0041910590000000005	0.147979668141111
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.0041910590000000005	0.147979668141111
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0041910590000000005	0.147979668141111
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0041910590000000005	0.147979668141111
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0037101139999999996	0.13099826046011037
CRANIOTELENCEPHALIC DYSPLASIA	0.0037101139999999996	0.13099826046011037
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0037101139999999996	0.13099826046011037
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0037101139999999996	0.13099826046011037
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0037101139999999996	0.13099826046011037
N SYNDROME	0.0037101139999999996	0.13099826046011037
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0037101139999999996	0.13099826046011037
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.003705979	0.13085226014664222
MICROPHTHALMIA, LENZ TYPE	0.003705979	0.13085226014664222
PAPILLOMA OF CHOROID PLEXUS	0.003705979	0.13085226014664222
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003705979	0.13085226014664222
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003705979	0.13085226014664222
GRANULOMATOSIS WITH POLYANGIITIS	0.003705979	0.13085226014664222
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0036848239999999997	0.13010531053807667
FLOATING-HARBOR SYNDROME	0.0036848239999999997	0.13010531053807667
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0036848239999999997	0.13010531053807667
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0036848239999999997	0.13010531053807667
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0036848239999999997	0.13010531053807667
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0036848239999999997	0.13010531053807667
DISTAL TRISOMY 6P	0.0036848239999999997	0.13010531053807667
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0036848239999999997	0.13010531053807667
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0036848239999999997	0.13010531053807667
FETAL TRIMETHADIONE SYNDROME	0.0036848239999999997	0.13010531053807667
FETAL HYDANTOIN SYNDROME	0.0036848239999999997	0.13010531053807667
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0036848239999999997	0.13010531053807667
SECKEL SYNDROME 1; SCKL1	0.003680689	0.12995931022460852
BRANCHIOOCULOFACIAL SYNDROME	0.003680689	0.12995931022460852
DUBOWITZ SYNDROME	0.003680689	0.12995931022460852
MARDEN-WALKER SYNDROME	0.0036664840000000002	0.12945775412961094
TRISOMY 18	0.0036664840000000002	0.12945775412961094
RITSCHER-SCHINZEL SYNDROME 1	0.0036664840000000002	0.12945775412961094
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.0036664840000000002	0.12945775412961094
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0036664840000000002	0.12945775412961094
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0036664840000000002	0.12945775412961094
COLE-CARPENTER SYNDROME	0.0036664840000000002	0.12945775412961094
XQ27.3Q28 DUPLICATION SYNDROME	0.0036664840000000002	0.12945775412961094
12Q14 MICRODELETION SYNDROME	0.0036664840000000002	0.12945775412961094
20Q11.2 MICRODELETION SYNDROME	0.0036664840000000002	0.12945775412961094
CUTIS LAXA	0.0036664840000000002	0.12945775412961094
DISTAL MONOSOMY 3P	0.003662349	0.1293117538161428
RING CHROMOSOME 10 SYNDROME	0.003662349	0.1293117538161428
WIEDEMANN-STEINER SYNDROME	0.003662349	0.1293117538161428
THANATOPHORIC DYSPLASIA	0.003662349	0.1293117538161428
ACROCARDIOFACIAL SYNDROME	0.003662349	0.1293117538161428
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.003662349	0.1293117538161428
DISTAL TRISOMY 15Q	0.003662349	0.1293117538161428
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00364964	0.12886301911629597
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00364964	0.12886301911629597
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00364964	0.12886301911629597
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00364964	0.12886301911629597
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00364964	0.12886301911629597
3MC SYNDROME 3	0.00364964	0.12886301911629597
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00364964	0.12886301911629597
HARDIKAR SYNDROME	0.00364964	0.12886301911629597
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00364964	0.12886301911629597
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00364964	0.12886301911629597
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00364964	0.12886301911629597
MAJEED SYNDROME	0.00364964	0.12886301911629597
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00364964	0.12886301911629597
CRYPTOSPORIDIOSIS	0.00364964	0.12886301911629597
AXENFELD-RIEGER SYNDROME	0.00364964	0.12886301911629597
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00364964	0.12886301911629597
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00364964	0.12886301911629597
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00364964	0.12886301911629597
CERNUNNOS-XLF DEFICIENCY	0.00364964	0.12886301911629597
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00364964	0.12886301911629597
FRANK-TER HAAR SYNDROME; FTHS	0.00364964	0.12886301911629597
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00364964	0.12886301911629597
DIAMOND-BLACKFAN ANEMIA 9	0.00364964	0.12886301911629597
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00364964	0.12886301911629597
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00364964	0.12886301911629597
AROMATASE DEFICIENCY	0.00364964	0.12886301911629597
CUSHING SYNDROME	0.00364964	0.12886301911629597
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00364964	0.12886301911629597
JUVENILE POLYPOSIS SYNDROME	0.00364964	0.12886301911629597
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00364964	0.12886301911629597
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00364964	0.12886301911629597
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00364964	0.12886301911629597
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00364964	0.12886301911629597
ACHALASIA-MICROCEPHALY SYNDROME	0.00364964	0.12886301911629597
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00364964	0.12886301911629597
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00364964	0.12886301911629597
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00364964	0.12886301911629597
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00364964	0.12886301911629597
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00364964	0.12886301911629597
T-SUBSTANCE ANOMALY	0.00364964	0.12886301911629597
FORMIMINOTRANSFERASE DEFICIENCY	0.00364964	0.12886301911629597
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00364964	0.12886301911629597
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00364964	0.12886301911629597
NEPHRONOPHTHISIS 1	0.00364964	0.12886301911629597
TYROSINE TRANSAMINASE DEFICIENCY	0.00364964	0.12886301911629597
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00364964	0.12886301911629597
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00364964	0.12886301911629597
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00364964	0.12886301911629597
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00364964	0.12886301911629597
CINCA SYNDROME; CINCA	0.00364964	0.12886301911629597
BARTH SYNDROME; BTHS	0.00364964	0.12886301911629597
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.00364964	0.12886301911629597
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00364964	0.12886301911629597
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00364964	0.12886301911629597
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00364964	0.12886301911629597
SERKAL SYNDROME	0.00364964	0.12886301911629597
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00364964	0.12886301911629597
LYSINE MALABSORPTION SYNDROME	0.00364964	0.12886301911629597
FAMILIAL HYPOALDOSTERONISM	0.00364964	0.12886301911629597
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00364964	0.12886301911629597
RING CHROMOSOME 13 SYNDROME	0.00364964	0.12886301911629597
NATHALIE SYNDROME	0.00364964	0.12886301911629597
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00364964	0.12886301911629597
HEREDITARY SPHEROCYTOSIS	0.00364964	0.12886301911629597
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00364964	0.12886301911629597
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00364964	0.12886301911629597
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00364964	0.12886301911629597
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00364964	0.12886301911629597
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00364964	0.12886301911629597
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00364964	0.12886301911629597
CHYLOMICRON RETENTION DISEASE	0.00364964	0.12886301911629597
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00364964	0.12886301911629597
NEPHRONOPHTHISIS 4	0.00364964	0.12886301911629597
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00364964	0.12886301911629597
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00364964	0.12886301911629597
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00364964	0.12886301911629597
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00364964	0.12886301911629597
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00364964	0.12886301911629597
GLYCOGEN STORAGE DISEASE IXA	0.00364964	0.12886301911629597
CITRULLINE TRANSPORT DEFECT	0.00364964	0.12886301911629597
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.12886301911629597
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.00364964	0.12886301911629597
ALPHA-HEAVY CHAIN DISEASE	0.00364964	0.12886301911629597
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00364964	0.12886301911629597
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.003559293	0.1256730093651698
CHROMOSOME 16P13.3 DELETION SYNDROME	0.003559293	0.1256730093651698
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.003559293	0.1256730093651698
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.003559293	0.1256730093651698
MONOSOMY 9Q22.3	0.003559293	0.1256730093651698
KABUKI SYNDROME 1	0.003559293	0.1256730093651698
2Q31.1 MICRODELETION SYNDROME	0.003559293	0.1256730093651698
MONOSOMY 9P	0.003559293	0.1256730093651698
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.003559293	0.1256730093651698
15Q13.3 MICRODELETION SYNDROME	0.003559293	0.1256730093651698
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.003559293	0.1256730093651698
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.003559293	0.1256730093651698
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.003559293	0.1256730093651698
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.003559293	0.1256730093651698
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.003559293	0.1256730093651698
C SYNDROME	0.003559293	0.1256730093651698
49,XXXXY SYNDROME	0.003559293	0.1256730093651698
WEAVER SYNDROME	0.003559293	0.1256730093651698
1Q21.1 MICRODUPLICATION SYNDROME	0.003559293	0.1256730093651698
48,XXXY SYNDROME	0.003559293	0.1256730093651698
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.003559293	0.1256730093651698
CHROMOSOME 10Q26 DELETION SYNDROME	0.003559293	0.1256730093651698
WIEDEMANN-STEINER SYNDROME; WDSTS	0.003559293	0.1256730093651698
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.11173561112182721
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.11173561112182721
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00316456	0.11173561112182721
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00316456	0.11173561112182721
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.11173561112182721
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.11173561112182721
JALILI SYNDROME	0.00316456	0.11173561112182721
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.11173561112182721
PROLIDASE DEFICIENCY	0.00316456	0.11173561112182721
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00316456	0.11173561112182721
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.11173561112182721
FISH-EYE DISEASE	0.00316456	0.11173561112182721
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.11173561112182721
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00316456	0.11173561112182721
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.11173561112182721
PSEUDOXANTHOMA ELASTICUM	0.00316456	0.11173561112182721
CONE ROD DYSTROPHY	0.00316456	0.11173561112182721
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00316456	0.11173561112182721
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00316456	0.11173561112182721
WAGR SYNDROME	0.00316456	0.11173561112182721
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00316456	0.11173561112182721
BRADYOPSIA	0.00316456	0.11173561112182721
GAPO SYNDROME	0.00316456	0.11173561112182721
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.11173561112182721
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.11173561112182721
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.11173561112182721
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.11173561112182721
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.11173561112182721
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00316456	0.11173561112182721
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.11173561112182721
VOGT-KOYANAGI-HARADA DISEASE	0.00316456	0.11173561112182721
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.11173561112182721
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.11173561112182721
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.11173561112182721
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.11173561112182721
BROOKE-SPIEGLER SYNDROME	0.00316456	0.11173561112182721
NEUROFIBROMATOSIS TYPE 2	0.00316456	0.11173561112182721
BETA-THALASSEMIA MAJOR	0.00316456	0.11173561112182721
CYSTINOSIS	0.00316456	0.11173561112182721
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.11173561112182721
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.11173561112182721
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.11173561112182721
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.11173561112182721
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.11173561112182721
GILLESPIE SYNDROME; GLSP	0.00316456	0.11173561112182721
TANGIER DISEASE; TGD	0.00316456	0.11173561112182721
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.11173561112182721
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00316456	0.11173561112182721
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.11173561112182721
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00316456	0.11173561112182721
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00316456	0.11173561112182721
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00316456	0.11173561112182721
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.11173561112182721
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.11173561112182721
ATAXIA WITH VITAMIN E DEFICIENCY	0.00316456	0.11173561112182721
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00316456	0.11173561112182721
MMEP SYNDROME	0.00316456	0.11173561112182721
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11173561112182721
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.11173561112182721
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.11173561112182721
ERDHEIM-CHESTER DISEASE	0.00316456	0.11173561112182721
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.11173561112182721
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.11173561112182721
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.11173561112182721
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.11173561112182721
BLUE CONE MONOCHROMATISM	0.00316456	0.11173561112182721
MUCOLIPIDOSIS TYPE III	0.00316456	0.11173561112182721
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.11173561112182721
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00316456	0.11173561112182721
ASCHER SYNDROME	0.00316456	0.11173561112182721
N SYNDROME	0.00316456	0.11173561112182721
MALT LYMPHOMA	0.00316456	0.11173561112182721
ACRODERMATITIS ENTEROPATHICA	0.00316456	0.11173561112182721
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.11173561112182721
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.11173561112182721
ALBINISM, OCULAR, TYPE I	0.00316456	0.11173561112182721
MANGANESE POISONING	0.00316456	0.11173561112182721
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00313927	0.11084266119979352
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00313927	0.11084266119979352
MOSAIC MONOSOMY X	0.00313927	0.11084266119979352
ELLIS VAN CREVELD SYNDROME	0.00313927	0.11084266119979352
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00313927	0.11084266119979352
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00313927	0.11084266119979352
PROGEROID SYNDROME, PETTY TYPE	0.00313927	0.11084266119979352
BRANCHIO-OCULO-FACIAL SYNDROME	0.00313927	0.11084266119979352
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00313927	0.11084266119979352
MONOSOMY X	0.00313927	0.11084266119979352
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00313927	0.11084266119979352
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00313927	0.11084266119979352
LAMBOTTE SYNDROME	0.00313927	0.11084266119979352
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00313927	0.11084266119979352
ALAGILLE SYNDROME	0.00313927	0.11084266119979352
TURNER SYNDROME	0.00313927	0.11084266119979352
MEIER-GORLIN SYNDROME 1; MGORS1	0.00313927	0.11084266119979352
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00312093	0.11019510479132778
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00312093	0.11019510479132778
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00312093	0.11019510479132778
THAKKER-DONNAI SYNDROME	0.00312093	0.11019510479132778
MONOSOMY 13Q14	0.00312093	0.11019510479132778
DIASTROPHIC DWARFISM	0.00312093	0.11019510479132778
CAT-EYE SYNDROME	0.00312093	0.11019510479132778
LAMBERT SYNDROME	0.00312093	0.11019510479132778
IMAGE SYNDROME	0.00312093	0.11019510479132778
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00312093	0.11019510479132778
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00312093	0.11019510479132778
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00312093	0.11019510479132778
JOHANSON-BLIZZARD SYNDROME	0.00312093	0.11019510479132778
PEARSON SYNDROME	0.00312093	0.11019510479132778
MATTHEW-WOOD SYNDROME	0.00312093	0.11019510479132778
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00312093	0.11019510479132778
NEUROFACIODIGITORENAL SYNDROME	0.00312093	0.11019510479132778
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0030178740000000003	0.10655636034035482
TOLUENE EMBRYOPATHY	0.0030178740000000003	0.10655636034035482
HADZISELIMOVIC SYNDROME	0.0030178740000000003	0.10655636034035482
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.0030178740000000003	0.10655636034035482
CRANIOSYNOSTOSIS 6; CRS6	0.0030178740000000003	0.10655636034035482
GERMAN SYNDROME	0.0030178740000000003	0.10655636034035482
MARINESCO-SJÖGREN SYNDROME	0.0030178740000000003	0.10655636034035482
2Q32Q33 MICRODELETION SYNDROME	0.0030178740000000003	0.10655636034035482
ARTERIAL TORTUOSITY SYNDROME	0.0030178740000000003	0.10655636034035482
CODAS SYNDROME	0.0030178740000000003	0.10655636034035482
MOWAT-WILSON SYNDROME	0.003013739	0.10641036002688668
5Q14.3 MICRODELETION SYNDROME	0.003013739	0.10641036002688668
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003013739	0.10641036002688668
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.003013739	0.10641036002688668
CHROMOSOME 18Q DELETION SYNDROME	0.003013739	0.10641036002688668
PALLISTER-KILLIAN SYNDROME	0.003013739	0.10641036002688668
FRAGILE X SYNDROME	0.003013739	0.10641036002688668
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.003013739	0.10641036002688668
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.003013739	0.10641036002688668
NOONAN SYNDROME 7; NS7	0.003013739	0.10641036002688668
LEIGH SYNDROME	0.003013739	0.10641036002688668
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.002980913	0.10525132585762298
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.002980913	0.10525132585762298
STT3B-CDG	0.002980913	0.10525132585762298
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002980913	0.10525132585762298
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.002980913	0.10525132585762298
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.002980913	0.10525132585762298
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002980913	0.10525132585762298
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002980913	0.10525132585762298
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.002980913	0.10525132585762298
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.002980913	0.10525132585762298
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002980913	0.10525132585762298
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002980913	0.10525132585762298
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.002980913	0.10525132585762298
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.002980913	0.10525132585762298
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.002980913	0.10525132585762298
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.002980913	0.10525132585762298
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.002980913	0.10525132585762298
CATEL-MANZKE SYNDROME; CATMANS	0.002980913	0.10525132585762298
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.002980913	0.10525132585762298
AL KAISSI SYNDROME; ALKAS	0.002980913	0.10525132585762298
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.002980913	0.10525132585762298
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.002980913	0.10525132585762298
RUVALCABA SYNDROME	0.002980913	0.10525132585762298
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002980913	0.10525132585762298
COFFIN-SIRIS SYNDROME 5	0.002980913	0.10525132585762298
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.002980913	0.10525132585762298
PETERS-PLUS SYNDROME; PTRPLS	0.002980913	0.10525132585762298
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002980913	0.10525132585762298
MACDERMOT-WINTER SYNDROME	0.002980913	0.10525132585762298
PALLISTER-HALL SYNDROME	0.002980913	0.10525132585762298
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00247232	0.08729371100207167
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00247232	0.08729371100207167
STEINERT MYOTONIC DYSTROPHY	0.00247232	0.08729371100207167
TRISOMY 20P	0.00247232	0.08729371100207167
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00247232	0.08729371100207167
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00247232	0.08729371100207167
TRISOMY 4P	0.00247232	0.08729371100207167
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00247232	0.08729371100207167
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00247232	0.08729371100207167
NON-DISTAL MONOSOMY 10Q	0.00247232	0.08729371100207167
8Q21.11 MICRODELETION SYNDROME	0.00247232	0.08729371100207167
NOONAN SYNDROME	0.00247232	0.08729371100207167
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00247232	0.08729371100207167
TETRASOMY 12P	0.00247232	0.08729371100207167
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00247232	0.08729371100207167
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00247232	0.08729371100207167
6P22 MICRODELETION SYNDROME	0.00247232	0.08729371100207167
COOPER-JABS SYNDROME	0.00247232	0.08729371100207167
REVESZ SYNDROME	0.002439494	0.08613467683280797
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002439494	0.08613467683280797
MOSAIC TRISOMY 9	0.002439494	0.08613467683280797
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.002439494	0.08613467683280797
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002439494	0.08613467683280797
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.002439494	0.08613467683280797
DYSKERATOSIS CONGENITA	0.002439494	0.08613467683280797
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.002439494	0.08613467683280797
DIAPHANOSPONDYLODYSOSTOSIS	0.002439494	0.08613467683280797
BRESEK SYNDROME	0.002439494	0.08613467683280797
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.002439494	0.08613467683280797
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.002439494	0.08613467683280797
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.002439494	0.08613467683280797
HOYERAAL-HREIDARSSON SYNDROME	0.002439494	0.08613467683280797
SYNDROMIC DIARRHEA	0.002439494	0.08613467683280797
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.002439494	0.08613467683280797
SAUL-WILSON SYNDROME; SWILS	0.002439494	0.08613467683280797
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.002439494	0.08613467683280797
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.002439494	0.08613467683280797
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.002439494	0.08613467683280797
%300712 CRANIOFACIOSKELETAL SYNDROME	0.002439494	0.08613467683280797
RABSON-MENDENHALL SYNDROME	0.002439494	0.08613467683280797
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.002439494	0.08613467683280797
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.002439494	0.08613467683280797
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.002439494	0.08613467683280797
SECKEL SYNDROME 9; SCKL9	0.002439494	0.08613467683280797
OCULO-PALATO-CEREBRAL SYNDROME	0.002439494	0.08613467683280797
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.002439494	0.08613467683280797
CONGENITAL VARICELLA SYNDROME	0.002439494	0.08613467683280797
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.002439494	0.08613467683280797
DE BARSY SYNDROME	0.002439494	0.08613467683280797
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.002439494	0.08613467683280797
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.002439494	0.08613467683280797
SILVER-RUSSELL SYNDROME; SRS	0.002439494	0.08613467683280797
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.002439494	0.08613467683280797
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.002439494	0.08613467683280797
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.002439494	0.08613467683280797
WARSAW BREAKAGE SYNDROME; WABS	0.002439494	0.08613467683280797
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002439494	0.08613467683280797
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.002439494	0.08613467683280797
TARP SYNDROME; TARPS	0.002439494	0.08613467683280797
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.002439494	0.08613467683280797
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.002439494	0.08613467683280797
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.002439494	0.08613467683280797
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.002439494	0.08613467683280797
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.002439494	0.08613467683280797
EAR-PATELLA-SHORT STATURE SYNDROME	0.002439494	0.08613467683280797
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.002439494	0.08613467683280797
LOWRY-MACLEAN SYNDROME	0.002439494	0.08613467683280797
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.002439494	0.08613467683280797
RETINITIS PIGMENTOSA 59; RP59	0.002435359	0.08598867651933982
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002435359	0.08598867651933982
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002435359	0.08598867651933982
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.002435359	0.08598867651933982
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002435359	0.08598867651933982
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002435359	0.08598867651933982
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.002435359	0.08598867651933982
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002435359	0.08598867651933982
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002435359	0.08598867651933982
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002435359	0.08598867651933982
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002435359	0.08598867651933982
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.002435359	0.08598867651933982
KAPUR-TORIELLO SYNDROME	0.002435359	0.08598867651933982
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.002435359	0.08598867651933982
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.002435359	0.08598867651933982
HARROD SYNDROME	0.002435359	0.08598867651933982
3-HYDROXYISOBUTYRIC ACIDURIA	0.002435359	0.08598867651933982
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.002435359	0.08598867651933982
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.002435359	0.08598867651933982
MENKES DISEASE	0.002435359	0.08598867651933982
11Q22.2Q22.3 MICRODELETION SYNDROME	0.002332303	0.08234993206836685
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002332303	0.08234993206836685
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002332303	0.08234993206836685
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.002332303	0.08234993206836685
PONTINE TEGMENTAL CAP DYSPLASIA	0.002332303	0.08234993206836685
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.002332303	0.08234993206836685
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.002332303	0.08234993206836685
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.002332303	0.08234993206836685
RUBINSTEIN-TAYBI SYNDROME	0.002332303	0.08234993206836685
POTOCKI-SHAFFER SYNDROME	0.002332303	0.08234993206836685
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.002332303	0.08234993206836685
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002332303	0.08234993206836685
CK SYNDROME	0.002332303	0.08234993206836685
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002332303	0.08234993206836685
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.002332303	0.08234993206836685
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002332303	0.08234993206836685
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.002332303	0.08234993206836685
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.002332303	0.08234993206836685
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.002332303	0.08234993206836685
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.002332303	0.08234993206836685
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.002332303	0.08234993206836685
ADAMS-OLIVER SYNDROME 2; AOS2	0.002332303	0.08234993206836685
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.002332303	0.08234993206836685
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002332303	0.08234993206836685
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.002332303	0.08234993206836685
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.002332303	0.08234993206836685
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002332303	0.08234993206836685
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.002332303	0.08234993206836685
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.002332303	0.08234993206836685
MEHMO SYNDROME; MEHMO	0.002332303	0.08234993206836685
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.002332303	0.08234993206836685
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.002332303	0.08234993206836685
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002332303	0.08234993206836685
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.002332303	0.08234993206836685
MENTAL RETARDATION, X-LINKED 90	0.002332303	0.08234993206836685
SSR4-CDG	0.002332303	0.08234993206836685
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.002332303	0.08234993206836685
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002332303	0.08234993206836685
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002332303	0.08234993206836685
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.002332303	0.08234993206836685
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.002332303	0.08234993206836685
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.002332303	0.08234993206836685
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002332303	0.08234993206836685
19P13.13 MICRODELETION SYNDROME	0.002332303	0.08234993206836685
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.002332303	0.08234993206836685
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.002332303	0.08234993206836685
MENTAL RETARDATION, X-LINKED 101; MRX101	0.002332303	0.08234993206836685
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002332303	0.08234993206836685
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002332303	0.08234993206836685
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002332303	0.08234993206836685
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.002332303	0.08234993206836685
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.002332303	0.08234993206836685
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.002313963	0.08170237565990113
MAPLE SYRUP URINE DISEASE	0.002313963	0.08170237565990113
DPAGT1-CDG	0.002313963	0.08170237565990113
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.002313963	0.08170237565990113
GRISCELLI SYNDROME	0.002313963	0.08170237565990113
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002313963	0.08170237565990113
SIMPSON-GOLABI-BEHMEL SYNDROME	0.002313963	0.08170237565990113
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.002313963	0.08170237565990113
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.002313963	0.08170237565990113
BARAITSER-WINTER SYNDROME 1; BRWS1	0.002313963	0.08170237565990113
KLEEFSTRA SYNDROME	0.002313963	0.08170237565990113
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.002313963	0.08170237565990113
15Q11Q13 MICRODUPLICATION SYNDROME	0.002313963	0.08170237565990113
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002313963	0.08170237565990113
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.002313963	0.08170237565990113
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.002313963	0.08170237565990113
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.002313963	0.08170237565990113
CODAS SYNDROME	0.002313963	0.08170237565990113
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002313963	0.08170237565990113
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.002313963	0.08170237565990113
FOLATE MALABSORPTION, HEREDITARY	0.002313963	0.08170237565990113
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.002313963	0.08170237565990113
2Q37 MICRODELETION SYNDROME	0.002313963	0.08170237565990113
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.002313963	0.08170237565990113
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.002313963	0.08170237565990113
FUCOSIDOSIS	0.002313963	0.08170237565990113
METHYLMALONIC ACIDURIA, CBLA TYPE	0.002313963	0.08170237565990113
MEVALONIC ACIDURIA	0.002313963	0.08170237565990113
PELIZAEUS-MERZBACHER DISEASE	0.002313963	0.08170237565990113
TRISOMY X	0.002313963	0.08170237565990113
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.002313963	0.08170237565990113
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.002313963	0.08170237565990113
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002313963	0.08170237565990113
3Q29 MICRODUPLICATION SYNDROME	0.002313963	0.08170237565990113
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.002313963	0.08170237565990113
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.002313963	0.08170237565990113
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.002313963	0.08170237565990113
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.002313963	0.08170237565990113
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.002313963	0.08170237565990113
20P12.3 MICRODELETION SYNDROME	0.002313963	0.08170237565990113
FREE SIALIC ACID STORAGE DISEASE	0.002313963	0.08170237565990113
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002313963	0.08170237565990113
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.002313963	0.08170237565990113
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.002313963	0.08170237565990113
PYRUVATE CARBOXYLASE DEFICIENCY	0.002313963	0.08170237565990113
KETOADIPICACIDURIA	0.002313963	0.08170237565990113
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002313963	0.08170237565990113
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.002313963	0.08170237565990113
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.002313963	0.08170237565990113
GRISCELLI SYNDROME, TYPE 1	0.002313963	0.08170237565990113
DISTAL MONOSOMY 19P13.3	0.002313963	0.08170237565990113
WALKER-WARBURG SYNDROME	0.002313963	0.08170237565990113
HOLOPROSENCEPHALY 2; HPE2	0.002313963	0.08170237565990113
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.002313963	0.08170237565990113
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.002313963	0.08170237565990113
HOLOPROSENCEPHALY	0.002313963	0.08170237565990113
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00189394	0.06687202749452481
MECKEL SYNDROME, TYPE 4; MKS4	0.00189394	0.06687202749452481
PHOCOMELIA, SCHINZEL TYPE	0.00189394	0.06687202749452481
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00189394	0.06687202749452481
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00189394	0.06687202749452481
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00189394	0.06687202749452481
FETAL AKINESIA DEFORMATION SEQUENCE	0.00189394	0.06687202749452481
CEREBROCOSTOMANDIBULAR SYNDROME	0.00189394	0.06687202749452481
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00189394	0.06687202749452481
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00189394	0.06687202749452481
ENG-STROM SYNDROME	0.00189394	0.06687202749452481
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00189394	0.06687202749452481
BLOOM SYNDROME	0.00189394	0.06687202749452481
MECKEL SYNDROME, TYPE 1; MKS1	0.00189394	0.06687202749452481
PHAVER SYNDROME	0.00189394	0.06687202749452481
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00189394	0.06687202749452481
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00189394	0.06687202749452481
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.00189394	0.06687202749452481
3M SYNDROME	0.00189394	0.06687202749452481
TETRALOGY OF FALLOT	0.00189394	0.06687202749452481
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00189394	0.06687202749452481
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00189394	0.06687202749452481
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00189394	0.06687202749452481
LETHAL FACIOCARDIOMELIC DYSPLASIA	0.00189394	0.06687202749452481
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00189394	0.06687202749452481
TETRAPLOIDY	0.00189394	0.06687202749452481
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00189394	0.06687202749452481
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00189394	0.06687202749452481
MULIBREY NANISM	0.00189394	0.06687202749452481
MARTINEZ-FRIAS SYNDROME	0.00189394	0.06687202749452481
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00189394	0.06687202749452481
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00189394	0.06687202749452481
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.00189394	0.06687202749452481
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00189394	0.06687202749452481
TRIPLOIDY	0.00189394	0.06687202749452481
TRANSALDOLASE DEFICIENCY	0.00189394	0.06687202749452481
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00189394	0.06687202749452481
VACTERL WITH HYDROCEPHALUS	0.00189394	0.06687202749452481
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00189394	0.06687202749452481
CRANE-HEISE SYNDROME	0.00189394	0.06687202749452481
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.00189394	0.06687202749452481
HYDROLETHALUS SYNDROME 1	0.00189394	0.06687202749452481
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.00189394	0.06687202749452481
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00189394	0.06687202749452481
BALLER-GEROLD SYNDROME	0.00189394	0.06687202749452481
JUBERG-HAYWARD SYNDROME	0.00189394	0.06687202749452481
ACRORENAL-MANDIBULAR SYNDROME	0.00189394	0.06687202749452481
MEIER-GORLIN SYNDROME 8; MGORS8	0.00189394	0.06687202749452481
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00189394	0.06687202749452481
MECKEL SYNDROME 12; MKS12	0.00189394	0.06687202749452481
19Q13.11 MICRODELETION SYNDROME	0.00189394	0.06687202749452481
NEU-LAXOVA SYNDROME 2; NLS2	0.00189394	0.06687202749452481
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00189394	0.06687202749452481
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00189394	0.06687202749452481
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00189394	0.06687202749452481
MITCHELL-RILEY SYNDROME; MTCHRS	0.00189394	0.06687202749452481
IMMUNODEFICIENCY 55; IMD55	0.00189394	0.06687202749452481
NIJMEGEN BREAKAGE SYNDROME	0.00189394	0.06687202749452481
VERVERI-BRADY SYNDROME; VERBRAS	0.00189394	0.06687202749452481
HOLZGREVE SYNDROME	0.00189394	0.06687202749452481
BLOOM SYNDROME	0.00189394	0.06687202749452481
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00189394	0.06687202749452481
ACRO-RENAL-MANDIBULAR SYNDROME	0.00189394	0.06687202749452481
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00189394	0.06687202749452481
METHIMAZOLE EMBRYOFETOPATHY	0.00189394	0.06687202749452481
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.00189394	0.06687202749452481
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00189394	0.06687202749452481
BARTSOCAS-PAPAS SYNDROME; BPS	0.00189394	0.06687202749452481
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00189394	0.06687202749452481
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00189394	0.06687202749452481
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00189394	0.06687202749452481
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00189394	0.06687202749452481
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00189394	0.06687202749452481
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00189394	0.06687202749452481
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00189394	0.06687202749452481
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00189394	0.06687202749452481
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00189394	0.06687202749452481
LEPRECHAUNISM	0.00189394	0.06687202749452481
NEU-LAXOVA SYNDROME	0.00189394	0.06687202749452481
ATRESIA OF SMALL INTESTINE	0.00189394	0.06687202749452481
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00189394	0.06687202749452481
ROIFMAN SYNDROME	0.00189394	0.06687202749452481
HEMOCHROMATOSIS, NEONATAL	0.00189394	0.06687202749452481
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00189394	0.06687202749452481
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00189394	0.06687202749452481
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00189394	0.06687202749452481
AREDYLD SYNDROME	0.00189394	0.06687202749452481
FRAXE INTELLECTUAL DISABILITY	0.00189394	0.06687202749452481
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00189394	0.06687202749452481
GENITOPALATOCARDIAC SYNDROME	0.00189394	0.06687202749452481
SECKEL SYNDROME 4	0.00189394	0.06687202749452481
MEIER-GORLIN SYNDROME 2; MGORS2	0.00189394	0.06687202749452481
APPARENT MINERALOCORTICOID EXCESS	0.00189394	0.06687202749452481
MEIER-GORLIN SYNDROME 3; MGORS3	0.00189394	0.06687202749452481
MODY	0.00189394	0.06687202749452481
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00189394	0.06687202749452481
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00189394	0.06687202749452481
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00189394	0.06687202749452481
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00189394	0.06687202749452481
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00189394	0.06687202749452481
HARTSFIELD SYNDROME	0.00189394	0.06687202749452481
BRADDOCK SYNDROME	0.00189394	0.06687202749452481
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00189394	0.06687202749452481
TRICHOHEPATOENTERIC SYNDROME 2	0.00189394	0.06687202749452481
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.00189394	0.06687202749452481
STIMMLER SYNDROME	0.00189394	0.06687202749452481
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00189394	0.06687202749452481
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00189394	0.06687202749452481
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00189394	0.06687202749452481
GRACILE SYNDROME	0.00189394	0.06687202749452481
RUSSELL-SILVER SYNDROME, X-LINKED	0.00189394	0.06687202749452481
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.001790884	0.06323328304355184
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.06323328304355184
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001790884	0.06323328304355184
MIETENS SYNDROME	0.001790884	0.06323328304355184
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.001790884	0.06323328304355184
CHAR SYNDROME	0.001790884	0.06323328304355184
SENIOR-LOKEN SYNDROME 9	0.001790884	0.06323328304355184
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001790884	0.06323328304355184
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.001790884	0.06323328304355184
LAMB-SHAFFER SYNDROME	0.001790884	0.06323328304355184
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.001790884	0.06323328304355184
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001790884	0.06323328304355184
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001790884	0.06323328304355184
MEIER-GORLIN SYNDROME 7	0.001790884	0.06323328304355184
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.06323328304355184
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.06323328304355184
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001790884	0.06323328304355184
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.06323328304355184
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.001790884	0.06323328304355184
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001790884	0.06323328304355184
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.001790884	0.06323328304355184
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001790884	0.06323328304355184
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001790884	0.06323328304355184
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.001790884	0.06323328304355184
OROFACIODIGITAL SYNDROME IX; OFD9	0.001790884	0.06323328304355184
3MC SYNDROME 2	0.001790884	0.06323328304355184
ROTHMUND-THOMSON SYNDROME	0.001790884	0.06323328304355184
OROFACIODIGITAL SYNDROME VIII; OFD8	0.001790884	0.06323328304355184
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001790884	0.06323328304355184
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001790884	0.06323328304355184
MARINESCO-SJOGREN SYNDROME; MSS	0.001790884	0.06323328304355184
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001790884	0.06323328304355184
FRONTOOCULAR SYNDROME	0.001790884	0.06323328304355184
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001790884	0.06323328304355184
RICHARDS-RUNDLE SYNDROME; RRNS	0.001790884	0.06323328304355184
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.001790884	0.06323328304355184
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.001790884	0.06323328304355184
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001790884	0.06323328304355184
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001790884	0.06323328304355184
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001790884	0.06323328304355184
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.06323328304355184
CHAR SYNDROME	0.001790884	0.06323328304355184
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.06323328304355184
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.001790884	0.06323328304355184
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.001790884	0.06323328304355184
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	0.06323328304355184
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.001790884	0.06323328304355184
GAUCHER DISEASE, TYPE IIIC	0.001786749	0.0630872827300837
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.001786749	0.0630872827300837
INCONTINENTIA PIGMENTI; IP	0.001786749	0.0630872827300837
CHIME SYNDROME	0.001786749	0.0630872827300837
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.001786749	0.0630872827300837
ATAXIA-TELANGIECTASIA	0.001786749	0.0630872827300837
SMITH-KINGSMORE SYNDROME; SKS	0.001786749	0.0630872827300837
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.001786749	0.0630872827300837
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.001786749	0.0630872827300837
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.001786749	0.0630872827300837
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.001786749	0.0630872827300837
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.001786749	0.0630872827300837
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001786749	0.0630872827300837
PROTEUS SYNDROME	0.001786749	0.0630872827300837
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.001786749	0.0630872827300837
BRANCHIOSKELETOGENITAL SYNDROME	0.001786749	0.0630872827300837
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.001786749	0.0630872827300837
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.001786749	0.0630872827300837
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.001786749	0.0630872827300837
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.001786749	0.0630872827300837
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001786749	0.0630872827300837
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.001786749	0.0630872827300837
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.001786749	0.0630872827300837
CONGENITAL HYDROCEPHALUS	0.001786749	0.0630872827300837
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001786749	0.0630872827300837
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001786749	0.0630872827300837
MENTAL RETARDATION, X-LINKED 21	0.001786749	0.0630872827300837
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.001786749	0.0630872827300837
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001786749	0.0630872827300837
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.001772544	0.06258572663508612
GENITOPATELLAR SYNDROME; GTPTS	0.001772544	0.06258572663508612
LATERAL MENINGOCELE SYNDROME	0.001772544	0.06258572663508612
17P13.3 MICRODUPLICATION SYNDROME	0.001772544	0.06258572663508612
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001772544	0.06258572663508612
LARSEN-LIKE SYNDROME	0.001772544	0.06258572663508612
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.001772544	0.06258572663508612
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001772544	0.06258572663508612
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001772544	0.06258572663508612
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.001772544	0.06258572663508612
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001772544	0.06258572663508612
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001772544	0.06258572663508612
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001772544	0.06258572663508612
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.001772544	0.06258572663508612
FRIED SYNDROME	0.001772544	0.06258572663508612
PEROXISOME BIOGENESIS DISORDER 3B	0.001772544	0.06258572663508612
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.001772544	0.06258572663508612
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.001772544	0.06258572663508612
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.001772544	0.06258572663508612
WAARDENBURG-SHAH SYNDROME	0.001772544	0.06258572663508612
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.001772544	0.06258572663508612
PRIMARY CONGENITAL HYPOTHYROIDISM	0.001772544	0.06258572663508612
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001772544	0.06258572663508612
3C SYNDROME	0.001772544	0.06258572663508612
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001772544	0.06258572663508612
ALG6-CDG	0.001772544	0.06258572663508612
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001772544	0.06258572663508612
PERMANENT CONGENITAL HYPOTHYROIDISM	0.001772544	0.06258572663508612
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001772544	0.06258572663508612
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06258572663508612
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.001772544	0.06258572663508612
MEVALONIC ACIDURIA; MEVA	0.001772544	0.06258572663508612
NIEMANN-PICK DISEASE, TYPE A	0.001772544	0.06258572663508612
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.001772544	0.06258572663508612
ATHYREOSIS	0.001772544	0.06258572663508612
TRANSKETOLASE DEFICIENCY	0.001772544	0.06258572663508612
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001772544	0.06258572663508612
MONOSOMY 18P	0.001772544	0.06258572663508612
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.001772544	0.06258572663508612
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.001772544	0.06258572663508612
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001772544	0.06258572663508612
THYROID ECTOPIA	0.001772544	0.06258572663508612
MICROPHTHALMIA, SYNDROMIC 3	0.001772544	0.06258572663508612
FAMILIAL THYROID DYSHORMONOGENESIS	0.001772544	0.06258572663508612
DISTAL MONOSOMY 9P	0.001772544	0.06258572663508612
THYROID HYPOPLASIA	0.001772544	0.06258572663508612
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.001772544	0.06258572663508612
THANATOPHORIC DYSPLASIA, TYPE I	0.001772544	0.06258572663508612
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.001772544	0.06258572663508612
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001772544	0.06258572663508612
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06258572663508612
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06258572663508612
14Q22Q23 MICRODELETION SYNDROME	0.001772544	0.06258572663508612
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001772544	0.06258572663508612
CHROMOSOME 9P DELETION SYNDROME	0.001772544	0.06258572663508612
OCCIPITAL HORN SYNDROME	0.001772544	0.06258572663508612
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.001772544	0.06258572663508612
HURLER SYNDROME	0.001772544	0.06258572663508612
ALPHA-MANNOSIDOSIS	0.001772544	0.06258572663508612
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001772544	0.06258572663508612
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001772544	0.06258572663508612
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.001772544	0.06258572663508612
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001772544	0.06258572663508612
GALACTOSE EPIMERASE DEFICIENCY	0.001772544	0.06258572663508612
17Q21.31 MICRODUPLICATION SYNDROME	0.001772544	0.06258572663508612
JOUBERT SYNDROME 8	0.001772544	0.06258572663508612
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.001768409	0.06243972632161797
HYPOPHOSPHATASIA	0.001768409	0.06243972632161797
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.001768409	0.06243972632161797
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.001768409	0.06243972632161797
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.001768409	0.06243972632161797
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001768409	0.06243972632161797
FETAL GAUCHER DISEASE	0.001768409	0.06243972632161797
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.001768409	0.06243972632161797
CAMOS SYNDROME	0.001768409	0.06243972632161797
X-LINKED CENTRONUCLEAR MYOPATHY	0.001768409	0.06243972632161797
ISOLATED SPINA BIFIDA	0.001768409	0.06243972632161797
CENTRONUCLEAR MYOPATHY	0.001768409	0.06243972632161797
SJÖGREN-LARSSON SYNDROME	0.001768409	0.06243972632161797
THANATOPHORIC DYSPLASIA TYPE 2	0.001768409	0.06243972632161797
METACHROMATIC LEUKODYSTROPHY	0.001768409	0.06243972632161797
ALG9-CDG	0.001768409	0.06243972632161797
ACUTE ADRENAL INSUFFICIENCY	0.001768409	0.06243972632161797
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.001768409	0.06243972632161797
L-2-HYDROXYGLUTARIC ACIDURIA	0.001768409	0.06243972632161797
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.001768409	0.06243972632161797
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.001768409	0.06243972632161797
ONDINE SYNDROME	0.001768409	0.06243972632161797
WOLF-HIRSCHHORN SYNDROME	0.001768409	0.06243972632161797
2Q23.1 MICRODELETION SYNDROME	0.001768409	0.06243972632161797
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.001768409	0.06243972632161797
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.001768409	0.06243972632161797
POTOCKI-SHAFFER SYNDROME	0.001768409	0.06243972632161797
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.001768409	0.06243972632161797
CRIGLER-NAJJAR SYNDROME	0.001768409	0.06243972632161797
METACHROMATIC LEUKODYSTROPHY	0.001768409	0.06243972632161797
OHDO SYNDROME	0.001768409	0.06243972632161797
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.001768409	0.06243972632161797
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001768409	0.06243972632161797
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.001768409	0.06243972632161797
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.001768409	0.06243972632161797
BETA-KETOTHIOLASE DEFICIENCY	0.001768409	0.06243972632161797
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.001768409	0.06243972632161797
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001768409	0.06243972632161797
ASPARTYLGLUCOSAMINURIA; AGU	0.001768409	0.06243972632161797
HYPERLYSINEMIA, TYPE I	0.001768409	0.06243972632161797
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.001768409	0.06243972632161797
GLYCINE ENCEPHALOPATHY; GCE	0.001768409	0.06243972632161797
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001768409	0.06243972632161797
GLUTARIC ACIDEMIA I; GA1	0.001768409	0.06243972632161797
VISCERAL STEATOSIS, CONGENITAL	0.001768409	0.06243972632161797
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.001768409	0.06243972632161797
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.001768409	0.06243972632161797
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.001768409	0.06243972632161797
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.001768409	0.06243972632161797
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.001768409	0.06243972632161797
THANATOPHORIC DYSPLASIA TYPE 1	0.001768409	0.06243972632161797
1P36 MICRODELETION SYNDROME	0.001768409	0.06243972632161797
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.001768409	0.06243972632161797
FAMILIAL BENIGN COPPER DEFICIENCY	0.001768409	0.06243972632161797
COFFIN-LOWRY SYNDROME; CLS	0.001768409	0.06243972632161797
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.001768409	0.06243972632161797
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.001768409	0.06243972632161797
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00124533	0.0439706337052687
ODONTOCHONDRODYSPLASIA	0.00124533	0.0439706337052687
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	0.0439706337052687
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	0.0439706337052687
ANTLEY-BIXLER SYNDROME	0.00124533	0.0439706337052687
SCARF SYNDROME	0.00124533	0.0439706337052687
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.0439706337052687
PETERS ANOMALY	0.00124533	0.0439706337052687
GLUTATHIONURIA	0.00124533	0.0439706337052687
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00124533	0.0439706337052687
MELNICK-NEEDLES SYNDROME	0.00124533	0.0439706337052687
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	0.0439706337052687
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	0.0439706337052687
WOOLLY HAIR	0.00124533	0.0439706337052687
FANCONI ANEMIA	0.00124533	0.0439706337052687
AASE-SMITH SYNDROME	0.00124533	0.0439706337052687
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00124533	0.0439706337052687
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00124533	0.0439706337052687
SCARF SYNDROME	0.00124533	0.0439706337052687
MASA SYNDROME	0.00124533	0.0439706337052687
PELVISCAPULAR DYSPLASIA	0.00124533	0.0439706337052687
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.0439706337052687
IVIC SYNDROME	0.00124533	0.0439706337052687
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.0439706337052687
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.0439706337052687
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	0.0439706337052687
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00124533	0.0439706337052687
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00124533	0.0439706337052687
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.0439706337052687
FEMORAL-FACIAL SYNDROME	0.00124533	0.0439706337052687
HYPERTELORISM, TEEBI TYPE	0.00124533	0.0439706337052687
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.0439706337052687
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00124533	0.0439706337052687
CHANARIN-DORFMAN SYNDROME	0.00124533	0.0439706337052687
JACKSON-WEISS SYNDROME	0.00124533	0.0439706337052687
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.0439706337052687
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00124533	0.0439706337052687
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00124533	0.0439706337052687
SUMMITT SYNDROME	0.00124533	0.0439706337052687
OTOMANDIBULAR SYNDROME	0.00124533	0.0439706337052687
COATS DISEASE	0.00124533	0.0439706337052687
FREEMAN-SHELDON SYNDROME	0.00124533	0.0439706337052687
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00124533	0.0439706337052687
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00124533	0.0439706337052687
URBAN-ROGERS-MEYER SYNDROME	0.00124533	0.0439706337052687
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.0439706337052687
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.0439706337052687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.0439706337052687
FOCAL DERMAL HYPOPLASIA	0.00124533	0.0439706337052687
CEREBROFACIOTHORACIC DYSPLASIA	0.00124533	0.0439706337052687
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	0.0439706337052687
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.0439706337052687
FETAL IODINE SYNDROME	0.00124533	0.0439706337052687
MCDONOUGH SYNDROME	0.00124533	0.0439706337052687
PROXIMAL SYMPHALANGISM	0.00124533	0.0439706337052687
GASTROCUTANEOUS SYNDROME	0.00124533	0.0439706337052687
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.0439706337052687
PETERS ANOMALY	0.00124533	0.0439706337052687
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00124533	0.0439706337052687
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.0439706337052687
ALAGILLE SYNDROME 1; ALGS1	0.00124533	0.0439706337052687
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.0439706337052687
GORLIN SYNDROME	0.00124533	0.0439706337052687
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.0439706337052687
MOSAIC TRISOMY 8	0.00124533	0.0439706337052687
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.0439706337052687
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00124533	0.0439706337052687
SECKEL SYNDROME 5; SCKL5	0.00124533	0.0439706337052687
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00124533	0.0439706337052687
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.0439706337052687
FRONTORHINY	0.00124533	0.0439706337052687
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00124533	0.0439706337052687
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00124533	0.0439706337052687
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00124533	0.0439706337052687
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.0439706337052687
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.0439706337052687
ROBINOW-SORAUF SYNDROME	0.00124533	0.0439706337052687
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00124533	0.0439706337052687
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.0439706337052687
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.0439706337052687
IVIC SYNDROME	0.00124533	0.0439706337052687
HEMIFACIAL MICROSOMIA	0.00124533	0.0439706337052687
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00124533	0.0439706337052687
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00124533	0.0439706337052687
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.0439706337052687
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00124533	0.0439706337052687
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00124533	0.0439706337052687
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.0439706337052687
CROSSED POLYSYNDACTYLY	0.00124533	0.0439706337052687
MULTIMINICORE MYOPATHY	0.00124533	0.0439706337052687
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00124533	0.0439706337052687
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.0439706337052687
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.0439706337052687
HAND-FOOT-GENITAL SYNDROME	0.00124533	0.0439706337052687
COSTELLO SYNDROME	0.00124533	0.0439706337052687
MCDONOUGH SYNDROME	0.00124533	0.0439706337052687
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00124533	0.0439706337052687
15Q26 OVERGROWTH SYNDROME	0.00124533	0.0439706337052687
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	0.0439706337052687
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	0.0439706337052687
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.0439706337052687
ABDUCENS PALSY	0.00124533	0.0439706337052687
MEIER-GORLIN SYNDROME 6; MGORS6	0.00124533	0.0439706337052687
BASAL CELL NEVUS SYNDROME	0.00124533	0.0439706337052687
LERI PLEONOSTEOSIS	0.00124533	0.0439706337052687
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.0439706337052687
STIFF SKIN SYNDROME	0.00124533	0.0439706337052687
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.0439706337052687
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.0439706337052687
LAURENCE-MOON SYNDROME	0.00124533	0.0439706337052687
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.0439706337052687
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00124533	0.0439706337052687
NATIVE AMERICAN MYOPATHY	0.00122699	0.04332307729680297
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00122699	0.04332307729680297
HYPERCALCEMIA, INFANTILE 2	0.00122699	0.04332307729680297
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.04332307729680297
KENNEDY DISEASE	0.00122699	0.04332307729680297
PRADER-WILLI SYNDROME (TYPE 1)	0.00122699	0.04332307729680297
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00122699	0.04332307729680297
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00122699	0.04332307729680297
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.04332307729680297
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00122699	0.04332307729680297
3Q13 MICRODELETION SYNDROME	0.00122699	0.04332307729680297
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00122699	0.04332307729680297
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00122699	0.04332307729680297
B4GALT1-CDG	0.00122699	0.04332307729680297
CRANIOFRONTONASAL DYSPLASIA	0.00122699	0.04332307729680297
WARBURG MICRO SYNDROME 1	0.00122699	0.04332307729680297
KEARNS-SAYRE SYNDROME	0.00122699	0.04332307729680297
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00122699	0.04332307729680297
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00122699	0.04332307729680297
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.04332307729680297
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00122699	0.04332307729680297
SPINOCEREBELLAR ATAXIA 13	0.00122699	0.04332307729680297
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00122699	0.04332307729680297
PORPHYRIA, ACUTE HEPATIC	0.00122699	0.04332307729680297
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00122699	0.04332307729680297
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00122699	0.04332307729680297
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00122699	0.04332307729680297
IMMUNODEFICIENCY 9; IMD9	0.00122699	0.04332307729680297
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00122699	0.04332307729680297
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00122699	0.04332307729680297
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00122699	0.04332307729680297
POLYMYOSITIS	0.00122699	0.04332307729680297
NEMALINE MYOPATHY 4	0.00122699	0.04332307729680297
NEMALINE MYOPATHY 7; NEM7	0.00122699	0.04332307729680297
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00122699	0.04332307729680297
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00122699	0.04332307729680297
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00122699	0.04332307729680297
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00122699	0.04332307729680297
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00122699	0.04332307729680297
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00122699	0.04332307729680297
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00122699	0.04332307729680297
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00122699	0.04332307729680297
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00122699	0.04332307729680297
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00122699	0.04332307729680297
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00122699	0.04332307729680297
MACS SYNDROME	0.00122699	0.04332307729680297
CENTRAL CORE DISEASE	0.00122699	0.04332307729680297
CAREY-FINEMAN-ZITER SYNDROME	0.00122699	0.04332307729680297
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00122699	0.04332307729680297
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00122699	0.04332307729680297
BEEMER-ERTBRUGGEN SYNDROME	0.00122699	0.04332307729680297
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.00122699	0.04332307729680297
ANTISYNTHETASE SYNDROME	0.00122699	0.04332307729680297
PIEBALDISM	0.00122699	0.04332307729680297
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00122699	0.04332307729680297
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.04332307729680297
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00122699	0.04332307729680297
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00122699	0.04332307729680297
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00122699	0.04332307729680297
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00122699	0.04332307729680297
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00122699	0.04332307729680297
DERMATOMYOSITIS	0.00122699	0.04332307729680297
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00122699	0.04332307729680297
INFANTILE SYSTEMIC HYALINOSIS	0.00122699	0.04332307729680297
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00122699	0.04332307729680297
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680297
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00122699	0.04332307729680297
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680297
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680297
CEREBELLAR HYPOPLASIA	0.00122699	0.04332307729680297
HAWKINSINURIA	0.00122699	0.04332307729680297
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00122699	0.04332307729680297
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00122699	0.04332307729680297
GRANT SYNDROME	0.00122699	0.04332307729680297
FRYNS-SMEETS-THIRY SYNDROME	0.00122699	0.04332307729680297
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00122699	0.04332307729680297
GLYCOGEN STORAGE DISEASE IV	0.00122699	0.04332307729680297
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00122699	0.04332307729680297
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00122699	0.04332307729680297
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00122699	0.04332307729680297
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00122699	0.04332307729680297
MYOTONIC DYSTROPHY 1	0.00122699	0.04332307729680297
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.04332307729680297
JUVENILE DERMATOMYOSITIS	0.00122699	0.04332307729680297
MULTIPLE METAPHYSEAL DYSPLASIA	0.00122699	0.04332307729680297
JUNG SYNDROME	0.00122699	0.04332307729680297
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.04332307729680297
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00122699	0.04332307729680297
ISOTRETINOIN SYNDROME	0.00122699	0.04332307729680297
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00122699	0.04332307729680297
SPONASTRIME DYSPLASIA	0.00122699	0.04332307729680297
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00122699	0.04332307729680297
SPINOCEREBELLAR ATAXIA 1	0.00122699	0.04332307729680297
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00122699	0.04332307729680297
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00122699	0.04332307729680297
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00122699	0.04332307729680297
SHPRINTZEN OMPHALOCELE SYNDROME	0.00122699	0.04332307729680297
OPSISMODYSPLASIA	0.00122699	0.04332307729680297
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00122699	0.04332307729680297
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.04332307729680297
DESBUQUOIS DYSPLASIA 1	0.00122699	0.04332307729680297
OPSISMODYSPLASIA; OPSMD	0.00122699	0.04332307729680297
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00122699	0.04332307729680297
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00122699	0.04332307729680297
OSTEOPENIA AND SPARSE HAIR	0.00122699	0.04332307729680297
MENTAL RETARDATION, X-LINKED 93	0.00122699	0.04332307729680297
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00122699	0.04332307729680297
ARTERIAL TORTUOSITY SYNDROME	0.00122699	0.04332307729680297
FAMILIAL LAMBDOID SYNOSTOSIS	0.00122699	0.04332307729680297
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00122699	0.04332307729680297
9Q SUBTELOMERIC DELETION SYNDROME	0.00122699	0.04332307729680297
CHIARI MALFORMATION TYPE II	0.00122699	0.04332307729680297
KYPHOMELIC DYSPLASIA	0.00122699	0.04332307729680297
INTESTINAL BOTULISM	0.00122699	0.04332307729680297
PRADER-WILLI SYNDROME (TYPE 2)	0.00122699	0.04332307729680297
INFANT BOTULISM	0.00122699	0.04332307729680297
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00122699	0.04332307729680297
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00122699	0.04332307729680297
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00122699	0.04332307729680297
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00122699	0.04332307729680297
ACID PHOSPHATASE DEFICIENCY	0.00122699	0.04332307729680297
PURE MITOCHONDRIAL MYOPATHY	0.00122699	0.04332307729680297
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00122699	0.04332307729680297
NEONATAL MARFAN SYNDROME	0.00122699	0.04332307729680297
VELOCARDIOFACIAL SYNDROME	0.00122699	0.04332307729680297
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00122699	0.04332307729680297
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00122699	0.04332307729680297
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00122699	0.04332307729680297
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00122699	0.04332307729680297
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00122699	0.04332307729680297
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00122699	0.04332307729680297
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00122699	0.04332307729680297
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00122699	0.04332307729680297
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00122699	0.04332307729680297
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00122699	0.04332307729680297
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.00122699	0.04332307729680297
LESCH-NYHAN SYNDROME; LNS	0.00122699	0.04332307729680297
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680297
LAURIN-SANDROW SYNDROME	0.00122699	0.04332307729680297
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00122699	0.04332307729680297
SMITH-MAGENIS SYNDROME	0.00122699	0.04332307729680297
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00122699	0.04332307729680297
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00122699	0.04332307729680297
AICARDI-GOUTIÈRES SYNDROME	0.001086973	0.038379298363098155
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.038379298363098155
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.038379298363098155
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.038379298363098155
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.038379298363098155
LISSENCEPHALY 4	0.001086973	0.038379298363098155
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.038379298363098155
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.038379298363098155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.038379298363098155
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.038379298363098155
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.038379298363098155
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.038379298363098155
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.038379298363098155
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.038379298363098155
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.038379298363098155
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.038379298363098155
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.038379298363098155
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.038379298363098155
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.038379298363098155
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.038379298363098155
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.038379298363098155
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.038379298363098155
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001086973	0.038379298363098155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.038379298363098155
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.038379298363098155
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.038379298363098155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.038379298363098155
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.038379298363098155
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.001086973	0.038379298363098155
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.038379298363098155
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.038379298363098155
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.038379298363098155
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.038379298363098155
KBG SYNDROME	0.001086973	0.038379298363098155
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.038379298363098155
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.038379298363098155
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.038379298363098155
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.038379298363098155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.038379298363098155
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.038379298363098155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.038379298363098155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.038379298363098155
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.038379298363098155
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.038379298363098155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.038379298363098155
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.038379298363098155
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.038379298363098155
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.038379298363098155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.038379298363098155
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.038379298363098155
KEUTEL SYNDROME	0.001086973	0.038379298363098155
SULFOCYSTEINURIA	0.001086973	0.038379298363098155
TIMOTHY SYNDROME; TS	0.001086973	0.038379298363098155
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.038379298363098155
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.038379298363098155
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.038379298363098155
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.038379298363098155
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.038379298363098155
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.038379298363098155
SIALIDOSIS TYPE 2	0.001086973	0.038379298363098155
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.038379298363098155
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.038379298363098155
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.038379298363098155
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.038379298363098155
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.038379298363098155
LANDAU-KLEFFNER SYNDROME	0.001086973	0.038379298363098155
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.038379298363098155
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.038379298363098155
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.038379298363098155
BAND HETEROTOPIA; BH	0.001086973	0.038379298363098155
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.001086973	0.038379298363098155
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.038379298363098155
MEND SYNDROME; MEND	0.001086973	0.038379298363098155
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.038379298363098155
PETTIGREW SYNDROME	0.001086973	0.038379298363098155
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.038379298363098155
GRISCELLI SYNDROME TYPE 1	0.001086973	0.038379298363098155
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.038379298363098155
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.038379298363098155
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.038379298363098155
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.038379298363098155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.038379298363098155
WAISMAN SYNDROME; WSMN	0.001086973	0.038379298363098155
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.038379298363098155
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.038379298363098155
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.038379298363098155
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.038379298363098155
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.038379298363098155
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.038379298363098155
XQ25 DUPLICATION SYNDROME	0.001086973	0.038379298363098155
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.038379298363098155
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.038379298363098155
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.038379298363098155
GLASS SYNDROME	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001086973	0.038379298363098155
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.038379298363098155
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.038379298363098155
HARTNUP DISORDER	0.001086973	0.038379298363098155
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.038379298363098155
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.038379298363098155
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.038379298363098155
NETHERTON SYNDROME	0.001086973	0.038379298363098155
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.038379298363098155
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.038379298363098155
ARGININOSUCCINIC ACIDURIA	0.001086973	0.038379298363098155
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.038379298363098155
CITRULLINEMIA, CLASSIC	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.038379298363098155
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.038379298363098155
PHACE ASSOCIATION	0.001086973	0.038379298363098155
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.038379298363098155
LISSENCEPHALY 1; LIS1	0.001086973	0.038379298363098155
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.038379298363098155
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.038379298363098155
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.038379298363098155
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.038379298363098155
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.038379298363098155
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.038379298363098155
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001086973	0.038379298363098155
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.038379298363098155
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.038379298363098155
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.038379298363098155
HOLOPROSENCEPHALY 7	0.001086973	0.038379298363098155
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.038379298363098155
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.038379298363098155
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.038379298363098155
DYSTONIA-APHONIA SYNDROME	0.001086973	0.038379298363098155
15Q14 MICRODELETION SYNDROME	0.001086973	0.038379298363098155
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.038379298363098155
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.038379298363098155
17Q12 MICRODELETION SYNDROME	0.001086973	0.038379298363098155
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.038379298363098155
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.038379298363098155
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.038379298363098155
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.038379298363098155
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.038379298363098155
L1 SYNDROME	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.038379298363098155
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.038379298363098155
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.038379298363098155
MEND SYNDROME	0.001086973	0.038379298363098155
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.038379298363098155
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.038379298363098155
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.038379298363098155
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.038379298363098155
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.038379298363098155
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.038379298363098155
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.038379298363098155
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.038379298363098155
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.038379298363098155
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.038379298363098155
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.038379298363098155
EAST SYNDROME	0.001086973	0.038379298363098155
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.038379298363098155
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.038379298363098155
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.038379298363098155
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.038379298363098155
ISOVALERIC ACIDEMIA	0.001086973	0.038379298363098155
MOSAIC TRISOMY 14	0.001086973	0.038379298363098155
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.038379298363098155
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.038379298363098155
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.038379298363098155
DISTAL TRISOMY 17Q	0.001086973	0.038379298363098155
WILSON-TURNER SYNDROME	0.001086973	0.038379298363098155
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.038379298363098155
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.038379298363098155
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.038379298363098155
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.038379298363098155
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.038379298363098155
CITRULLINEMIA TYPE II	0.001086973	0.038379298363098155
DISTAL MONOSOMY 1Q	0.001086973	0.038379298363098155
8P11.2 DELETION SYNDROME	0.001086973	0.038379298363098155
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.038379298363098155
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.038379298363098155
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.038379298363098155
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.038379298363098155
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.038379298363098155
STT3A-CDG	0.001086973	0.038379298363098155
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.038379298363098155
COWDEN SYNDROME	0.001086973	0.038379298363098155
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.038379298363098155
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.038379298363098155
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.038379298363098155
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.038379298363098155
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.038379298363098155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.038379298363098155
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.038379298363098155
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.038379298363098155
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.038379298363098155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.01926264933828315
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.01926264933828315
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.01926264933828315
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.01926264933828315
NOONAN SYNDROME 5; NS5	0.000545554	0.01926264933828315
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.01926264933828315
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.01926264933828315
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.01926264933828315
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.01926264933828315
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.01926264933828315
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.01926264933828315
NOONAN SYNDROME 11; NS11	0.000545554	0.01926264933828315
OGDEN SYNDROME; OGDNS	0.000545554	0.01926264933828315
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.01926264933828315
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.01926264933828315
AUSTRALIA ANTIGEN	0.000545554	0.01926264933828315
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.01926264933828315
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.01926264933828315
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.01926264933828315
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.01926264933828315
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.01926264933828315
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.01926264933828315
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.01926264933828315
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.01926264933828315
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.01926264933828315
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.01926264933828315
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.01926264933828315
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.01926264933828315
FRIAS SYNDROME	0.000545554	0.01926264933828315
NOONAN SYNDROME 3; NS3	0.000545554	0.01926264933828315
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.01926264933828315
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.01926264933828315
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.01926264933828315
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.01926264933828315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.01926264933828315
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.01926264933828315
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.01926264933828315
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.01926264933828315
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.01926264933828315
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.01926264933828315
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.01926264933828315
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.01926264933828315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.01926264933828315
OTOFACIOCERVICAL SYNDROME	0.000545554	0.01926264933828315
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.01926264933828315
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.01926264933828315
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.01926264933828315
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.01926264933828315
JAWAD SYNDROME	0.000545554	0.01926264933828315
EVEN-PLUS SYNDROME	0.000545554	0.01926264933828315
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.01926264933828315
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.01926264933828315
NOONAN SYNDROME 6; NS6	0.000545554	0.01926264933828315
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.01926264933828315
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.01926264933828315
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.01926264933828315
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.01926264933828315
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.01926264933828315
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.01926264933828315
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.01926264933828315
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.01926264933828315
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.01926264933828315
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.01926264933828315
JOUBERT SYNDROME 27	0.000545554	0.01926264933828315
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.01926264933828315
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.01926264933828315
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.01926264933828315
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.01926264933828315
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.01926264933828315
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.01926264933828315
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.01926264933828315
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.01926264933828315
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.01926264933828315
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.01926264933828315
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.01926264933828315
TEMTAMY SYNDROME	0.000545554	0.01926264933828315
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.000545554	0.01926264933828315
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.01926264933828315
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.01926264933828315
WEAVER SYNDROME	0.000545554	0.01926264933828315
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.01926264933828315
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.01926264933828315
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.01926264933828315
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.01926264933828315
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.01926264933828315
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.01926264933828315
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.01926264933828315
ICF SYNDROME	0.000545554	0.01926264933828315
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01926264933828315
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.01926264933828315
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.01926264933828315
CURRY-JONES SYNDROME	0.000545554	0.01926264933828315
HYDROXYKYNURENINURIA	0.000545554	0.01926264933828315
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.01926264933828315
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.01926264933828315
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01926264933828315
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.01926264933828315
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.01926264933828315
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.01926264933828315
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.01926264933828315
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.01926264933828315
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.01926264933828315
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.01926264933828315
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.01926264933828315
HYPERTRICHOSIS CUBITI	0.000545554	0.01926264933828315
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.01926264933828315
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.01926264933828315
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.01926264933828315
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.01926264933828315
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.01926264933828315
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.01926264933828315
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.01926264933828315
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.01926264933828315
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.01926264933828315
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.01926264933828315
TRISOMY 12P	0.000545554	0.01926264933828315
SAY-BARBER-MILLER SYNDROME	0.000545554	0.01926264933828315
HEREDITARY OROTIC ACIDURIA	0.000545554	0.01926264933828315
ZECHI-CEIDE SYNDROME	0.000545554	0.01926264933828315
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.01926264933828315
HOLMES-GANG SYNDROME	0.000545554	0.01926264933828315
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.01926264933828315
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.01926264933828315
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.01926264933828315
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.01926264933828315
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.01926264933828315
LIG4 SYNDROME	0.000545554	0.01926264933828315
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.01926264933828315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.01926264933828315
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.01926264933828315
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.01926264933828315
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.01926264933828315
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.01926264933828315
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.01926264933828315
TRISOMY 8Q	0.000545554	0.01926264933828315
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.01926264933828315
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.01926264933828315
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.01926264933828315
NOONAN SYNDROME 2; NS2	0.000545554	0.01926264933828315
3Q29 MICRODELETION SYNDROME	0.000545554	0.01926264933828315
CDAGS SYNDROME	0.000545554	0.01926264933828315
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.01926264933828315
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.01926264933828315
MICROVILLUS INCLUSION DISEASE	0.000545554	0.01926264933828315
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.01926264933828315
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.01926264933828315
OXOGLUTARIC ACIDURIA	0.000545554	0.01926264933828315
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.01926264933828315
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.01926264933828315
DISTAL TRISOMY 18Q	0.000545554	0.01926264933828315
TRISOMY 9P	0.000545554	0.01926264933828315
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.01926264933828315
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.01926264933828315
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.01926264933828315
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.01926264933828315
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.01926264933828315
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.01926264933828315
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.01926264933828315
SEPTOOPTIC DYSPLASIA	0.000545554	0.01926264933828315
SECKEL SYNDROME 8; SCKL8	0.000545554	0.01926264933828315
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.01926264933828315
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.01926264933828315
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.01926264933828315
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.01926264933828315
OGDEN SYNDROME	0.000545554	0.01926264933828315
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.01926264933828315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.01926264933828315
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.01926264933828315
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.01926264933828315
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.01926264933828315
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.01926264933828315
CULLER-JONES SYNDROME; CJS	0.000545554	0.01926264933828315
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.01926264933828315
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.01926264933828315
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.01926264933828315
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.01926264933828315
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.01926264933828315
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.01926264933828315
STEEL SYNDROME; STLS	0.000545554	0.01926264933828315
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.01926264933828315
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.01926264933828315
JOUBERT SYNDROME 25	0.000545554	0.01926264933828315
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.01926264933828315
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.01926264933828315
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.01926264933828315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.01926264933828315
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.01926264933828315
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.01926264933828315
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.01926264933828315
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.01926264933828315
8P23.1 DUPLICATION SYNDROME	0.000545554	0.01926264933828315
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.01926264933828315
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.01926264933828315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.01926264933828315
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.01926264933828315
JOUBERT SYNDROME 26	0.000545554	0.01926264933828315
48,XYYY SYNDROME	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.01926264933828315
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.01926264933828315
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.01926264933828315
NOONAN SYNDROME 9; NS9	0.000545554	0.01926264933828315
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.01926264933828315
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.01926264933828315
CHOPS SYNDROME; CHOPS	0.000545554	0.01926264933828315
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.01926264933828315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.01926264933828315
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.01926264933828315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.01926264933828315
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.01926264933828315
AL-RAQAD SYNDROME; ARS	0.000545554	0.01926264933828315
MECKEL SYNDROME 13; MKS13	0.000545554	0.01926264933828315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.01926264933828315
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.01926264933828315
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.01926264933828315
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.01926264933828315
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.01926264933828315
AU-KLINE SYNDROME; AUKS	0.000545554	0.01926264933828315
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.01926264933828315
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.01926264933828315
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.01926264933828315
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.01926264933828315
BARDET-BIEDL SYNDROME 2	0.000545554	0.01926264933828315
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.01926264933828315
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.01926264933828315
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.01926264933828315
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.01926264933828315
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.01926264933828315
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.01926264933828315
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.01926264933828315
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.01926264933828315
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.01926264933828315
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.01926264933828315
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.01926264933828315
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.01926264933828315
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.01926264933828315
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.01926264933828315
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.01926264933828315
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.01926264933828315
RIDDLE SYNDROME	0.000545554	0.01926264933828315
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.01926264933828315
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.01926264933828315
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.01926264933828315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.01926264933828315
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.01926264933828315
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.01926264933828315
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.01926264933828315
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.01926264933828315
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.01926264933828315
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.01926264933828315
ALAZAMI SYNDROME; ALAZS	0.000545554	0.01926264933828315
JOUBERT SYNDROME 28	0.000545554	0.01926264933828315
OROTIC ACIDURIA	0.000545554	0.01926264933828315
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.01926264933828315
RIGID SPINE SYNDROME	0.000545554	0.01926264933828315
HOLOPROSENCEPHALY 11	0.000545554	0.01926264933828315
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.01926264933828315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.01926264933828315
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.01926264933828315
ABETAL34V AMYLOIDOSIS	0.000545554	0.01926264933828315
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.01926264933828315
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.01926264933828315
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.01926264933828315
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.01926264933828315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.01926264933828315
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.01926264933828315
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.01926264933828315
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.01926264933828315
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.01926264933828315
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.01926264933828315
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.01926264933828315
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.01926264933828315
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.01926264933828315
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.01926264933828315
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.01926264933828315
ATELOSTEOGENESIS TYPE III	0.000545554	0.01926264933828315
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.01926264933828315
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.01926264933828315
DEXTROCARDIA	0.000545554	0.01926264933828315
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.01926264933828315
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.01926264933828315
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.01926264933828315
PELLAGRA-LIKE SYNDROME	0.000545554	0.01926264933828315
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.01926264933828315
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.01926264933828315
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.01926264933828315
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.01926264933828315
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.01926264933828315
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.01926264933828315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.01926264933828315
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.01926264933828315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.01926264933828315
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.01926264933828315
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.01926264933828315
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.01926264933828315
JOUBERT SYNDROME 15	0.000545554	0.01926264933828315
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.01926264933828315
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.01926264933828315
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.01926264933828315
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.01926264933828315
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.01926264933828315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.01926264933828315
RAINE SYNDROME	0.000545554	0.01926264933828315
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.01926264933828315
OPITZ G/BBB SYNDROME	0.000545554	0.01926264933828315
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.019116649024815007
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.019116649024815007
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.019116649024815007
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.019116649024815007
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.019116649024815007
HYPER-BETA-ALANINEMIA	0.000541419	0.019116649024815007
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.019116649024815007
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.019116649024815007
EBOLA HEMORRHAGIC FEVER	0.000541419	0.019116649024815007
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.019116649024815007
KIFAFA SEIZURE DISORDER	0.000541419	0.019116649024815007
LUJO HEMORRHAGIC FEVER	0.000541419	0.019116649024815007
RAMON SYNDROME	0.000541419	0.019116649024815007
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.019116649024815007
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.019116649024815007
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.019116649024815007
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.019116649024815007
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.019116649024815007
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.019116649024815007
CYSTATHIONINURIA	0.000541419	0.019116649024815007
HEREDITARY HYPEREKPLEXIA	0.000541419	0.019116649024815007
HENNEKAM SYNDROME	0.000541419	0.019116649024815007
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.019116649024815007
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.019116649024815007
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.019116649024815007
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.019116649024815007
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.019116649024815007
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.019116649024815007
GITELMAN SYNDROME	0.000541419	0.019116649024815007
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.019116649024815007
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.019116649024815007
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.019116649024815007
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.019116649024815007
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.019116649024815007
HYPERPROLINEMIA, TYPE II	0.000541419	0.019116649024815007
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.019116649024815007
SYSTEMIC SCLEROSIS	0.000541419	0.019116649024815007
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.019116649024815007
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.019116649024815007
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.019116649024815007
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.019116649024815007
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.019116649024815007
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.019116649024815007
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.019116649024815007
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.019116649024815007
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.019116649024815007
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.019116649024815007
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.019116649024815007
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.019116649024815007
PARIETAL FORAMINA	0.000541419	0.019116649024815007
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.019116649024815007
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.019116649024815007
SNEDDON SYNDROME	0.000541419	0.019116649024815007
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.019116649024815007
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.019116649024815007
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.019116649024815007
STURGE-WEBER SYNDROME	0.000541419	0.019116649024815007
MOYAMOYA DISEASE	0.000541419	0.019116649024815007
RAMON SYNDROME	0.000541419	0.019116649024815007
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.019116649024815007
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.019116649024815007
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.019116649024815007
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.019116649024815007
LASSA FEVER	0.000541419	0.019116649024815007
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.019116649024815007
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.019116649024815007
CRONKHITE-CANADA SYNDROME	0.000541419	0.019116649024815007
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.019116649024815007
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.019116649024815007
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.019116649024815007
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.019116649024815007
PAPILLORENAL SYNDROME	0.000541419	0.019116649024815007
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.019116649024815007
DARIER-WHITE DISEASE; DAR	0.000541419	0.019116649024815007
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.019116649024815007
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.019116649024815007
FLYNN-AIRD SYNDROME	0.000541419	0.019116649024815007
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.019116649024815007
NASU-HAKOLA DISEASE	0.000541419	0.019116649024815007
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.019116649024815007
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.019116649024815007
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.019116649024815007
PORENCEPHALY	0.000541419	0.019116649024815007
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.019116649024815007
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.019116649024815007
ISOLATED BILIARY ATRESIA	0.000541419	0.019116649024815007
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.019116649024815007
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.019116649024815007
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.019116649024815007
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.019116649024815007
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.019116649024815007
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.019116649024815007
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.019116649024815007
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.019116649024815007
DIAMINOPENTANURIA	0.000541419	0.019116649024815007
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.019116649024815007
2Q33.1 DELETION SYNDROME	0.000541419	0.019116649024815007
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.019116649024815007
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.019116649024815007
ASPARTYLGLUCOSAMINURIA	0.000541419	0.019116649024815007
EPILEPSY-TELANGIECTASIA	0.000541419	0.019116649024815007
FOUNTAIN SYNDROME	0.000541419	0.019116649024815007
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.019116649024815007
FRYNS SYNDROME; FRNS	0.000541419	0.019116649024815007
BERNARD-SOULIER SYNDROME	0.000541419	0.019116649024815007
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.019116649024815007
SECONDARY SYRINGOMYELIA	0.000541419	0.019116649024815007
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.019116649024815007
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.019116649024815007
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.019116649024815007
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.019116649024815007
ALEXANDER DISEASE	0.000541419	0.019116649024815007
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.019116649024815007
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.019116649024815007
SUBEPENDYMOMA	0.000541419	0.019116649024815007
EPENDYMOMA	0.000541419	0.019116649024815007
NIPAH VIRUS DISEASE	0.000541419	0.019116649024815007
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.019116649024815007
JUVENILE HUNTINGTON DISEASE	0.000541419	0.019116649024815007
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.019116649024815007
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.019116649024815007
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.019116649024815007
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.019116649024815007
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.019116649024815007
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.019116649024815007
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.019116649024815007
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.019116649024815007
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.019116649024815007
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.019116649024815007
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.019116649024815007
MOYNAHAN SYNDROME	0.000541419	0.019116649024815007
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.019116649024815007
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.019116649024815007
MYASTHENIA GRAVIS	0.000541419	0.019116649024815007
RECURRENT ACUTE PANCREATITIS	0.000541419	0.019116649024815007
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.019116649024815007
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.019116649024815007
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.019116649024815007
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.019116649024815007
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.019116649024815007
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.019116649024815007
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.019116649024815007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.019116649024815007
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.019116649024815007
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.019116649024815007
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.019116649024815007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.019116649024815007
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.019116649024815007
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.019116649024815007
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.019116649024815007
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.019116649024815007
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.019116649024815007
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.019116649024815007
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.019116649024815007
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.019116649024815007
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.019116649024815007
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.019116649024815007
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.019116649024815007
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.019116649024815007
PERRAULT SYNDROME 3	0.000541419	0.019116649024815007
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.019116649024815007
NEVUS COMEDONICUS SYNDROME	0.000541419	0.019116649024815007
EPISODIC ATAXIA, TYPE 6	0.000541419	0.019116649024815007
LHERMITTE-DUCLOS DISEASE	0.000541419	0.019116649024815007
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.019116649024815007
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.019116649024815007
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.019116649024815007
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.019116649024815007
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.019116649024815007
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.019116649024815007
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.019116649024815007
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.019116649024815007
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.019116649024815007
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.019116649024815007
KLEEFSTRA SYNDROME	0.000541419	0.019116649024815007
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.019116649024815007
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.019116649024815007
ADIPOSIS DOLOROSA	0.000541419	0.019116649024815007
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.019116649024815007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.019116649024815007
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.019116649024815007
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.019116649024815007
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.019116649024815007
LISSENCEPHALY 3; LIS3	0.000541419	0.019116649024815007
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.019116649024815007
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.019116649024815007
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.019116649024815007
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.019116649024815007
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.019116649024815007
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.019116649024815007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.019116649024815007
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.019116649024815007
HYPERPROLINEMIA TYPE 1	0.000541419	0.019116649024815007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.019116649024815007
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.019116649024815007
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.019116649024815007
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.019116649024815007
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.019116649024815007
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.019116649024815007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.019116649024815007
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.019116649024815007
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.019116649024815007
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.019116649024815007
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.019116649024815007
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.019116649024815007
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.019116649024815007
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.019116649024815007
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.019116649024815007
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.019116649024815007
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.019116649024815007
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.019116649024815007
PSEUDO-TORCH SYNDROME 2	0.000541419	0.019116649024815007
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.019116649024815007
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.019116649024815007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000541419	0.019116649024815007
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.019116649024815007
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.019116649024815007
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.019116649024815007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.019116649024815007
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.019116649024815007
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.019116649024815007
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.019116649024815007
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.019116649024815007
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.019116649024815007
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.019116649024815007
LIPOID PROTEINOSIS	0.000541419	0.019116649024815007
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.019116649024815007
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.019116649024815007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.019116649024815007
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.019116649024815007
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.019116649024815007
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.019116649024815007
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.019116649024815007
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.019116649024815007
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.019116649024815007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.019116649024815007
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.019116649024815007
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.019116649024815007
COWDEN SYNDROME 5; CWS5	0.000541419	0.019116649024815007
COWDEN SYNDROME 6; CWS6	0.000541419	0.019116649024815007
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.019116649024815007
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.019116649024815007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.019116649024815007
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.019116649024815007
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.019116649024815007
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.019116649024815007
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.019116649024815007
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.019116649024815007
PORPHYRIA	0.000541419	0.019116649024815007
ALZHEIMER DISEASE 3; AD	0.000541419	0.019116649024815007
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.019116649024815007
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.019116649024815007
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.019116649024815007
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.019116649024815007
ENCEPHALITIS LETHARGICA	0.000541419	0.019116649024815007
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.019116649024815007
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.019116649024815007
SCRUB TYPHUS	0.000541419	0.019116649024815007
CENTRAL DIABETES INSIPIDUS	0.000541419	0.019116649024815007
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.019116649024815007
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.019116649024815007
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.019116649024815007
MERCURY POISONING	0.000541419	0.019116649024815007
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.019116649024815007
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.019116649024815007
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.019116649024815007
FABRY DISEASE	0.000541419	0.019116649024815007
TETRASOMY 18P	0.000541419	0.019116649024815007
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.019116649024815007
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.019116649024815007
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.019116649024815007
GRISCELLI SYNDROME TYPE 2	0.000541419	0.019116649024815007
PORPHYRIA VARIEGATA	0.000541419	0.019116649024815007
HHHH SYNDROME	0.000541419	0.019116649024815007
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.019116649024815007
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.019116649024815007
THYROCEREBRORENAL SYNDROME	0.000541419	0.019116649024815007
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.019116649024815007
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.019116649024815007
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.019116649024815007
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.019116649024815007
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.019116649024815007
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.019116649024815007
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.019116649024815007
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.019116649024815007
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.019116649024815007
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.019116649024815007
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.019116649024815007
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.019116649024815007
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.019116649024815007
THYROCEREBRORETINAL SYNDROME	0.000541419	0.019116649024815007
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.019116649024815007
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.019116649024815007
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.019116649024815007
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.019116649024815007
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.019116649024815007
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.019116649024815007
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.019116649024815007
FRONTAL ENCEPHALOCELE	0.000541419	0.019116649024815007
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.019116649024815007
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.019116649024815007
ATKIN-FLAITZ SYNDROME	0.000541419	0.019116649024815007
ADDISON DISEASE	0.000541419	0.019116649024815007
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.019116649024815007
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.019116649024815007
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.019116649024815007
CLARK-BARAITSER SYNDROME	0.000541419	0.019116649024815007
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.019116649024815007
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.019116649024815007
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.019116649024815007
EPISODIC ATAXIA TYPE 3	0.000541419	0.019116649024815007
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.019116649024815007
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.019116649024815007
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.019116649024815007
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.019116649024815007
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.019116649024815007
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.019116649024815007
GALACTOSIALIDOSIS	0.000541419	0.019116649024815007
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.019116649024815007
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.019116649024815007
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.019116649024815007
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.019116649024815007
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.019116649024815007
BETA-MANNOSIDOSIS	0.000541419	0.019116649024815007
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.019116649024815007
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.019116649024815007
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.019116649024815007
RABIES	0.000541419	0.019116649024815007
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.019116649024815007
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.019116649024815007
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.019116649024815007
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.019116649024815007
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.019116649024815007
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.019116649024815007
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.019116649024815007
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.019116649024815007
WORSTER-DROUGHT SYNDROME	0.000541419	0.019116649024815007
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.019116649024815007
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.019116649024815007
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.019116649024815007
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.019116649024815007
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.019116649024815007
ROSAÏ-DORFMAN DISEASE	0.000541419	0.019116649024815007
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.019116649024815007
MOGS-CDG	0.000541419	0.019116649024815007
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.019116649024815007
ALG2-CDG	0.000541419	0.019116649024815007
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.019116649024815007
VIRAL HEMORRHAGIC FEVER	0.000541419	0.019116649024815007
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.019116649024815007
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.019116649024815007
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.019116649024815007
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.019116649024815007
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.019116649024815007
CRISPONI SYNDROME	0.000541419	0.019116649024815007
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.019116649024815007
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.019116649024815007
HEREDITARY COPROPORPHYRIA	0.000541419	0.019116649024815007
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.019116649024815007
GURRIERI SYNDROME	0.000541419	0.019116649024815007
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.019116649024815007
WHIPPLE DISEASE	0.000541419	0.019116649024815007
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.019116649024815007
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.019116649024815007
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.019116649024815007
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.019116649024815007
